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Abstract
Murine embryonic stem cells are derived from the inner cell mass of a pre-implantation mouse
blastocyst. According to the conditions in which they are cultured, these cells exhibit dual
defining characteristics of indefinite self-renewal and pluripotent differentiation. This thesis
sought to explore two different methods of functional genetic analysis of embryonic stem cells,
namely antisense gene trapping and RNA interference.
Antisense gene trapping in embryonic stem cells involves the sequential genomic integration of
two vectors: the first to randomly trap active gene promoters and the second to induce functional
antisense gene knockout. These putative "knockout" clones were screened for mutant phenotypes
using a methylcellulose differentiation assay. However, for reasons of technical inefficiency and
biological variability, such a screening strategy proved to be experimentally impractical. Instead,
clones were selected according to the sequence identity of the trapped locus. Five such gene-trap
clones were characterised (Tsix, Catns, Rex2, Nasp, and Ctbp2) and the analyses of these clones
are presented.
RNA interference involves the targeted knockdown of a known gene via the action of a sequence-
homologous double-stranded RNA molecule. In mammalian cells, gene knockdown can be
achieved using short interfering RNA duplexes 19-21 base pairs in length. Using various
mammalian cell lines, the nature of this interference process is characterised and shown to operate
predominantly at the transcriptional DNA level, rather than the post-transcriptional mRNA level
as exhibited by Drosophila cells. The use of RNA interference to study embryonic stem cell
biology is explored including demonstration of knockdown of the maintenance methyltransferase
gene, Dnmtl, that results in significant demethylation of genomic DNA.
Antisense gene trapping and RNA interference represent two complementary strategies for the
functional genetic analysis of the mammalian cell. In both cases, the goal is to correlate genotype
with phenotype, or vice versa, through the bi-allelic knockdown of a target gene. By contrast with
one another, while gene trapping has the potential to define novel genes according to their
function, RNA interference can only be used for known genes whose functions are predicted from
their respective sequences. Intriguingly, both methodologies involve double-stranded RNA
suggesting a commonality of underlying molecular mechanism: in the case of antisense gene
trapping this is generated endogenously, while in the case of RNA interference it is introduced
exogenously in the form of short duplexes. In this manner, double-stranded RNA represents a
unifying thread to this thesis.
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Jacques Monod, in his essays on the natural philosophy of modern biology, claimed that evolution
is without purpose and driven only by "chance and necessity". The same might also be said of a
PhD thesis. When the work for this thesis was commenced in 1999, the phenomenon of RNA
interference had only recently been described and it was not until two years later that mammalian
genes were first shown to be silenced using short interfering RNA duplexes. But the pace of
scientific discovery is unrelenting and, since then, the use of double-stranded RNA to manipulate
gene expression has almost become routine in the laboratory with genome-wide libraries of
molecules now available for high-throughput cellular analysis using phenotypic screens.
However, more often than not, RNA interference is being used merely as a convenient genetic
tool. This thesis has attempted to answer some basic mechanistic questions about how double-
stranded RNA silences genes in mammalian cells. Some of the findings presented here have been
corroborated by published data elsewhere while others remain admittedly contentious. Either
way, in reading this work, it should be borne in mind that the experimental results were generated
over the period between 1999 and 2002 when RNA interference, as applied to mammalian
systems, was still in its infancy.
The other major landmark in biology to occur during the period of completion of this thesis was
the publication of the human (and mouse) genome, a resource that is now almost taken for granted
but which represents the remarkable culmination of fifty years of modern molecular biology since
the discovery of the double helix. As testament to this, the gene sequence of the first gene trap
clone generated in the course of experimental work presented here was that of an X-linked gene of
unknown function that was not pursued further. However, it was only in revisiting this sequence
four years later, during the write-up of this thesis, that its identity was revealed as being Tsix, a
key player in coordinating X chromosome inactivation.
Finally, there is no little irony in the fact that the two methods of gene silencing presented in this
thesis, namely antisense gene trapping and RNA interference, share with one another a similar
mechanism that involves the generation of double-stranded RNA. In antisense gene trapping, this
is produced endogenously and envisioned to inhibit gene expression via an antisense mechanism,
while in RNA interference, it is introduced exogenously in the form of short RNA duplexes and
the mechanism is assumed to be one of homology-driven mRNA cleavage. However, this
mechanistic overlap between the two methodologies was not obviously evident at the outset of the
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Chapter 1 - Introduction
1.1 INTRODUCTION
1.1.1 What is life?
Molecular biology was born sixty years ago with the publication of Erwin Schrodinger's classic
book, "What Is Life?''''. In it, the Austrian physicist, and father of quantum wave mechanics,
reflected upon the essence of living organisms, which hitherto had remained almost a complete
mystery to science (Ref: Schrodinger E., What is Life? The Physical Aspect of the Living Cell,
published 1944/ Schrodinger argued that life might be thought of as the expression of biological
information contained within a "hereditary code-script" whose structure would be that of an
"aperiodic crystal". Through its internal arrangement of atoms, such a material would contain all
the instructions necessary for making a living organism. Less than ten years later, the nature of
this aperiodic crystal was elucidated by Watson and Crick, both strongly influenced by
Schrodinger's writings, in their unravelling of the structure of deoxyribonucleic acid, or DNA
(Ref: Watson J.D. and Crick F.H., 1953a). Their remarkable insight, based upon the crystal
diffraction data of Wilkins and Franklin, revealed that this "life substance" comprised a non¬
repeating sequence of sugar bases contained within a linear molecular chain (Refs: Franklin R.E.
and Gosling R.G., 1953; and Wilkins M.H. et al., 1953). Moreover, the very structure of the DNA
molecule embodied a clear mechanism for the copying of this coded sequence, something that had
long been recognised as being a necessary property of life's genetic material (Ref: Watson J.D.
and Crick F.H., 1953b).
Fifty years on from this seminal discovery, an international collaborative effort has succeeded in
unravelling the entire DNA sequence of over three billion letters that comprises the human
genome, the so-called "book of life" (Refs: Lander E.S. et al., 2001; McPherson J.D. et al., 2001;
Venter J.C. et al., 2001; International Human Genome Sequencing Consortium, 2004). This
landmark achievement denotes the start of a new era in the exploration of human biology.
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1.1.2 The language of life
DNA is comprised of four chemical bases, adenine (A), guanine (G), thymine (T), and cytosine
(C), arranged in a non-repeating sequence. The discrete nature of this sequence of letters is akin to
the digital nature of computing language and represents the fundamental hallmark feature of any
information-containing system. The encoding of biological information in such a manner
underpins the two defining antagonistic properties of Darwinian evolution, namely the heredity of
phenotypic features via a high-fidelity copying process and the emergence of new phenotypic
features via perturbation of the sequence through copying errors. This emergence of new features
in an organism, and their subsequent inheritance in the progeny, gave rise to the notion of the gene
as the basic unit of heredity. In eukaryotic organisms, two copies of each gene are inherited and
segregated singly into the germ cells, then paired up at random via fertilisation allowing shuffling
of hereditary units at each generation. The deciphering of the "genetic code" in the early 1960s
heralded the defining of the gene as a molecular entity and gave birth to the notion of genotype as
the molecular correlate of phenotype. The understanding of the genotypic basis of cell and
organism phenotype remains the overarching goal ofmolecular biology today.
1.1.3 Syntax and semantics
The "Central Dogma" of biology states that the flow of information in a cell is unidirectional from
the nucleic acid to the protein: the gene, defined by its sequence of nucleotides in the DNA, is
transcribed into a mobile molecule, the messenger RNA, that becomes translated into the protein
which is responsible for enacting the gene's proscribed function. Using a figurative analogy, a
computer program comprises a string of digital information that is transcribed into letters of the
alphabet and translated into words on this page. To extend this analogy further, the code of a
computer program must follow certain syntactical rules in order to generate the correct semantic
output (Ref: Hofstadter D.R. Godel, Escher, Bach, published 1980). Such is the case also with the
3
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genotype and the phenotype. The exhaustive identification of genes in the human genome
represents a remarkable achievement, but the identification of the rules of grammar, the syntax of
the genome, is far from complete. In a multicellular organism, this encompasses not only which
gene is transcribed and translated but when and where this occurs. The "genetic syntax"
responsible for coordinating the temporal and spatial expression of genes is necessarily embedded
in the primary code of the DNA contained in the fertilised egg. The "semantic consequence" of
this process is the coordinated interaction of myriad different proteins whose interacting functions
determine cell behaviour and lead to development of an organism.
1.1.4 What is differentiation?
The totipotency of a fertilised egg refers to the remarkable feat whereby, given the right
environment, it will develop into a multicellular organism composed of differentiated tissues. The
demonstration, originally in amphibians (Ref: Gurdon J.C. et al., 1958) and more recently in
mammals (Ref: Campbell K.H. et al., 1996), that an apparently normal animal can be produced
following enucleation of the egg and the transfer of a donor nucleus derived from a somatic cell,
reveals that the genome contained in committed cells is the same as that of the original egg. The
further implication is that it is the intracellular environment of the egg that is able to "re-boot" the
somatic cell derived genome and re-initiate the developmental program. This developmental
program is characterised by a cascade of coordinated gene expression regulated spatially and
temporally by feedback loops impinging on the genome. The dissection of this interplay between
the genome and the microenvironment of the nucleus, which in turn is influenced by cytoplasmic
and extracellular factors, represents a seemingly insurmountable challenge. However, while the
complete description of differentiation in all its detail might not be fully realisable, its
comprehension in broad principle should be. One experimental tool that has yielded countless
insights into this differentiation process is the murine embryonic stem cell that provides an in vitro
model of in vivo development.
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1.1.5 Revealing gene function
While the cell is clearly more than the sum of all its genes, nonetheless the reductionist approach
to elucidating gene function has served cell biology well over the past fifty years. This permits
function to be ascribed to the gene in terms of the cellular phenotype yielded when the gene is
deleted from the cell's repertoire. The bringing together of genotype and phenotype in this
manner represents the overarching goal of molecular biology and has traditionally been achieved
in one of two ways. The classical approach, or forward genetics, has been to isolate mutants
defined in terms of a suitable biological screen and identify the causative gene lesion. The
alternative approach, or reverse genetics, involves the isolation of the gene on the basis of its
sequence or structure and its functional deletion, or mutagenisation, by appropriate means. These
two approaches are exemplified in this thesis by two contrasting strategies: the forward genetic
approach employs a novel variation of gene trapping to identify genes important to differentiation
in murine ES cells; while the reverse genetic approach takes advantage of a biological process
termed RNA interference to knockdown expression of pre-determined genes in murine ES cells as
well as other cell lines. The nature of gene trapping and the biology of RNA interference are
described in greater detail below, while the rationale for the use of these two approaches in the
context of the current thesis is outlined thereafter.
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1.2 EMBRYONIC STEM CELLS
1.2.1 Introduction
Embryonic stem (ES) cells are pluripotent cells derived from pre-implantation mouse embryos via
dissection and culture of the inner cell mass of a developing blastocyst (Ref: Evans M.J. and
Kaufman M.H., 1981). While maintained on embryonic fibroblasts and grown in the presence of
Leukaemia Inhibitory Factor (LIF; also known as Differentiation Inhibiting Activity, or DIF),
murine ES cells exhibit indefinite self-renewal (Refs: Williams R.L. et al. 1988; Smith A.G. et al.,
1988). However, if introduced into a host blastocyst, ES cells will contribute to all tissue lineages
resulting in production of a chimaeric mouse (Ref: Bradley A. et al., 1984), or using tetraploid
blastocysts wholly ES-derived mice (Ref: Wang Z.Q. et al., 1997). This includes contribution to
the germ cells allowing passage of the ES genome into the progeny and testifying to totipotency of
the ES cell. This is the basis whereby mouse models, carrying discrete genetic mutations, can be
generated using appropriately manipulated ES cells. This includes both knockout animals by gene
deletion through homologous recombination and over-expressing animals by introduction of a
transgene under a powerful promoter.
While ES are best maintained in an undifferentiated state by culture on embryonic fibroblasts, it
was demonstrated early on that recombinant LIF on its own is sufficient for culture of
undifferentiated ES cells even in the absence of so-called feeders (Ref: Pease S. et al., 1990) and
moreover for the isolation of new ES cell lines (Ref: Nichols J. et al., 1990). ES cells that are
removed from the presence of LIF, or intimacy with embryonic fibroblasts, cease exhibiting self-
renewal activity and instead undergo spontaneous differentiation into various lineages according
to the culture conditions. Differentiation of ES cells in vitro has provided a powerful model
system for addressing questions regarding lineage commitment that are less readily addressed in
vivo. The most widely utilised approach has been to seed ES cells in methylcellulose and generate
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clonal proliferations called embryoid bodies (EBs) that show evidence of mimicking early
embryogenesis. This is reflected by the expression of genes indicative of primitive endoderm and
mesoderm (Ref: Keller et al., 1993). Moreover, after extended periods of culture, EBs can
generate cells of haematopoietic (Ref: Wiles M.V. et al., 1991), endothelial (Ref: Risau W. et al.,
1988), muscle (Ref: Robbins J. et al., 1990) and neuronal (Ref: Bain G. et al., 1995) lineages.
Thus, ES cell differentiation in vitro appears to closely recapitulate that of embryo development in
vivo highlighting the value of ES cells as a model for the study of lineage commitment (Ref:
Keller G.M., 1995).
Thus, ES cells exhibit dual defining criteria: one is the ability to undergo indefinite self-renewal in
an undifferentiated state while the other is the ability to undergo pluripotent differentiation when
so induced. The POU transcription factor Oct4 appears to play an essential role in both the
maintenance of this undifferentiated state and the initiation of normal differentiation as revealed
by the observation that cells derived from the inner cell mass of Oct4-deficient embryos are not
pluripotent (Ref: Nichols J. et al., 1998). Indeed, it is the precise level of expression of the Oct4
locus that determines ES cell fate as revealed by the fact that both up and down-regulation of the
gene, from normal self-renewal levels, induce divergent developmental programs (Ref: Niwa H. et
al., 2000). The role of LIF in this molecular switching process appears to be mediated through a
receptor complex comprising the LIF receptor subunit (LIF-R) and the signal transducer gpl30.
However, the findings that embryos lacking LIF-R or gpl30 can develop beyond gastrulation
provide experimental evidence for existence of one or more alternative pathways governing the
maintenance of pluripotent state (Ref: Dani C. et al., 1998). This was verified by the
identification of the homeodomain protein, Nanog, which directs propagation of undifferentiated
ES cells and is not expressed in differentiated cells (Ref: Chambers I. et al., 2003). Endogenous
Nanog acts in parallel with LIF-induced activation of Stat3 to drive ES cell self-renewal via
maintenance of Oct4 levels and establishes a central role for Nanog in the transcription factor
hierarchy that defines ES cell identity (Ref: Mitsui K. et al., 2003).
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Recent interest in ES cells has been further fuelled by the isolation of cells from human
blastocysts that exhibit features akin to those derived from mice (Ref: Thomson J.A. et al., 1998).
These human ES cells proliferate in an undifferentiated state while maintaining the capacity for
pluripotent differentiation under appropriate conditions. More recently, the feasibility of isolating
human ES cells from cloned blastocysts derived by somatic cell nuclear transfer has also been
realised (Ref: Hwang W.S. et al., 2004). However, despite these advances, knowledge of the
broad principles regulating the pluripotent state, let alone precise understanding of the molecular
cascade that regulates differentiation, remain surprisingly limited.
1.2.2 Maintenance of ES cells in an undifferentiated state
As outlined above, Es cells can be maintained in an undifferentiated state by co-culture with
mouse embryonic feeder cells (Ref: Evans M.J. and Kaufman M.H., 1981). LIF was subsequently
identified as one of the feeder-cell-derived molecules that plays a pivotal role in this process (Ref:
Smith et al., 1992) and, in the presence of suitable batches of foetal calf serum, this is sufficient to
replace the feeder cells altogether and maintain an undifferentiated ES cell state. More recently,
BMP4 has also been shown to play a key role in ES cell growth (Ref: Ying Q.L. et al., 2003) and
in the presence of LIF can supplant the need for serum. Thus, it is now possible to grow ES cells
with defined factors in the absence of both feeder cells and serum.
Molecular analyses have revealed that LIF functions through the gpl30 activation of STAT3 (Ref:
Niwa et al., 1998), whereas BMP4 signalling appears to by mediated via Smad activation leading
to induction of helix-loop-helix Id factors. In addition to STAT3 and Id, two other transcription
factors, Oct3/4 (Ref: Niwa H. et al., 2000) and nanog (Ref: Chambers I. et al., 2003; Matsui K. et
al., 2003), have been shown to play pivotal roles in maintaining ES cells in an undifferentiated
state.
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1.2.3 Differentiation of ES cells in culture
ES cells will exhibit spontaneous differentiation when removed from the factors that would
otherwise maintain them in an undifferentiated state. This differentiation will yield progeny
identifiable as belonging to one of the three embryonic germ layers, mesoderm, ectoderm, and
endoderm (Ref: Keller G., 1995). Interestingly, wild-type ES cells are unable to differentiate into
trophoectoderm in culture reflecting the potential of their founder embryonic population, the inner
cell mass.
Broadly speaking, there are two general approaches for studying ES cell differentiation. The first
is to allow the ES cells to form embryoid bodies. These can be generated either by aggregation in
medium, for instance suspending in hanging drops, (Ref: Doetschman T.C. et al., 1985) or by
clonal expansion, such as by seeding in semi-solid methylcellulose (Ref: Keller G., 1995). The
alternative strategy is to culture the differentiating ES cells as a monolayer. This might be
achieved either using stromal cells such as the OP9 cell line (Ref: Nakano T. et al., 1994) or on
extracellular matrix proteins (Ref: Nishikawa S.I. et al., 1998). Both embryoid body formation
and monolayer differentiation have their respective advantages and disadvantages. Embryoid
bodies retain some semblance of three-dimensional structure that retains important cell-cell
interactions important for certain developmental programs. Conversely, the complexity of
embryoid body differentiation can complicate the interpretation of experiments where factors
determining lineage commitment are being sought. The latter is sometimes better dissected out
using two-dimensional monolayer growth despite the fact this loses some of the physiology of
normal embryonic development. Indeed, it is often a combination of both methodologies that has
been employed for analysing ES cell differentiation and in this regard the haematopoietic lineage
represents probably the best characterised. Here, the processes determining ES cell lineage
commitment appear to closely mimic normal haematopoietic development in the early embryo
making in vitro ES cell differentiation an especially valuable research tool.
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1.2.4 Haematopoietic development in the embryo
Haematopoiesis in the early embryo arises initially at two distinct sites. These are the extra¬
embryonic yolk sac and shortly thereafter an intra-embryonic region termed the aorto-gonado-
mesonephros, or AGM (Ref: Medvinsky A. and Dzierzak E., 1996). Haematopoietic development
in these two sites appears to follow different genetic programs referred to respectively as primitive
and definitive haematopoiesis. Primitive haematopoiesis, occurring in the yolk sac within distinct
blood islands, gives rise to primitive erythrocytes that are large and nucleated and contain an
embryonic form of haemoglobin. By contrast, definitive haematopoiesis, occurring within the
AGM, gives rise to erythroid cells that undergo enucleation prior to entering the bloodstream, are
smaller than those ofprimitive lineage and produce adult forms of haemoglobin.
The other major defining criterion that distinguishes primitive from definitive haematopoiesis
relates to their potential for giving rise to so-called haematopoietic stem cells. Primitive
haematopoiesis, occurring in the yolk sac, appears unable to give rise to haematopoietic stem cells
while definitive haematopoiesis, occurring initially in the AGM, is able to give rise to such cells,
which are defined by their ability for multi-lineage repopulation of the bone marrow. Of some
relevance in this regard is the fact that the generation of haematopoietic stem cells from ES cells
remains a major challenge to investigators in the field and, to date, efforts to identify such cells
using ES cell culture have largely met with failure (Ref: Keller G., 2005). Only by forced over-
expression of the HoxB4 gene in ES cells has it been possible to derive haematopoietic stem cells
that are able to repopulate primary recipients with significant levels of engraftment (Ref: Kyba M.
et al., 2002). [A more recent paper showing bone marrow reconstitution of irradiated recipients
using CD45+c-kit+ cells isolated from day 7-10 EBs is yet to be formally reproduced (Ref: Burt
R.K. et al., 2004)]. With the isolation of human ES cells, the derivation of potentially limitless
haematopoietic stem cells from ES cell culture, for the purpose of therapeutic marrow rescue,
represents a highly desirable goal.
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1.2.5 Haematopoietic differentiation of ES cells
For the ES cell system to be valid model of early haematopoietic development, and ultimately a
source of haematopoietic stem cells, it has been necessary to demonstrate that in vitro ES cell
differentiation closely recapitulates the genetic and transcriptional program of the embryo.
Several different studies have demonstrated striking parallels between the ES cell model and the
early embryo, providing important insights into the embryonic origins of the haematopoietic
system (Ref: Keller G., 2005). Lineage commitment in ES cell culture can be followed in a
number of ways: by monitoring gene expression patterns (Ref: Schmitt R. et al., 1991); by noting
the appearance of specific cell surface markers (Ref: Kabrun N. et al., 1997); and by the
development of clonable progenitor cells (Ref: Keller G. et al., 1993). In optimised culture
conditions following serum induction, ES cells will undergo haematopoietic differentiation with
over 50% of cells expressing the haematopoietic/vascular receptor tyrosine kinase Flk-1 (Ref:
Kabrun N. et al., 1997) and up to 5% can represent a clonable haematopoietic progenitor (Ref:
Keller G. et al., 1993). Detailed analyses of the early stages of haematopoietic commitment have
shown that both gene expression patters and the kinetics of lineage development within EBs
accurately reflect that found in the yolk sac (Ref: Robertson S.M. et al., 2000). This is
characterised by the transient appearance of the primitive erythroid lineage arising within EBs at
around 4 days followed by the macrophage, definitive erythroid, and mast cell lineages occurring
in the same temporal order as found in the yolk sac. Lymphoid progenitors and haematopoietic
stem cells have not been identified among the progeny of the early stage EBs, suggesting that the
initial stages ofEB haematopoiesis represent the equivalent of yolk sac haematopoiesis.
The faithful recapitulation of haematopoietic development in the yolk sac provides good evidence
that the ES/EB model is similar, if not identical, to that of the early embryo. Further support for
this interpretation is provided by gene targeting studies that have helped to define the role of
specific transcription factors. These include Scl/tal-1 (Ref: Begley C.G. et al., 1989), Runxl (Ref:
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Wang S.W. and Speck N.A., 1992), and GATA-1 (Ref: Orkin S.H., 1992) in the establishment of
the haematopoietic system. Each of these three factors have been shown to play key roles at
certain stages of blood cell differentiation such that Scl/tal-1 is required for the development of all
haematopoietic lineages, Runxl for the definitive lineages but not primitive erythropoiesis, and
GATA-1 for late-stage primitive and definitive erythroid maturation. All of these three defects
have been accurately replicated in vitro using the ES cell differentiation model, once again
validating the notion that embryoid bodies faithfully mimic embryonic haematopoiesis and in so
doing provide an exceedingly versatile tool for functional gene analysis.
The single most useful by-product of the ES cell differentiation model is the fact that it provides
insights to early developmental stages that are otherwise difficult to access in the embryo. One
particular area of controversy that the model has shed light upon is the long-standing hypothesis
that the haematopoietic and endothelial lineages develop from a common progenitor known as the
haemangioblast. Formal demonstration that such a progenitor does indeed exist was provided by
studies using the ES differentiation model (Ref: Choi K. et al., 1998; Nishikawa S. et al., 1998).
Carefully timed analysis of very early EBs led to the identification of a progenitor known as the
blast colony-forming cell (BL-CFC) that gives rise to blast colonies consisting of haematopoietic
and vascular progenitors in methylcellulose cultures in the presence of vascular endothelial growth
factor (Ref: Kennedy M. et al., 1997). Subsequent studies have shown this progenitor expresses
the receptor tyrosine kinase Flk-1, the transcription factor Runxl, and the mesoderm gene
brachyury, suggesting it might represent a subpopulation of mesoderm undergoing commitment to
the haematopoietic and vascular lineages. Recently, a similar progenitor has been demonstrated in
the early mouse embryo confirming that BL-CFC is not an artefact of the ES cell model and that
this entity is the best candidate for the illusive haemangioblast (Ref: Huber T.L. et al., 2004).
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1.3 GENE TRAPPING
1.3.1 Trapping genes in embryonic stem cells
Gene trapping in embryonic stem cells represents an efficient approach to the functional analysis
of the murine genome (Refs: Joyner A.L., 1991; Evans M.J. et al., 1997). In essence, gene
trapping involves the random integration of a gene trap vector into genomic DNA. Where the site
of insertion is within intronic DNA, the gene trap vector will be transcribed by the upstream
promoter of the host gene. The resultant RNA transcript will then undergo nuclear processing
whereupon the gene trap vector sequence is spliced into the mRNA via its own splice donor site
and becomes contiguous with the gene's upstream exons (Refs: Skarnes W.C., 1993; Cecconi F.
and Meyer B.I., 2000). The basic design of the gene trap vector comprises an antibiotic resistance
gene in tandem with a reporter gene, thereby permitting selection of successful gene trap clones
and the monitoring of the transcriptional activity of the trapped promoter in the cell (Ref: Skarnes
W.C., 1992). Typically, the reporter gene is P-galactosidase and the selection gene is neomycin
phosphotransferase (Ref: Friedrich G. and Soriano P., 1991) although the hygromycin
phosphotransferase gene has also been successful utilised for gene trapping purposes (Ref:
Natarajan D. and Boulter C.A., 1995). Gene trapping in ES cells represents an efficient approach
to the functional analysis of the murine genome since it couples gene discovery with genomic
mapping and expression pattern (Ref: Townley D.J. et al., 1997). Moreover, since the integration
event results in insertional mutagenesis at the site of the trapped gene locus, it is possible via
blastocyst injection to derive chimaeric mice from which knockout animals can bred (Ref:
Auerbach W. et al., 2000). This capacity to transmit the mutated gene trap locus into the germ
line permits phenotype to be correlated with genotype and represents the most powerful facet of
ES cell gene trapping technology (Refs: Brennan J. and Skarnes W.C., 1999; Cecconi F. and
Gruss P., 2002; Chen W.V. and Soriano P., 2003).
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1.3.2 Examples of genes identified by gene trapping
The functional characterisation of genes through gene trapping is exemplified by numerous
examples: the secretory protein Sec8 required for paraxial mesoderm patterning (Ref: Friedrich
G.A. et al., 1997); a cardiac gene homologous to the human transcription factor TFEB and
repressed by retinoic acid (Ref: McClive P. et al., 1998); Bodenin, a novel gene expressed in
restricted areas of the brain (Ref: Faisst A.M. and Gruss P., 1998); Aquarius, a mesodermal gene
that is strongly induced by retinoic acid (Ref: Sam M. et al., 1998); histone 3.3A gene, associated
with sub-fertility, stunted growth, and neonatal lethality in transgenic mice (Ref: Couldrey C. et
al., 1999); Hzf and Hhl, two genes expressed during haematopoiesis and induced by culture on
OP9 cells (Ref: Hidaka M. et al., 2000); a novel gene expressed in foregut endoderm that serves as
an marker of early liver development (Ref: Watt A.J. et al., 2001); and Wnkl kinase, deficiency of
which in the heterozygous state is associated with significant fall in blood pressure (Ref:
Zambrowicz B.P. et al., 2003).
An analysis of the efficiency of the gene trap approach has been undertaken providing some
quantitative measure of its success in yielding successful integration that will lead to a null
mutation (Ref: Voss A.K. et al., 1998). Finally, other modifications of the basic gene trap vector
that incorporate a transmembrane peptide motif (Ref: Skarnes W.C., 1995) have been used to
identify and functionally analyse cell surface proteins (Ref: Skarnes W.C., 2000) and secretory
proteins (Ref: Mitchell K.J. et al., 2001). Other gene trap vector modifications have included the
incorporation of a thymidine kinase cassette for negative selection and identification of loci with
potential haematopoietic function (Ref: Cannon J.P. et al., 1999), development of a poly A trap
that allows for capture of genes that are inactive in undifferentiated ES cells but become active
during differentiation (Ref: Salminen M. et al., 1998), and the use of a GFP reporter in a poly A
trap retroviral vector that allows for reversible disruption and expression monitoring of genes in
living cells (Ref: Ishida Y. and Leder P., 1999).
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1.3.3 Strategies for screening of gene trap clones
In order to realise the undisputed potential of gene trapping for the identification and functional
analysis of novel genes in ES cells, it is necessary to incorporate an effective screening strategy
that will select those ES clones that harbour a gene trap integration within a gene of interest. Early
gene trapping established that integration events occur predominantly within genes that lie
adjacent to CpG islands (Ref: Macleod D. et al., 1991) thereby allowing identification of genes
active in ES cells. Subsequently, simple phenotypic screens were introduced that identified genes
involved in early pattern formation (Ref: Hill D.P. and Wurst W., 1993). More sophisticated
induction gene trap screens were developed to identify genes that were either induced or repressed
by the presence of retinoic acid (Ref: Forrester L.M. et al., 1996) that typically exhibited spatially
restricted or tissue-specific patterns of expression and revealed a novel family of repeat sequences
in the mouse genome responsive to retinoic acid (Ref: Sam M. et al., 1996). Differentiation
screens were developed to allow for the in vitro pre-selection of gene trapped ES clones that
exhibit [3-galactosidase expression in certain cell lineages during ES cell differentiation (Ref:
Bonaldo P. et al., 1998), thereby increasing the likelihood that blastocyst injection of the ES cells
might yield a transgenic animal carrying a tissue-specific phenotype (Refs: Baker R.K. et al.,
1997; Stuhlmann H., 2003). Such an approach has generated a mouse strain, jumonji, that exhibits
abnormal neural tube formation (Ref: Takaeuchi T., 1997). Finally, using a novel induction gene
trap strategy to screen a library of sequence tagged gene trap clones (Ref: Wiles M.V. et al., 2000)
for homeoprotein gene targets, genes such as the bullous pemphigoid antigen 1, Bpagl, gene have
been revealed and insertionally mutated (Ref: Mainguy G. et al., 2000) by gene trapping.
1.3.4 High throughput screening approaches
The gene trap methodology lends itself to the efficient identification of genes whose functional
disruption leads to a revealing biological phenotype (Ref: Joyner A.L. et al., 1992). Increasingly,
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the goal in gene trap technology is towards screening strategies that permit the high throughput
identification of key genes (Ref: Zambrowicz B.P. and Friedrich G.A., 1998). Currently, there are
of the order of approximately 35,000 genes identified by sequence and mapping of the human
genome. However, expression data is available for only a relatively small proportion of these
genes and functional data for still fewer again. Gene trap mutagenesis has established a public
resource of over 8,000 ES cell lines, each carrying a potential loss-of-function insertionally-
mutated gene ready for phenotypic analysis (Ref: Stanford W.L. et al., 2001). Early large-scale
screens simply looked for developmental ly regulated genes from an extensive library of ES gene
trap clones (Ref: Wurst W. et al., 1995) or combined expression pattern data with DNA sequence
information to provide a molecular characterisation of the trapped gene (Ref: Holzschu D. et al.,
1997). More sophisticated gene trap screens have been used for the large-scale disruption and
identification of genes involved in the development of the mammalian nervous system (Ref:
Stoykova A. et al., 1998), of genes regulated during haematopoietic differentiation of ES cells
(Ref: Muth K. et al., 1998), and of genes destined for the endothelial lineage (Ref: Stanford W.L.
et al., 1998). Recently, with the completion of the sequencing of the mouse genome, it has
become possible to undertake saturation mutagenesis of the mouse genome using gene trap vectors
to insertionally mutate a major proportion of transcribed genes (Refs: Floss T. and Wurst W.,
2002; Hansen J. et al., 2003). Such a resource of gene trap ES cell clones, each clone carrying a
sequence-tagged gene, has been made publicly available (Ref: Stryke D. et al., 2003) and can be
accessed via the website of the International Gene Trap Consortium (www.igtc.ca). This library
of cell lines has yielded a number of mutant mouse models, many of which have phenotypes that
mimic the knockout animal. Similar technologies also lie behind at least one commercial venture
(Omnibank™, Lexicon Inc.) whose stated goal is to perform saturation mutagenesis of mouse
genome in order generate a library of transgenic mice for functional gene analyses (Ref:
Zambrowicz B.P. et al., 1998). Finally, by applying expression profiling of cDNA arrays obtained
from gene trap mouse ES cell clones, it is possible to identify those genes whose absent expression
suggests likely loss-of-function disruption (Ref: Matsuda E. et al., 2004).
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1.3.5 Strategies for generating homozygous gene trap mutants
The principal shortcoming of the gene trap methodology for elucidating gene function is that it can
only lead to the loss, by random insertional mutagenesis, of one copy of the gene, thereby
rendering the cell hemizygous for the mutation. In the presence of a normal functioning copy of
the same gene on the homologous chromosome, this heterozygous state of affairs would typically
be insufficient for yielding a discernible phenotype in ES cells, thus limiting the ability to perform
recessive screens in cultured cells. As a consequence, the judgment of whether or not to derive
chimaeric animals from the gene trap clone and proceed to breeding homozygous offspring must
be based upon other data such as the expression pattern of the gene during in vitro ES cell
differentiation or its inferred function as deduced from the DNA sequence (Ref: Van de Putte T. et
al., 2001). One strategy for circumventing this problem is based upon selection of gene trap
clones for transgene homozygosity in order to create chromosome-specific loss of heterozygosity,
thereby revealing recessive mutations through perturbation of the cellular phenotype (Ref:
Lefebvre L. et al., 2001). A more refined albeit similar approach has recently been described
using ES cells that are deficient for the Bloom's syndrome protein (Blm) gene (Ref: Guo G. et al.,
2004). These cells exhibit a high rate of mitotic recombination that result in regions of loss of
heterozygosity. By appropriate selection, it is possible to isolate gene trap ES cell clones that have
undergone a chromosomal recombination event and duplication of the mutated gene, so converting
the mutation from heterozygosity into homozygosity. This method, which involves a revertible
gene trap retrovirus described previously (Ref: Ishida Y. and Leder P, 1999), has enabled the
generation of a genome-wide library ofmutant ES cell clones. By way of proof-of-principle of the
methodology, this ES library has been successfully screened to isolate clones defective in DNA
mismatch repair, revealing known and unknown genes in the process. In a similar fashion, using
appropriate in vitro screens designed to detect discrete phenotype-based recessive genetic
abnormalities, this novel approach will undoubtedly broaden the application of gene trapping by
allowing phenotype and genotype to be more closely correlated at the cell level.
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1.3.6 Functional homozygous knockouts by antisense gene trapping
A different approach that, like the one described above, aims to reveal recessive genetic mutations
in diploid cells is termed random homozygous knockout (RHKO). This strategy, also referred to
as antisense gene trapping, was originally used in NIH3T3 cells to reveal the tumour susceptibility
gene, tsglOl (Ref: Li L. and Cohen S.N. et al., 1996). Antisense gene trapping permits the
isolation of previously unknown genes encoding selectable recessive phenotypes through the
random integration of a modified gene trap vector designed to yield an antisense RNA from a
transactivated promoter. Thus, the trapped gene is homozygously disrupted, one copy through
insertional mutagenesis and the other copy via functional antisense knockout. Removal of the
transactivator, via Cre-lox recombination, permits the reversal of the antisense knockout, thereby
reverting the cell back to a heterozygous state. As applied to NIH3T3 cells, the strength of this
technique lay principally in the simplicity of the phenotypic screen, which selected cells exhibiting
a transformed phenotype by growth in 0.5% agar and then tested their tumourigenicity by
subcutaneous injection in nude mice. While claims that the human homologue of the tsglOl gene
was mutated in breast cancer (Ref; Li L. et al., 1997) proved subsequently to be erroneous (Refs:
Gayther S.A. et al, 1997; Li L. et al. 1998), persuasive evidence has now accumulated to show
that deficiency of this gene leads to genome instability (Ref: Xie W. et al., 1998) possibly on
account of its role in regulating the key cell-cycle genes Mdm2 and p53 (Ref: Li L. et al., 2001).
The latter appears to be borne out the fact that the targeted mouse knockout causes early
embryonic lethality with accumulation of p53 and defective cell proliferation (Ref: Ruland J. et
al., 2001) giving some confirmation that the original screening strategy was biologically valid.
This approach, of random homozygous knockout in NIH3T3 cells, has similarly been used to
identify three other candidate tumour suppressor genes: the vasodilator stimulated phosphoprotein
(Vasp) gene (Ref: Liu K. et al., 1999), the calpain protease (nCL-4) gene (Ref: Liu K. et al.,
2000a), and a novel RNA-binding nuclear protein termed Sam68 (Ref: Liu K. et al., 2000b).
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1.3.7 Screening functional ES gene trap knockout clones for "differentiation genes"
Based upon its proven efficacy in identifying candidate tumour susceptibility genes in NIH3T3
cells, this strategy of random homozygous knockout (RHKO) outlined above was chosen here as a
plausible experimental basis for deriving functional homozygous mutants in ES cells. The goal of
the current work was to establish a proof-of-principle for this approach, hereafter referred to as
antisense gene trapping, for the purpose of identifying recessive genes important for normal ES
cell differentiation using an in vitro methylcellulose differentiation screen for mutant ES cell
clones. The results are presented relating to the experimental efficiency of the methodology, the
functional analysis of the trapped genes, and the technical shortcomings of the screening method
chosen.
19
Chapter 1 - Introduction
1.4 RNA INTERFERENCE
1.4.1 Silencing genes by RNA interference
RNA interference (RNAi) represents an evolutionarily ancient and highly conserved biological
process that appears to be present in some form or other within most, if not all, eukaryotic
organisms. As such, it represents an evolutionary relic of the earliest life forms on earth and might
plausibly exist today as a distant echo of the so-called "RNA World", when it is proposed that
RNA may have been both the genetic material and biological catalyst for emerging life (Refs:
Joyce G.F. and Orgel L.E., 1999; Gilbert W., 1986). When exposed to foreign genetic material
(RNA or DNA), organisms mount a highly specific counter attack to silence the invading nucleic
acid before the sequence is able to integrate into the host genome or subvert cellular processes. At
the heart of this sequence-directed immunity is double-stranded RNA (dsRNA). The role of
dsRNA in the interference process was first revealed in 1998 when it was shown that such
molecules were able to mediate the potent and specific silencing of gene expression in the
nematode worm, Caenorhabditis elegans, in a sequence directed manner (Refs: Fire A. et al.,
1998). To the considerable surprise of the investigators, this interference process, which was
substantially more effective at gene silencing than either strand individually, could be produced
throughout the body of the organism distant to the site of injection and could even be propagated
to the progeny (Ref: Sharp P.A. and Zamore P.D., 2000).
With hindsight, it is clear that this interference phenomenon could explain a number of previously
recognised but hitherto poorly explained processes (Ref: Guo S. and Kemphues K.J., 1995)
whereby sense RNA had been found to be equally effective as antisense RNA in suppressing
genes in C. elegans due to overlooked contamination of each preparation with dsRNA. Moreover,
some years prior to this observation, plant biologists working with petunias had been surprised to
find that the introduction of numerous copies of a gene that codes for deep purple flowers led, not
20
Chapter 1 - Introduction
as expected, to an even darker purple hue, but rather to plants with white or patchy flowers (Refs:
Napoli C. et al., 1990; van der Krol A.R. et al., 1990). Somehow the transgenes had silenced both
themselves and the plants' own "purple flower" genes. Similarly, when plants were infected with
an RNA virus that had been genetically engineered to contain fragments of a plant gene, the gene
itself became silenced (Ref: Wassenegger M. et al., 1994).
This phenomenon of "co-suppression" in plants later came to be termed post-transcriptional gene
silencing (PTGS) and was shown to be functionally analogous to a similar process called
"quelling" identified in the fungus Neurospora crassa which, when transformed with homologous
sequences, underwent transient gene inactivation (Ref: Romano N. and Macino G., 1992). In
nematodes, the usefulness of RNAi as a tool for functional gene analysis was enhanced still
further by the discovery that genes could be efficiently silenced simply by soaking the worms in
dsRNA (Ref: Tabara H. et al., 1998) or providing food containing bacterially expressed dsRNA
(Refs: Timmons L. and Fire A., 1998; Timmons L. et al., 2001). The early realisation that RNAi
is evolutionarily highly conserved, sharing a common underlying mechanism in many organisms,
was soon followed by the demonstration of RNAi-induced gene silencing in Drosophila (Ref:
Kennerdell J.R. and Carthew R.W., 1998) as well as several other organisms, some of which were
otherwise unsuited to genetic analysis (Refs: Ngo H. et al., 1998; Bosher J.M. and Labouesse M.).
1.4.2 Short interfering RNAs (siRNAs)
Early insight into the molecular mechanism responsible for the RNA interference came from the
study of post-transcriptional gene silencing in plants which revealed that this process was
accompanied by the production of short RNA molecules, some 20 to 25 nucleotides long, that
matched the gene being silenced (Ref: Hamilton A.J. and Baulcombe D.C., 1999). These RNAs
are much shorter than typical mRNAs and ribosomal RNAs, perhaps explaining why this
fundamental process remained undiscovered until relatively recently.
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At around the same time, efforts were made to recapitulate the biochemistry of the RNAi process
in vitro using ffuitfly extracts (Refs: Tuschl T. et al., 1999; Zamore P.D. et al., 2000). These
studies demonstrated that the long dsRNAs used to trigger gene silencing in cells were diced up,
by enzymes in the extract, into short RNA molecules that shared a common structure (Ref: Tuschl
T., 2001). This structure was that of an RNA duplex comprised of two 21 nucleotide strands
paired together in a staggered fashion so by leaving two unpaired nucleotides at each ends (Ref:
Elbashir S.M. et al., 2001a). This molecular species was dubbed a short interfering RNA (siRNA)
and, in a landmark paper, it was demonstrated that these entities, when synthesised exogenously
and introduced into mammalian cells, were able to mediate sequence specific interference of co-
transfected target reporter genes (Ref: Elbashir S.M. et al., 2001b). This use of synthetic siRNAs,
21-22 nucleotides in length, were found to bypass the well-documented so-called "interferon
response", which represents a non-specific anti-viral response triggered by longer dsRNA, leaving
just the sequence-specific effect directed at the target gene (Ref: Caplen N.J. et al., 2001). This
discovery represents the first demonstration of an RNAi-induced phenotype in cultured
mammalian cells and was soon extended to the knock down of endogenous genes also, thereby
rendering the entire human genome theoretically amenable to this powerful new technology (Ref:
Harborth J. et al., 2001; Elbashir S.M. et al., 2002).
1.4.3 Processing of double-stranded RNAs
The enzyme responsible for the cleavage of dsRNA into siRNAs is termed Dicer (Ref: Bernstein
E. et al., 2001). This is an RNAse-III-type endonuclease that has a dsRNA-binding domain and a
catalytic domain (Ref: Ketting R.F. et al. 2001). Processing of the dsRNA by Dicer yields RNA
duplexes of about 21 nucleotides in length that have 5' phosphates and 2-nucleotide 3' overhangs
(Ref: Elbashir S.M. et al., 2001). Several organisms, such as Drosophila and Arabidopsis, contain
more than one Dicer gene with each Dicer preferentially processing dsRNAs that come from a
specific source, while in mammals and nematodes there appears to be only a single such enzyme.
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In the mouse, disruption of the Dicer 1 gene by targeted mutation results in embryonic lethality and
depletion of stem cells in Dicer 1 null embryos suggesting a functional link between RNA
interference and early mammalian development (Ref: Bernstein E. et al., 2003). In C. elegans,
using a screen for RNAi deficient strains, two other key genetic elements of the RNAi process, the
rde-1 and rde-4 loci, have been identified (Ref: Tabara H. et al., 1999) and shown to mediate
distinct and non-overlapping roles in the interference pathway (Ref: Parrish S. and Fire A., 2001).
1.4.4 Molecular mechanism of gene interference
Following processing of the dsRNA into siRNA duplexes by Dicer, the siRNA molecules are
incorporated into a complex of proteins termed the RNA-induced silencing complex (RISC) that
appears to be responsible for mediating the actual interference process (Ref: Hammond S.M. et
al., 2000). This siRNA-containing effector complex, which has an estimated molecular mass of
between 130 and 160 kDa in human cells (Ref: Martinez J. and Tuschl T., 2004), includes one key
component that belongs to the Argonaute (Ago) protein family and appears to be responsible for
direct binding to the RNA (Ref: Fagard M. et al. 2000). The assembly of the RISC is an ATP-
dependent process that likely reflects the requirement for energy-driven unwinding of the siRNA
that is required for sequence-specific base-pairing between the antisense strand of the duplex and
the sense strand of the target mRNA (Ref: Nykanen A. et al., 2001). The cleavage of the mRNA
within the region of complementary base pairing with the antisense strand of the siRNA results in
the post-transcriptional destruction of the gene with consequential knockdown of its expression
(Ref: Martinez J. et al., 2002). The RISC cleaves the target mRNA in the middle of the
complementary region, ten nucleotides upstream of the nucleotide paired with the 5' end of the
guide siRNA (Ref: Elbashir S.M. et al., 2001c), after which the mRNA fragments are released and
the RISC is able to mediate cleavage of further mRNA strands. In this manner, the siRNA-
induced RISC-mediated interference process is highly efficient at bringing about the functional
knock down of the target gene (Ref: Mello C.C. and Conte D., 2004).
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1.4.5 Biochemistry of the RISC
A number of different proteins have been identified as essential for RNA interference or as
components of the RISC. Of these it is the Dicer and Argonaute proteins that appear to play the
major roles in assembly and function of the RISC. Dicers are approximately 200kDa proteins and
generally contain ATPase/RNA helicase and PAZ domains, two catalytic RNase III domains, and
a C-terminal dsRNA binding domain. Their primary role is to process precursor molecules into
siRNAs and miRNAs, but the enzymes also function in downstream steps of RNAi. Vertebrates
and C. elegcms contain single Dicer genes, while Drosophila expresses at least two Dicers with
specialised functions. Of the two Drosophila Dicers, Dcr-1 functions mainly in the processing of
miRNA precursors, while Dcr-2 is required for RNAi (Ref: Lee Y.S. et al., 2004). Argonautes are
1 OOkDa proteins with characteristic PAZ and PIWI domains and are the only proteins consistently
found in all RISC and miRNP complexes. They fall into two families, namely Ago and Piwi. Of
the Ago proteins, four are ubiquitously expressed in mammals and two in Drosophila, Agol
functioning primarily in miRNA and Ago2 in RNAi pathways.
siRNA molecules are the effector molecules of RNA interference. They are short double-stranded
RNAs of which only one strand, referred to as the guide strand, is incorporated into the RISC,
while the other strand, a passenger strand, is discarded. The choice of which strand becomes
chosen for incorporation appears to be determined by whose 5'-terminus resides at the
thermodynamically less stable end of the duplex. In Drosophila, a heterodimer on one of its
Dicers, Dcr-2, and another protein termed R2D2 senses the differential stability of the duplex ends
and determines which strand will enter the RISC. The Dcr-2-R2D2-siRNA ternary complex is the
best-characterised assembly in the RISC formation pathway that pre-empts the unwinding of the
duplex within a sub-compartment termed the RISC loading complex. The Dcr-2-R2D2
heterodimer is then displaced by Ago2 which then catalyses the cleavage of the target mRNA
thereby carrying out the main functional role of the RISC.
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That the Argonaute protein is indeed the catalytic engine of the RISC was shown by the
demonstration that an active RISC can be reconstituted from a bacterially expressed human Ago2
and a single-stranded siRNA (Ref: Rivas F.V. et al., 2005). Within the resulting Ago-siRNA
complex, the 5'-phosphorylated guide strand end docks with the PIWI pocket and the opposite 3'
end contacts the PAZ domain (Ref: Tomari Y. et al., 2004). The elucidation of the crystal
structure shows that the phosphorylated 5'-terminal nucleotide of the guide strand is anchored
within a highly conserved basic pocket stabilising the binding of the siRNA. Evidence suggests
that the 5'phosphate is required for efficient unwinding and release of the passenger strand than
for subsequent steps of the RISC cycle.
Within the RISC, mRNA cleavage occurs between residues base paired to nucleotides 10 and 11
of the siRNA, and the cleavage itself does not require ATP. The guide siRNA remains associated
with the complex, allowing it to carry out multiple rounds of RNA cleavage. The turnover of the
enzyme is dependent on ATP, suggesting that release of the cleaved mRNA halves involves an
RNA helicase. Two models of Argonaute function in the RISC have been proposed. These are
the "two-state" model proposed by Tomari and Zamore (Ref: Tomari Y. and Zamore P.D., 2005)
and the "fix-ends" model (Ref: Ma J.B. et al., 2004). In essence, while the former requires
recurrent disruption of the guide-PAZ contact, the latter does not. Further evaluation of these
models is required to determine which one best describes the molecular machinery of the RISC
complex.
Finally, little is known about how the RISC processes miRNAs which are increasingly being
revealed to play important roles in normal and abnormal cellular physiology. This, together with
the further understanding of the other proteins comprising the RISC, remains a major challenge in
elucidating the mechanism ofpost-transcriptional RNA interference (Ref: Filipowicz W. 2005).
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1.4.6 Alternative theories of RNA interference
Despite the model outlined above, the complete dissection of the RNAi silencing pathway remains
to be fully elucidated. Moreover, it is also becoming increasingly apparent that there exist distinct
functional differences between various species in the exact mechanics of the interference process
(Ref: Bass B.L., 2001). Thus, a key gene family involved in the silencing pathways in plants (Ref:
Dalmay T. et al. 2000), fimgi (Ref: Cogoni C. and Macino G.. 1999), and C. elegans (Ref: Sijen T.
et al., 2001) contains genes that encode putative cellular RNA-dependent RNA polymerases
(RdRPs). Members of this family of proteins were identified in forward genetic screens and were
found in plants to be required for transgene-induced silencing but not for viral genes, perhaps
because viruses provide their own RNA polymerase. The mechanism whereby the RdRP mediates
silencing appears to be via generation of a dsRNA intermediary upon recognition of foreign
nucleic acid, which is then processed by Dicer leading to gene interference as per the classical
route. In support of this mechanism is the observation of so-called transitive RNAi whereby, in C.
elegans, dsRNA that targets one gene is able also to silence other splice variants of the gene, even
if they do not share any sequence homology (Ref: Alder M.N. et al., 2003). Such a mechanism
has led some investigators to postulate that RNAi represents a process of "random degradative
PCR" in which siRNA primers are able to convert mRNA into dsRNA that is then degraded by
Dicer into new siRNAs thereby setting up an RNA-dependent polymerase chain reaction (Ref:
Lipardi C. et al., 2001). Such a mechanism would explain, through the inherent amplification that
results from a small amount of "trigger" dsRNA, one of the most intriguing features of the
interference process, namely its remarkable potency and ability to propagate throughout an
organism (Ref: Nishikura K., 2001). However, while this theory has intrinsic appeal, it does not
appear to be broadly applicable to all organisms and nor is RNA-dependent RNA polymerase
activity an absolute requirement for successful RNAi-induced gene knockdown.
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1.4.7 Transcriptional gene silencing
As described above, there are many common features between post-transcriptional gene silencing
in plants and RNA interference in animals (Ref: Ketting R.F. and Plasterk R.H., 2000). However,
by intricate experimental dissection of the gene silencing mechanism in Arabidopsis, it appears
that the silencing effect in plants is mediated by two distinct molecular species of siRNA, one that
is 21-22 nucleotides long and the other that is 24-26 nucleotides long (Ref: Hamilton A. et al.,
2002). While the former is associated with mRNA degradation, the latter correlates more closely
with transcriptional gene repression operating via methylation of the genomic DNA (Ref:
Timmons L., 2002). This consolidates a more permanent state of gene suppression that is induced
both by transgene and viral RNAs (Refs: Mette M.F. et al., 2000; Jones L. et al., 2001). Recently
these findings have been extended by the observations that siRNA-directed DNA methylation in
plants is also linked to chromatin structure (Ref: Morel J.B. et al., 2000) and histone modification
(Refs: Zilberman D. et al., 2003). The latter discovery tallies closely with the demonstration in
fission yeast that heterochromatin formation at centromere boundaries is associated with siRNAs
(Refs: Volpe T. et al., 2002; Reinhart B.J. and Bartel D.P., 2002).
The notion that RNA interference might play a role in transcriptional regulation via chromatin
modification is an attractive one (Ref: Allshire R., 2002) and suggests that gene silencing
pathways might operate at more than one level. Such a conclusion is supported also in Drosophila
where two types of transgene silencing were revealed in the case of the alcohol dehydrogenase
unit (Ref: Pal-Bhadra M. et al., 2002), one operating transcriptionally and is Polycomb dependent
and the other operating post-transcriptionally with molecular features of classical RNAi.
Moreover, recent data suggests that the RNAi machinery itself appears to play an indispensable
role in the process that leads to heterochromatic silencing of genes in Drosophila cells (Ref: Pal-
Bhadra M. et al., 2004). Similarly, in C. elegans, using an elegant strategy whereby RNAi was
used to identity genes required for RNAi, suppression of three mes genes (mes-3, mes-4, mes-6),
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that are homologues of the Drosophila chromatin-binding Polycomb-group proteins, has identified
their critical role in mediating gene silencing (Ref: Dudley N.R. et al., 2002).
1.4.8 Role of the RNAi machinery in heterochromatin formation
Thus, it is evident that components of the RNAi machinery can be involved in nuclear processes
leading to heterochromatin formation and transcriptional gene silencing. Indeed, this process of
nuclear RNAi appears to be a natural epigenetic gene regulation mechanism that is active in most
eukaryotes and controls heritable changes in gene expression that are not caused by mutations. It
also serves as a surveillance mechanism against foreign nucleic acids, is involved in the regulation
of developmental genes, and contributes to accurate chromosome segregation during cell division.
The mechanism of RNA-mediated heterochromatin formation is perhaps best understood in S.
pombe. Here, the initial step appears to require bidirectional transcriptional of the target loci to
produce primary dsRNAs. From this, siRNAs are generated via the action of Dicer. These are
incorporated into the RNA-induced initiator of transcriptional silencing (RITS) complex via the
Argonaute protein, Agol, thereby directing the RITS to complementary sites of the genome. It is
unclear whether the RITS binds only to nascent target transcripts or pairs to corresponding DNA.
Either way, binding of the complex enables the recruitment of chromatin-modifying proteins,
including a histone H3 lysine 9 (H3K9) methyltransferase (Clr4). This appears to stabilise the
binding of the RITS to the chromatin and suggests the likelihood of RITS/DNA binding in
addition to RNA binding. Once stabilised, the RITS interacts with the RNA-directed RNA
polymerase complex leading to the generation of secondary dsRNA using nascent transcripts as a
templates (Ref: Motamedi M.R. et al., 2004). Thus, a self-perpetuating loop is established that
consolidates the heterochromatinisation of the gene locus. It also implies that this mode of gene
silencing depends upon the primary transcription of the target locus to initiate the whole cascade
of heterochromatin formation (Ref: Wassenegger M., 2005).
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1.4.9 RNAi-induced epigenetic changes in mammalian cells
In the case of mammalian cells, recent evidence suggests that, here also, RNAi might play a key
role in regulating gene expression at the transcriptional level. Using human tissue culture cells, it
has been shown that promoter directed siRNAs inhibit transcription of an integrated proviral
EF1A promoter-GFP reporter gene, and of endogenous EF1A (Ref: Morris K.V. et al., 2004).
Moreover, this silencing, which is dependent upon transport of the siRNA into the nucleus, was
associated with DNA methylation of the targeted sequence. This evidence is further strengthened
by another study that similarly demonstrated that synthetic siRNAs targeted to the CpG islands of
an E-cadherin promoter are able to induce significant DNA methylation and histone H3
methylation both in the MCF-7 human cell line and in primary mammary epithelial cells (Ref:
Kawasaki H. and Taira K., 2004). As a result, these siRNAs repressed expression of the E-
cadherin gene at the transcriptional level. Likewise, vector-based siRNAs targeted to the erbB2
promoter also induced CpG methylation and gene down-regulation in MCF-7 cells. That this
phenomenon was dependent upon the presence of a DNA methyltransferase was confirmed by the
demonstration that disruption, by RNAi, of either the DNMT1 or DNMT3B genes leads to the
abolishment of this siRNA-mediated DNA methylation. Both these papers point to the presence
of a fundamental cellular process that exists in mammalian cells whereby the gene silencing
effects ofRNA interference can be consolidated at the level of genomic DNA.
1.4.10 Novel strategy variations designed to induce gene interference
The use of siRNAs to functionally dissect the mammalian genome has been based in the main
upon the introduction of exogenously generated siRNAs, either synthesised chemically or by in
vitro transcription (Ref: Donze O. and Picard D., 2002), or by transfection of PCR products from
which sequence-specific siRNA molecules are transcribed intra-cellularly (Ref: Castanotto D. et
al, 2002). However, in view of the problems relating to delivery of the siRNAs into the cell and
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the transience of the knockdown effect, other more novel strategies have been devised that can
achieve stable suppression of gene expression. Such strategies typically rely upon the integration
of a suitably designed construct which, when transcribed, yields a hairpin RNA molecule that
functionally mimics the siRNA (Ref: Paddison P.J. et al., 2002a). So-called short hairpin RNAs
(shRNAs) undergo processing by Dicer into active siRNA molecules that are able to induce
sequence-specific silencing in mammalian cells (Ref: Brummelkamp T.R. et al., 2002). Typically,
this shRNA construct is transcribed from an RNA polymerase III promoter (Ref: Paddison P.J. et
al. 2002b) or alternatively from a U6 promoter that leaves four uridine 3' overhangs (Ref:
Miyagishi M. and Taira K., 2002). A further recent elaboration of this methodology has resulted
in the development of an inducible and reversible system for the conditional knockdown of a
target gene (Ref: Gupta S. et al., 2004).
1.411 Translation ofRNAi technology in vivo
The potential for applying RNAi to therapeutic ends by using shRNAs to direct knockdown of
disease-related genes in vivo has been realised in a proof-of-principle experiment demonstrating
the suppression of a reporter gene in vivo in mice and also the effective targeting of a sequence
from the hepatitis C virus (Ref: McCaffrey A.P. et al., 2002). The development of a lentivirus-
based delivery system, for the efficient introduction of the DNA construct encoding the shRNA
into cycling and non-cycling mammalian cells, represents an important further advance in
achieving this goal of delivering therapeutically-directed shRNAs (Ref: Rubinson D.A. et al.,
2003). To this end, another proof-of-principle experiment has established that viral delivery of
shRNA-expressing DNAs can markedly suppress both exogenous and endogenous genes in vivo in
the mouse brain and liver (Ref: Xia H. et al., 2002).
Other strategies for delivery of functional siRNA molecules have employed cationic liposomes
(Ref: Sorensen D.R. et al., 2003), facile high-pressure injection methods (Ref: Lewis D.L. et al.,
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2002), and stabilising chemical modifications (Ref: Soutschek J. et al., 2004). In addition to viral
genes expressed by hepatitis C (Ref: Davidson B.L., 2003) and HIV-1 (Ref: Novina C.D. et al.,
2002), cancer genes have also been successfully targeted including the leukaemia fusion
oncogenes BCR/ABL (Ref: Wilda M. et al, 2002) and AML/ETO (Ref: Heidenreich O. et al.,
2003). These results testily to the considerable promise for the use of siRNA technology for
therapeutic (Ref: Wall N.R. and Shi Y., 2003).
1.4,12 RNAi as applied to embryonic stem cells
The first demonstration of RNA interference in murine cells used long double-stranded RNA
molecules introduced into fertilised oocytes to induce knockdown of specific genes in pre-
implantation embryos (Ref: Wianny F. and Zernicka-Goetz M., 2000). The effects of the
interference were gene-specific and mimicked the phenotypes of the null mutants. This was
followed by the demonstration of reporter gene knockdown, also in mouse oocytes, using
expression vectors encoding short hairpin RNA (shRNAs) molecules (Ref: Svoboda P. et al.,
2001). The gene knockdown effects of long dsRNA molecules were subsequently revealed in
mouse embryonal teratocarcinoma cell lines (Ref: Billy E. et al., 2001) and in undifferentiated
embryonic stem cells (Ref: Yang S. et al., 2001). This gene knockdown could be rendered stable
in embryonic stem cells using DNA vectors encoding short hairpin RNAs (Ref: Tang F.C. et al.,
2004). RNAi technology has found widespread application in dissecting the molecular processes
leading to ES cell differentiation, as exemplified by the use of shRNAs to knockdown the Oct4
gene in murine cells (Ref: Velkey J.M. and O'Shea K.S., 2003) and siRNAs to do similarly in
human cells (Ref: Hay D.C. et al., 2004), in both cases inducing similar patterns of endoderm and
trophoblast differentiation. Likewise, siRNAs have been used to key haematopoietic transcription
factors in differentiating ES cells to influence lineage commitment (Ref: Zou G.M. et al., 2003).
Using the method of tetraploid aggregation to generate fully ES-derived embryos, ES cells
carrying stably integrated vectors expressing gene-specific shRNAs have yielded mutant embryos
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that mimick the genetic null phenotype (Ref: Kunath T. et al., 2003). Thus, RNAi has rapidly
established itself as an invaluable tool in the molecular understanding of differentiation both in ES
cells and early embryonic development.
1.4.13 Theories on the biological role of small RNA molecules
The discovery that small RNA molecules exhibit sequence-directed properties has been one of the
most remarkable breakthroughs in molecular biology in recent years (Ref: Zamore P.D., 2001).
However, the physiological role of RNA interference remains largely conjecture. The fact that it
is evolutionarily ancient and has been highly conserved throughout eukaryotes suggests that it
serves indispensable cellular functions (Ref: Zamore P.D., 2002). The most attractive theory is
that this mechanism of RNA silencing provides the cell's genome with its own immune system
against invading transposons and viruses (Ref: Platerk R.H., 2002). Such a defence mechanism
has dual attributes of specificity and potency necessary for the sequence-directed suppression of
mobile genetic elements and silencing of foreign viral genes.
An alternative theory argues that RNAi is a major physiological regulator of gene expression.
Such an argument has received further credence by the discovery of countless so-called
microRNAs (Ref: Ambros V., 2004). These are small hairpin RNA molecules that regulate the
expression of complementary messenger RNAs with roles in developmental timing, cell death,
cell proliferation, haematopoiesis and patterning of the nervous system. Hundreds of microRNA
genes have been found in diverse animals, and many of these are phylogenetically conserved
suggesting that their regulatory impact is extremely pervasive. Indeed, bioinformatic analyses
indicate that target genes in vertebrate species may number in the thousands. These target genes
are regulated by the microRNAs through down-regulation at transcriptional, post-transcriptional
and translational levels via RNA silencing pathways that are similar, if not identical, to those
classical RNA interference (Ref: Sontheimer E.J., Carthew R.W., 2005).
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1.4.14 Future prospects for RNAi in biology and medicine
The realisation that small RNA molecules can carry out diverse physiological roles within the cell,
including regulation of gene expression and interference of foreign genetic elements, represents a
landmark discovery in molecular biology. Moreover, because of the ease with which a cell's
genes can be knocked out using homologous double-stranded RNAs, RNA interference has
become a convenient tool for the functional analysis of genes in many model organisms (Ref:
Paddison P.J. and Hannon G.J., 2002). The identification of short interfering RNAs, as an
intermediate in the interference process that can be used to knock down gene targets in
mammalian cells, represents a timely advance in the post-genome era for the functional dissection
of the mouse and human genomes (Ref: McManus M.T. and Sharp P.A., 2002). There is an
emerging consensus on the necessary safeguards required for stringent experimental control when
using RNAi as an experimental methodology (Ref: Lassus P. et al., 2002), although these almost
invariably affirm the specificity of the interference effect. The most powerful application of the
RNAi technology has been when combined with high-throughput screening strategies to produce
an exhaustive functional trawl of genes that yield a particular phenotype upon knockdown. Such
functional genomic analyses have been performed on C. elegans (Ref: Fraser A.G. et al., 2000)
and Drosophila cells (Ref: Kiger A. et al., 2003), and libraries of validated short hairpin RNAs
have been constructed covering large portions of the mouse and human genomes (Ref: Paddison
P.J. et al., 2004).
Unsurprisingly, RNAi holds considerable promise in medicine too, as revealed by the proof-of-
principle demonstration of knockdown of a variety of disease-related genes. The recent landmark
publication describing a simple method for delivering siRNAs in a living mouse disease model
(Ref: Soutschek J. et al., 2004), represent a key step in realising this therapeutic potential.
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1.5 AIMS OF THESIS
The central goal of this thesis is the examination of two different strategies for the functional
analysis of genes in mammalian cells. These are antisense gene trapping, presented in results
chapter one, and RNA interference, presented in results chapters two, three, and four. The
individual aims of each of the chapters are as below:
❖ Aim I: To attain proof-of-principle for the use of antisense gene trapping in murine
embryonic stem cells for the identification of genes relevant to differentiation.
❖ Aim II: To demonstrate that short interfering RNA molecules are able to knockdown
reporter genes in mammalian cells and to explore the biology of this phenomenon.
❖ Aim HI: To define the molecular determinants for effective interference and to identify
the site of action of short interfering RNAs in mammalian cells.
❖ Aim IV: To investigate the feasibility of using short interfering RNAs to knockdown
endogenous gene targets in various cell lines including murine embryonic stem cells.
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2.1 CELL CULTURE
2.1.1 Culture of embryonic stem cells
ES cells were cultured according to standard protocols (Refs: Smith A.G., 1991; Robertson E.J.,
1987). ES cell culture medium was made up using Dulbecco's Modified Eagle's Medium
(DMEM) containing 10% foetal calf serum and supplemented with non-essential amino acids
(lOOpM), sodium glutamate (2mM), sodium pyruvate (ImM), 2-mercaptoethanol (1/10,000) and
leukaemia inhibitory factor, LIF, (lOOU/ml). Alternatively, lOx stock concentration Glasgow's
Modified Eagle's Medium (GMEM) was used at a 1 in 10 dilution in distilled autoclaved water
that was appropriately buffered to a pH of 7.4 with sodium bicarbonate. The foetal calf serum was
selected prior to purchase by careful batch testing using a limiting dilution clonal assay to ensure
optimal ES cell growth conditions. Typically, medium was also supplemented with 1%
penicillin/streptomycin (50U/ml and 50pg/ml respectively) to prevent bacterial contamination.
All the above reagents were purchased from Invitrogen Inc. except serum, which was purchased
from various commercial suppliers. The LIF was derived in-house using conditioned medium
from a recombinant COS-7 cell line and assayed according to its ability to maintain ES cells in an
undifferentiated state (Ref: Robertson E.J., 1987).
ES cells were cultured on gelatin coated tissue culture grade plastic flasks/plates and passaged
when confluent. Passaging of ES cells involved the removal of serum-containing medium
followed by washing in phosphate buffered saline (PBS) and finally treatment for one to two
minutes with 0.1% trypsin {Invitrogen Inc.). The cells were then re-suspended in fresh medium
and re-plated at an approximate lOx dilution, typically 4x104 cells per cm2 (or 106 per T25 flask)
using a haemocytometer to count cell density when necessary. Most experiments were performed
using the stromal-independent ES cell line, El 4, (Ref: Fisher J.P. et al., 1989) which can be
passaged in the absence of feeder cells. Early experiments were performed using the stromal-
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dependent ES cell line, CCE, which requires passaging of cells on a bed of irradiated primary
embryonic fibroblasts (PEFs) derived from day 12.5 mouse embryos.
2.1.2 Production of primary embryonic fibroblasts
Primary embryonic fibroblasts (PEFs) were generated from day 12.5 mouse embryos homozygous
for a targeted knockout of the GDI D4 locus (Ref: Lelias J.M. et al., 1993) on chromosome 12
(Ref: Adra C.N. et al., 1994). These fibroblasts therefore carry two copies of the neomycin-
resistance gene that is driven from a constitutive phosphoglycerate kinase (PGK) promoter (Ref:
Guillemot J.C. et al., 1996). The heads of the embryos were removed and the torsos were
dissected mechanically and disaggregated using trypsin and collagenase. Embryonic fibroblasts
were expanded for several passages until a population of homogenous fibroblasts were obtained
(Ref: Robertson E.J., 1987). These were then harvested and irradiated using a standard dosage of
gamma irradiation calibrated to yield viable but non-dividing fibroblasts.
2.1.3 Methylcellulose differentiation of embryonic stem cells
24g methylcellulose powder was dissolved in Iscove's Modified Dulbecco's Medium (IMDM)
and autoclaved to generate a 2x stock of sterile methylcellulose suspension. This suspension was
then submitted to a number of freeze-thaw cycles, with stirring, until the consistency was even and
semi-fluid. A 1.2% methylcellulose differentiation mixture was then made up using the following
recipe: 50% 2x methylcellulose suspension, 20% foetal calf serum, 10% ES cells suspended at
10,000 cells per ml in fresh medium (without LIF). The remaining 20% was comprised of DMEM
supplemented with 1% monothioglycerol (lOpl in 4ml stock), 1% penicillin/streptomycin (50U/ml
and 50pg/ml respectively), 1% sodium glutamate (200mM), and 1% non-essential amino acids
(lOmM). Typically, growth factors were also added as follows: erythropoietin at 2U/ml, murine
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interleukin-1 at 50U/ml, murine interleukin-3 at 500U/ml, stem cell factor at lOpg/ml, made up in
a 1% cocktail mixture (Ref: Wiles M.V. et al., 1991).
The methylcellulose-cell suspension was made up to a volume of 3mls at a concentration of 1000
cells/ml and this was split equally onto two 4cm non-tissue culture (bacterial) dishes which were
placed together with a third dish, containing water for humidification, onto a 10cm plate. The
plate was then incubated at 37 C. After a few days, clonally derived embryoid bodies emerged
and underwent differentiation that was assessed visually under light microscopy (Ref: Keller G,
1995).
2.1,4 Electroporation of embryonic stem cells
Two ES cell lines were used, namely, CCE cells, which are cultured on irradiated fibroblasts, and
E14 cells, which are a feeder-independent line. Otherwise, the protocol employed for
electroporation of plasmid constructs was identical in both cases and outlined below:
Cells were grown to semi-confluence on a T75 flask giving approximately 1-2 x 107 cells. They
were then trypsinised using 0.25% trypsin (Invitrogen Inc.), ensuring single cell suspension with
gentle pipetting, re-suspended in complete medium, and centrifuged for 5 minutes at l,000rpm.
The pellet was then re-suspended in PBS and the cell density estimated using a haemocytometer
prior to re-centrifugation. Finally, the cells were once again re-suspended, this time at a
concentration of 107 per ml in PBS or electroporation buffer (20mM Hepes pH7, 137mM NaCl,
5mM KC1, 0.7mM Na2HP04, 6mM dextrose, O.lmM P-mercaptoethanol, distilled water, filter-
sterilised). An aliquot of 0.8ml was transferred to an Eppendorf tube and 10-50pg of plasmid
DNA (either circularised or linearised) was added and gently mixed. The cells were allowed to
stand for 10 minutes at room temperature before transfer to a 0.8ml volume electroporation
cuvette with an electrode gap of 0.4cm. The electroporation apparatus used was a BioRad
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GenePulser™ machine (BioRad Inc.) and the specific parameters used were voltage of 800V and
capacitance of 3 pF with a discharge time constant of approximately 4-5 milliseconds. Following
electric discharge, the cells were immediately re-suspended in a suitable volume of complete
medium and re-plated on four 10cm diameter gelatin-coated tissue-culture dishes at a
concentration ofapproximately 2 x 106 cells per dish.
2.1.5 Antibiotic selection of embryonic stem cell clones
Electroporated cells were allowed to recover by growth in fresh complete medium for
approximately 24-36 hours. This was then replaced with medium containing the appropriate
antibiotic selection agent at lethal concentration. This concentration was gauged for each cell line
and sub-line by prior testing using a range of antibiotic dosages and confirmed by ensuring 100%
lethality of parallel control plates (containing cells electroporated in the absence of plasmid).
Three antibiotic selective agents were used in the course of these experiments, namely neomycin
and hygromycin, which are toxic to wild-type cells, and ganciclovir, which is only toxic to cells
expressing the adenoviral thymidine kinase for which it is a suitable substrate. The toxic dosages




Fresh antibiotic-containing medium was initially replaced daily, while cell death was extensive,
and subsequently on alternate days. Discrete colonies emerged at around day 8-10 after
electroporation. These were left to grow to a size where they could be successfully picked using a
fine long-tipped 200pl pipette tip under microscope guidance in a laminar-flow hood. Each
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colony was picked directly into an individual well of a 96 well plate and disaggregated by brief
incubation in a drop of trypsin before re-plating on a 48 well plate. Cells were then expanded
under reduced antibiotic stringency, typically 25% of the selection concentration. Clones were
split when confluent onto a number of wells of a 24 well plate for LacZ staining, RNA extraction,
freezing, and further downstream experimentation.
2.1.6 Assay for expression of p-galactosidase
P-galactosidase expression was assessed by in situ staining of cells using the following protocol:
1) Cells were washed in PBS and fixed in freshly-prepared fixative solution (0.4ml 25%
gluteraldehyde, 2.5ml lOOmM EGTA, 0.1ml 1M magnesium chloride, 47ml 0.1M sodium
phosphate at pH 7.3), or alternatively in 3% paraformaldehyde in PBS, for 15 minutes.
2) Cells were washed three times in wash buffer (0.1ml 1M magnesium chloride, 0.5ml 2%
NP40, 0.5ml 1% deoxycholate, 48.9ml 0.1M sodium phosphate pH 7.3).
3) Cells were stained in X-gal stain (0.106g potassium ferrocyanide, 0.082g potassium
ferricyanide, 2ml 25mg/ml X-gal reagent in dimethylformamide, 48ml 0.1M sodium
phosphate pH 7.3) and incubated from 4 hours to overnight at room temperature or 37°C, as
appropriate, alongside wild-type cells as negative controls.
P-galactosidase staining reflects the transcriptional activity of the trapped promoter in driving
expression of the figeo gene via the splice acceptor bridge. This can be performed on
undifferentiated ES cells and also on differentiating embryoid bodies when staining will reflect
evidence of lineage-restricted expression.
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2.2 MOLECULAR BIOLOGY
2.2.1 Extraction of genomic DNA from cells
Cells were trypsinised, washed in ice cold PBS, then digested overnight in digestion buffer
containing lOOmM NaCl, lOmM TrisCl (pH8.0), 25mM EDTA (pH8.0), 0.5% (w/v) SDS and
O.lmg/ml proteinase K. Genomic DNA was then extracted from samples, using an equal volume
of phenol, chloroform and isoamyl alcohol, and centrifuged at 1700 x g for 10 minutes. The upper
aqueous layer was transferred to a fresh tube and mixed with % volume of 7.5M ammonium
acetate (or 3M sodium acetate) and 2 volumes of 100% ethanol resulting in precipitation of the
DNA. The mixture was then centrifuged at 1700 x g for 5 minutes and the fluid carefully
decanted. Finally, the DNA precipitate was washed once with 70% ethanol and briefly air-dried
before re-suspension in an appropriate volume of TE buffer or distilled water. The concentration
of the DNA was calculated using a spectrophotometer to measure the optical density of an
appropriately diluted aliquot at 260nm and multiplying the result by 50 to give a reading in mg/ml.
The purity of the DNA solution was indicated by the ratio of OD readings at 260nm and 280nm
with pure preparations of DNA having an OD260/OD280 ratio of 1.8.
2.2.2 Extraction of total RNA from cells
RNA was extracted using the Total RNA Isolation Reagent™ (TRIzol™, purchased from
Invitrogen Inc.) as per the manufacturer's instructions. Cells were lysed directly in the tissue
culture dish by adding 1ml of TRIzol Reagent™ per 10cm2 dish, and passing the cell lysate
several times through a pipette. The homogenised mixture was then incubated for 5 minutes at
room temperature to permit complete dissociation of nucleoprotein complexes. 0.2ml of
chloroform was added per 1ml of TRIzol™ used and the mixture briefly vortexed and incubated
for a further 2 minutes. The sample was then centrifuged at 12,000 x g for 15 minutes at 2 to 8°C
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to achieve phase separation with a lower red, phenol-chloroform phase, an interphase layer, and a
colourless upper aqueous phase. The RNA remains exclusively in the latter, which comprises
about 60% of the total volume. This was transferred to a fresh tube and the RNA precipitated by
mixing with isopropyl alcohol (0.5ml per 1ml TRIzol™) and incubating for 10 minutes at room
temperature followed by centrifugation at 12,000 x g for 10 minutes at 2 to 8°C. Finally, the
supernatant was removed and the RNA pellet washed with 75% ethanol, vortexed and re-
centrifuged at 7,500 x g. The RNA was air-dried and dissolved in a suitable volume of RNAse-
free water (pre-treated with diethylpyrocarbonate, DEPC) and the concentration calculated by
multiplying the optical density at 260nm by 40 (purity assessed by an OD26o/OD28o ratio of 1.6).
2.2.3 PCR analysis for contained genomic sequence
PCR analysis for contained genomic sequences was performed using Taq DNA polymerase and a
PCR kit purchased from Invitrogen Inc. The manufacturer's recommended protocol was applied
and optimised as appropriate. The following components were added to a sterile 0.5ml micro¬
centrifuge tube to a total volume of 50jul (or else a master mix prepared for multiple reactions):
Component Volume
lOx PCR buffer 5pl
1OmM dNTP mixture 1 pi
50mM MgCl2 1.5pl
Primer mix (1OpM each) 1 pi
Template DNA (lpg/pl) lpl
Taq DNA polymerase 0.5pi
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The mixture was incubated in a thermal cycler at 94°C for 2 minutes to completely denature the
template. Where a "hot start" was performed, the Taq enzyme was added at this stage else a heat-
activated enzyme (such as Platinum Taq™, Invitrogen Inc.) was used and added at the outset.
PCR amplification was then achieved by performing 25-35 cycles, using a heated-lid (or oil
emersion) to prevent evaporation, as below:
Denature 94°C for 30-60 seconds
Anneal 55-62°C for 30-60 seconds
Extend 72°C for 1 minute per kilobase ofDNA
2.2.4 RT-PCR analysis for transcribed sequence
Successful RT-PCR analysis for transcribed RNA sequences is dependent upon high purity RNA.
The method involves an initial step of reverse transcription of the messenger RNA followed by
amplification of the resultant cDNA using conventional PCR methods. The first strand cDNA
synthesis reaction was carried out using a master mix comprising the following components:
Component Volume Final Concentration
RNA Guard™ (.Pharmacia Inc.) 0.5pl 20 units
5x first strand buffer 4pl Ix
DTT (dithiothreitol at 0.1mM) 2pl lOmM
dNTPs at 25mM 0.8pl ImM
Reverse transcriptase (MoMuLV) lpl 200 units
Oligo dT (at 1 pg/pl) 0.2pl lOng/pl
Autoclaved distilled water 1.5pl
Total volume 10pl
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The RNA, extracted as described above, was diluted to a concentration of I (ig in lOpl H20.
Denaturisation was achieved by incubation at 65°C for 5 minutes, then quenching on ice and
spinning down briefly. lOpl of the reverse transcription master mix was then added, making a
final volume of 20pi per tube, and incubated at 37°C for 1 hour. For each RT-PCR reaction, a
control sample was prepared in parallel using the identical mix as above but lacking the reverse
transcriptase enzyme (thereby distinguishing amplified cDNA sequences from those arising from
contaminating genomic DNA). Finally, the samples were spun down and stored at -20°C or used
directly in the second amplification step.
The amplification step, which includes the second strand cDNA synthesis, was performed as per
the PCR protocol described above. Specifically, lpl of the first strand reaction product was used
in place of the template DNA and the mixture was denatured for 5 minutes at 95°C followed by 30
amplification cycles: denaturation at 94°C for 30seconds; annealing at 62°C for 60 seconds; and
extension at 72°C for 1 minute.
Finally, the amplification product was analysed by agarose gel electrophoresis using a 1.5% gel
and visualised by ethidium bromide staining alongside an appropriate molecular weight ladder.
2.2.5 Identification of gene trapped sequences by the method of 5' Rapid
Amplification of cDNA Ends (5'RACE)
RNA was extracted from gene trap clones using the Total RNA Isolation Reagent™ (TRIzol™,
purchased from Invitrogen Inc.) as per the manufacturer's instructions and described here in
Section M.1.12. The identification of expressed gene trap sequences was achieved using the
method of 5' rapid amplification of cDNA ends, or 5'RACE, using a kit purchased from
Invitrogen Inc., The 5'RACE System™, and applied as per the manufacturer's instructions.
5'RACE, or "anchored PCR", is a technique that facilitates the isolation and characterisation of
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5'ends from low-copy messages (Ref: Frohman, 1994). The basic methodology is outlined in
principle below and schematically overleaf (Figures M.2.3 and M.2.4):
1) First strand cDNA synthesis is primed from total RNA using a LacZ-specific antisense
oligonucleotide, termed primer 1, using Superscript™ II, an RNAse H- derivative of the
MuMoLV reverse transcriptase. This permits cDNA conversion of the gene trapped mRNA
and maximises the potential for complete extension to the 5'-end of the message.
2) The first strand product, the original mRNA template is by treatment with the RNase
Mix™ (mixture of RNAseH, which is specific for RNA:DNA heteroduplex molecules, and
RNAse Tl).
3) The cDNA is purified by removal of unincorporated dNTPs, primer, and proteins using a
SNAP column (GlassMax Spin Cartridge™).
4) A homopolymeric tail is then added to the 3'-end of the cDNA using TdT (terminal
deoxynucleotidyl transferase) and dCTP to generate an oligo dC anchor sequence.
5) The dC-tailed cDNA is then amplified by PCR using a deoxyinosine-containing anchor
primer (Abridged Universal Amplification Primer, AUAP™) and a nested LacZ-specific
antisense oligonucleotide, termed primer 2, which anneals to a site upstream of primer 1.
6) An additional PCR amplification step is performed on a dilution of the product from the
previous step, this time using a second nested LacZ-specific antisense oligonucleotide,
termed primer 3.
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2.2.6 Sequence analysis of 5'RACE products
Following amplification of upstream gene trapped sequences, as outlined above, 5'RACE products
were either sequenced directly using the P-galR3 (or LacR3) primer or alternatively cloned into a
TA cloning vector (pGEM-T Kit™, Promega Inc.) and sequenced bi-directionally using forward
T7 and reverse M13 sequencing primers. The DNA was labelled as per the dideoxy method (Ref:
Sanger, 1977) using the Big Dye Terminator Kit™ (PE Systems Inc.) and sequenced on an ABI




2.2.7 Identification of gene trapped loci by BLAST database analysis
DNA sequence data was manipulated using the DNAStar™ computer software package. DNA
sequences were analysed using the nucleotide blast search facility available on-line from the
National Center for Biotechnology Information, NCBI, at the following internet website:
http://www.ncbi.nlm.nih.gov/BLAST. The success or otherwise of a gene trap integration event
could then be determined by demonstrating correct fusion of the adenoviral splice acceptor site
with the intronic sequence of a known, or unknown, gene.
2.2.8 Measurement of cytosine methylation using nearest neighbour analysis
Analysis of cytosine methylation at CpG dinucleotides within genomic DNA was kindly
performed by B.H. Ramsahoye PhD (Ref: Ramsahoye 2002). Briefly, samples of genomic DNA
were extracted, as described previously (Section M.1.10), from inducible ES cell clones
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expressing either Dnmt3a or Mbd2b, and from an inducible CHO cell clone expressing Dnmt3a.
For each inducible clone, cells were cultured in duplicate wells either with or without doxycycline
(yielding with repression or induction of the corresponding gene respectively). lOpg of DNA was
digested with 30 units of the restriction enzyme Fokl (purchased from New England Biolabs Inc.),
which cuts at the sequence GGATGN9.13, for 2 h at 37°C in a 150-pl reaction volume. The
enzyme was heat-inactivated (60°C for 20 min) and the restriction fragments were precipitated in
ethanol and resuspended in 20 pi of TE buffer (10 mM Tris/1 mM EDTA, pH 8). An aliquot of
2pg (4pl) of DNA was labelled in a 12-pl reaction volume with 20 pCi of 32P dNTP (10 pCi/pl
and 3000 Ci/mmol; 1 Ci =37 GBq) using 2.5 units of Klenow (Amersham Pharmacia Inc.) and the
manufacturer's fill-in buffer. After labelling for 15 min at 15°C, the reaction was stopped by
addition of 2 pi of 0.2 M EDTA and unincorporated nucleotides were removed using Sephadex
G50 spin columns (Boehringer Mannheim Inc.). The DNA was digested to deoxyribonucleotide
3'-monophosphates and separated by two-dimensional TLC using isobutyric acid-based solvent
(66 parts isobutyric acid [Sigma] to 18 parts water to 3 parts 30% ammonia solution) in both
dimensions of a 20 x 20 cm glass-backed cellulose TLC plate (Merck Inc.). Finally, the
radioactive TLC plates were exposed onto photographic film allowing the relative proportions of
methylated to unmethylated cytosine nucleotides to be quantified using Scion™ imaging software
and the percentage CpG methylation calculated.
2.2.9 Transformation of competent E. coli
Competent bacteria were either purchased commercially (Invitrogen Inc., Subcloning Efficiency
DH5a Chemically Competent E. coli™) or generated as per established protocols using the
calcium chloride method. Briefly, this involved the inoculation of a single colony of E. coli into
50ml of LB medium, overnight growth at 37°C, then transfer of 4mls culture into 400ml of LB
medium and further growth until the optical density reached 0.375 at 590nm (representing early to
mid-log phase growth). The culture was then divided into 8 pre-chilled 50ml tubes, left on ice for
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5-10minutes, then centrifiiged and re-suspended in lOmls ice-cold CaCl2 twice, and finally re-
suspended in 2mls of ice-cold CaCl2 and aliquoted into 250pl tubes and frozen at minus 70°C.
Transformation of competent cells was performed for large-scale generations of plasmid DNA.
Competent cells were thawed rapidly on ice, then inoculated with approximately lng of DNA,
mixed gently, and incubated on ice for 30 minutes. The cells were then subjected to heat-shock
for 20-45 seconds at 37-42°C as appropriate, placed on ice for 2 minutes, and finally diluted in
0.95ml of room temperature SOC or LB medium and shaken at 225rpm for 1 hour at 37°C.
Various aliquots of a 1 in 10 dilution of this medium were then spread on LB plates containing
lOOpg/ml Ampicillin and incubated overnight at 37°C alongside negative (no plasmid DNA) and
positive (pUC 19 plasmid) control plates. Individual colonies were picked for further expansion.
2.2.10 Large-scale harvest of plasmid DNA
Bacterial cultures were performed under continuous antibiotic selection, initially in ~5mls LB
medium for 6-8 hours and subsequently overnight in a volume of 400-600mls LB medium. This
was then centrifuged to yield a pellet of bacteria from which the plasmid DNA was to be
harvested. The method of plasmid extraction was based on a modification of the alkaline lysis
procedure, followed by purification by binding in an anion-exchange resin column. The Qiagen
Maxi Plasmid Kit™ (Qiagen Inc.) was used for this purpose according the manufacturer's
recommended instructions. In general, this approach yielded relatively large amounts of pure
plasmid DNA at a concentration of approximately 1 pg/pl for use in subsequent experiments.
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2.3 RNAi METHODOLOGY
2.3.1 Design and synthesis of short interfering RNA (siRNA) oligonucleotides
The siRNA oligonucleotides were designed according to published on-line recommendations
available at http://www.rockefeller.edu/labheads/tuschl/sirna.html (Ref: Tuschl et al., 2002, "The
siRNA User Guide"). Subsequent experimental results lent additional insights into optimal design
outlined in the corresponding results chapter. In brief, the targeted region is selected from a given
cDNA sequence beginning 50 to 100 nucleotides downstream of the start codon. Sequences of the
form AA(N 19)TT are identified, or alternatively AA(N21) where the former is not present. The
G/C content appears to be an important determinant of siRNA function with 50% being optimal.
The sense RNA strand corresponds to the N19 sequence and the antisense to its complementary
sequence. In either case, the 3'end carries a TT di-nucleotide pair. This creates a symmetric
overhang that helps ensure that equal ratios of siRNPs are generated without affecting recognition
of the target mRNA which is directed solely by the antisense strand. Finally, a blast search is
performed using the NCB1 database (Ref: http://www.ncbi.nlm.nih.gov/BLAST/) to ensure that
the target region is uniquely represented within the genome of the cell of interest.
In addition to the above rules guiding optimal choice of siRNA sequence, a number of further
insights were gained in the course of experimentation. These findings have since been borne out
by other investigators and are now generally recommended. The most important finding was that
there is a preference for at least one or more guanine-cytosine pairings at the proximal 5' end of
the siRNA duplex and an adenine-thymine pairing at the distal 3' end of the siRNA duplex. It is
plausible that this finding reflects the need for strong sense-antisense base-pairing at the 5' end,
and conversely weaker base-pairing at the 3'end, of the siRNA duplex with implications regarding
the molecular mechanism of interference. The other finding was for a general avoidance of
palindromic sequences and G/C strings within the siRNA molecule.
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siRNA oligonucleotides were chemically synthesised by a commercial custom siRNA service
(Xeragon inc.) using a proprietary method involving protection of the 2'-OH group using 2'-0-Tri-
isopropylsilyl-Oxy-Methyl to protect against RNA degradation. This so-called TOM-chemistry™
enables a high coupling efficiency of over 99.5% facilitating the automated synthesis of RNA
oligonucleotides up to lOOmers in length at high yield and purity.
2.3.2 Synthesis of siRNAs using an in vitro transcription method
The in vitro synthesis of siRNAs was achieved using the Silencer™ siRNA Construction Kit
(Ambion Inc.) according to the manufacturer's recommendations (performed by Anestis Tsakiridis
BSc, masters degree candidate, Edinburgh University, 2002). This is described in outline only
here. The Silencer™ Kit employs an in vitro transcription method that uses T7 RNA polymerase
to generate individual strands of the siRNA. Templates for the reactions are produced from two
DNA oligonucleotides encoding the desired siRNA strands. These oligonucleotides are designed
to include an 8 base sequence complementary to the 5' end of a T7 promoter primer. These are
annealed to one another and a fill-in reaction, using Klenow fragment, generates a double-stranded
template ready for use in the in vitro transcription reaction. After transcription, the reactions are
combined to permit annealing of the two siRNA strands. These are then treated with DNAse, to
remove the template, and RNase, to polish the ends of the duplex, and finally, purified using a
glass fibre column. The eluted siRNA duplexes are similar to those produced by chemical
synthesis but have uridine dimers at both 3'ends rather than thymidine dimers.
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2.3.3 Method of transfection of siRNAs into cells in culture
siRNA transfection experiments were typically performed in 24 well plate format. Cells were
plated out the day before the experiment so as to have a confluence of around 50% at the time of
transfection (around 105 cells per well depending on cell type). Fresh medium was added shortly
before the experiment. The transfection reagent mix was made up comprising a 10 to 1 dilution of
Oligofectamine™ in Opti-MEM™ I Reduced Serum Medium (Invitrogen Inc.). This was added
to the siRNA oligonucleotide diluted to the desired concentration in 40pl Opti-MEM. The
complete siRNA/Oligofectamine/Opti-MEM cocktail was allowed to stand for 15 minutes to allow
complexes to form. 150pl of serum-free medium (minus antibiotics) was added to each well and
the 50|il cocktail added making a final volume of 200pl. The range of quantities of siRNA used
for each experiment typically varied in 10-fold log increments from lpg up to lpg per well. This
equates to a molar amount of approximately 0.067fmoles up to 0.067nmoles or a molar
concentration of approximately 335fM up to 335nM respectively. The cells were incubated at
37°C for 4 hours after which the medium was supplemented with 20pl of serum per well. siRNA-
induced target gene knockdown was assayed at variable time intervals post-transfection, usually
around 48 hours. All experiments were controlled using a secondary siRNA oligonucleotide
whose sequence was alien to the cell genome, often a GFP or LacZ siRNA, and all experiments
where possible were performed in parallel triplicates.
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2.3.4 Sequences of siRNA molecules used in current experiments
The sequences of the various siRNAs used in gene knockdown experiments are listed below:
Firefly luciferase siRNA - A GAAAGGCCCGGCGCCAUUCdTdT
Firefly luciferase siRNA -B2 CGUACGCGGAAUACUUCGAdTdT
Firefly luciferase siRNA -B3 CUUACGCUGAGUACUUCGAdTdT
Firefly luciferase siRNA - C GCUAUGAAACG AUAUGGGCdTdT
GFP (green fluorescent protein) GUUC AGCGUGUCCGGCGAGdTdT
LacZ (p-galactosidase) UGGCGCUUUGCCUGGUUUCdTdT
Dnmtl (de novo methyltransferase) GGCUACCUGGCUAAAGUC AdTdT
TK (murine thymdine kinase) GUAUGCCAAAGACACGCGCdT dT
HPRT (murine Hprt gene) GUGUUU AUUCCUC AUGGACdTdT
TERT1 (human telomerase RT) GCACUUCCUCUACUCCUCAdTdT
TERT2 (human telomerase RT) CC AAGAAGUUC AUCUCCCUdTdT
ESG-1 (embryonal stem cell gene) GAACUUAUCGAGGUCUUCAdTdT
EHOX (murine Ehox gene) UGAGGGAGAGAGUGUACUGdTdT
AET (amll-eto translocation) CCUCGAAAUCGUACUGAGAdTdT
NB: Not all the experimental data arising from use of the above siRNAs is presented here.
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2.3.5 Co-transfection of siRNAs with DNA or RNA gene reporters
The prototypic siRNA knockdown experiment used here to study the RNA interference
phenomenon employed a Firefly luciferase (Photinus pyralis) target and a Renilla luciferase
(Renilla reniformis, also know as sea pansy) internal control. Experiments were generally
performed by co-transfection of the relevant reporter constructs (purchased commercially from
Promega Inc.). These included the following:
Firefly luciferase plasmids pGL2 and pGL3
Firefly mRNA reporter mGL2
Renilla luciferase plasmid pRL
Most experiments aimed to measure siRNA-induced Firefly luciferase knockdown (either plasmid
pGL2/pGL3 or mRNA mGL2) and used the Renilla luciferase (pRL) as an internal control. In all
cases, the reporter construct was simply added to the siRNA/Opti-MEM™ mix prior to adding to
the Oligofectamine™ reagent mix, which is able to efficiently co-transfect both siRNA and
luciferase reporter. Typically, the respective amounts of the three luciferase reporters used in the
experiments were 2pg pGL2, 1 pg pGL3, and 0.5pg mGL2 (together with 20ng of the pRL internal
control), which yielded satisfactory luminescence for purpose of assaying expression.
2.3.6 Quantification ofFirefly / Renilla luciferase expression by luminescence
measurement
Luciferase siRNA knockdown experiments were assayed using the Dual-Luciferase Reporter™
(DLR) Assay System (Promega Inc.) according to the manufacturer's instructions. This system
provides an efficient means of performing two reporter assays in parallel, namely the activities of
Firefly {Photinus pyralis) and Renilla {Renilla reniformis, also know as sea pansy) luciferases.
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These are measured sequentially from a single sample obtained by passive lysis of the adherent
cells in situ in each well. Briefly, the Firefly luciferase reporter is measured first by adding the
Luciferase Assay™ Reagent II to generate a luminescent signal after which the reaction is
quenched and the Renilla luciferase reaction initiated simultaneously by adding Stop and Glo™
Reagent to the same sample. The luminescent signal was measured on a Turner Designs 20/20
luminometer system over a linear range of five orders of magnitude with negligible background
endogenous activity.
2.3.7 Flow cytometry analysis of siRNA-induced knockdown of endogenously
expressed green fluorescent protein in embryonic stem cells
siRNA-induced knockdown of GFP in ES cells was performed using a constitutively-expressing
cell line generated by random integration of a CMV-driven transgene (Ref: Gilchrist G.S. et al.,
2003). GFP expression levels were assessed at various time-points post-transfection using
fluorescent microscopy. Formal quantitative measure of the GFP expression levels was obtained
by FACS analysis of trypsinised cells suspended in a 0.1% solution of sodium azide in PBS.
Appropriate gating parameters were set according to negative (wild-type ES cells transfected with
GFP-specific siRNA) and positive (GFP-ES cells transfected with an irrelevant siRNA) controls.
2.3.8 Analysis of telomerase activity using PCR/ELISA-based assay
Telomerase activity was assayed using the Telomerase PCR ELISA Kit™ (Roche Inc.) according
to the manufacturer's instructions (assay performed by Anestis Tsakiridis BSc, masters degree
candidate, Edinburgh University, 2002). This assay is based on the addition of telomeric repeats
(TTAGGG) by telomerase to the 3' end of a biotin-labelled synthetic primer, Pl-TS. The
elongation products are then amplified by PCR using the primers Pl-TS and P2, thus generating
PCR products with the telomerase-specific hexanucleotide increments. An aliquot of the PCR
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product is denatured and hybridised to a telomeric repeat-specific detection probe labelled with
digoxigenin. The resulting product is then immobilised via the biotin labelled primer to a
streptavidin-coated microtitre plate and detected using an antibody against digoxigenin (anti-DIG-
POD) that is conjugated to peroxidase. Finally, the probe is visualised by virtue of peroxidase
metabolising the TMB substrate (tetramethyl benzidine) to form a coloured reaction product
whose absorption is measured at 450nm.
2.3.9 Optimisation of siRNA cell transfection by various methods including use of
HIV-derived Tat transduction peptide molecules
A number of transfection strategies were compared (by measurement of luciferase knockdown) for
their ability to deliver siRNAs into cells, including the following: calcium phosphate precipitation,
electroporation, a proprietary lipid vesicle formulation, and various commercial liposomal
preparations (Lipofectamine 2000™ and Oligofectamine™ [Invitrogen Inc.] and Transmessenger
Reagent™ [Qiagen Inc.]). Of these strategies, Oligofectamine™ was found to give the most
consistent and impressive results (data not shown).
In collaboration with Xinsheng Nan PhD (Cystic Fibrosis Gene Therapy Group, Molecular
Medicine Centre, Edinburgh University) we sought to enhance the effectiveness of
Oligofectamine™ by combining it with a novel delivery agent, short peptide molecules derived
from the HIV gene tat. This work was based on preliminary unpublished data that demonstrates
the efficacy of Tat peptides in the delivery of large nucleic acid molecules, specifically reporter
plasmids. The Tat peptide sequence comprises nine basic amino acids (RKKRRQRRR) derived
from the transduction domain of the tat gene and is reminiscent of similar peptide molecules
derived from other genes, including the Drosophila homeotic transcription factor Antennapedia,
and the herpes simplex protein VP22.
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Here, we sought to investigate whether Tat might serve as a lipid-sparing agent able to enhance
01igofectamine™-mediated delivery of luciferase-specific siRNAs, assessed by knockdown of
Firefly luciferase in CHO-LUC cells. In order to exaggerate the magnitude of this enhancement,
we used siRNAs homologous to the region 195-213 of GL2 that gave a maximum knockdown of
approximately 80% in transient transfection experiments using the plasmid pGL2. The
knockdown was performed, as per previous experiments, in 24 well format using 1 pi siRNA per
well and a reduced dose of 0.15pl Oligofectamine™, rather than lpl, combined with 2pg of Tat
peptide. The controls were Oligofectamine™ or Tat used as single agents at the same dosage.
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2.4 QUANTITATIVE METHODOLOGY
2.4.1 Statistical considerations
Wherever possible, quantitative data have been subjected to appropriate statistical analyses.
Where the data comprises paired outcome measurements for two distinct experimental starting
conditions, the means of the two populations have been compared using the Student's paired t-test.
Here, the test statistic is assumed to exhibit a Student's t distribution and the two populations are
assumed to exhibit identical variances. The Student's t-test yields a p-value that represents the
probability that the observed outcome might have occurred by chance alone. By convention, an
arbitrary level of statistical significance of 5% has been used to conclude whether the
measurement is statistically significant.
Where applicable, graphic representations of data contain error bars for each value. Where the
value is the mean of two independent measurements the error bars represent the range and where
the value represents the mean ofmore than two independent measurements the error bars represent
the standard error. If a value was derived from a unique experimental measurement, for instance
for experiments performed over a range of substrate concentrations where dosage effects apply,
then error bars are not appropriate. On such occasions, the dosage effect has been used to support
or refute statistically significant differences between the two populations of data by using the
paired Student's t-test as described above.
The following web-based statistical program was used to perform Student t-test analyses and
calculate p-values: http://www.physics.csbsju.edu/stats/t-test.html.
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2.4.2 Statistical analyses: Results 2
All comparative data in this thesis has been represented graphically and, where appropriate,
subjected to statistical analyses using paired Student's t-test as outlined above. Where the data-
points are derived from single experiments, error bars have not been applied. Where the data-
points are derived from duplicate experiments, error bars shown represent the range of those
experiments. Where the data-points are derived from triplicate experiments, error bars shown
represent the standard error of those experiments. All graphical representations of data have been
performed using Microsoft Excel™ (Microsoft Inc.) and error bars have been calculated according
to the software of this program.
The graphical figures appearing in the three results chapters relating to RNA interference, namely
Chapters 4, 5 and 6, are listed here below by way of clarifying the actual data being compared and
the whether the outcome is statistically significant as determined by the calculated p-value:
Figure 4.1 Demonstration that knockdown of Firefly luciferase in ES and 3T3 cells using
sequence-specific siRNA exhibits dose-dependent potency. No formal statistical
analysis performed as data-points are derived from single experiments.
Figure 4.2 Demonstration that double-stranded siRNAs yield strong gene interference while
single-stranded sense or antisense RNAs are no different to control siRNAs.
Data-points are derived from single experiments and hence error bars have not
been applied and statistical analysis not performed.
Figure 4.3 Demonstration that siRNA-induced interference in 3T3 cells is maximal when
sense and antisense RNA strands are in 1:1 equimolar ratio. No formal statistical
analysis performed as data-points are derived from single experiments.
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Figure 4.4 Demonstration that both sense and antisense RNA strands are necessary for gene
interference. Statistically significant difference between double-strands and
single sense (p-value < 0.001) or antisense (p-value < 0.001) strands using paired
Student's t-test to compare relevant sets of data.
Figure 4.5 Demonstration of the importance of siRNA-target gene sequence fidelity for
yielding strong gene interference by comparing matched with mismatched
siRNAs. The result is corroborated by the reciprocal experiment in which the
target gene sequence rather than the siRNA is altered (although no formal
statistical analysis is possible as data-points are derived from single experiments).
Figure 4.7 Comparison of three different siRNAs according to levels of interference of
Firefly luciferase following transient co-transfection with a luciferase plasmid in
3T3 cells. Data-points are derived from duplicate experiments and error bars
represent the range. Statistical analysis is not warranted.
Figure 4.8 Comparison of three different siRNAs as for Figure 4.7 above but for a range of
different siRNA doses. Data-points are derived from single experiments and
hence error bars have not been applied.
Figure 4.9 Comparison of levels of interference ofFirefly luciferase in 3T3 cells using three
different siRNAs either alone or in combination with one another. Data-points are
derived from duplicate experiments and error bars represent the range.
Figure 4.10 Comparison of levels of interference ofFirefly luciferase in 3T3 cells using non¬
homologous sense and antisense pairs ofRNA strands. Data-points are derived
from duplicate experiments and error bars represent the range.
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Figure 4.11 Demonstration that there is a dose-dependent knockdown ofFirefly luciferase
throughout a time-course starting 4 hours post-transfection and up to 7 hours.
Comparison of the highest dose of test siRNA with the control confirms that this
is a statistically significant result using a paired Student's t-test (p=0.02).
Figure 4.12 Linear-log plot of Firefly luciferase interference observed for three different levels
of siRNA for a range of plasmid doses. No error bars have been applied.
Figure 4.13 Log-log plot of Firefly luciferase interference observed for three different levels
of siRNA for a range of plasmid doses. No error bars have been applied.
Figure 4.14 Demonstration of the effect of delayed siRNA transfection on the level of
interference of Firefly luciferase observed for a range of siRNA doses. Data-
points are derived from single experiments and error bars have not been applied.
Figure 4.15 Demonstration of the effect of delayed plasmid transfection on the level of
interference of Firefly luciferase observed for a range of siRNA doses. Data-
points are derived from single experiments and error bars have not been applied.
Figure 4.16: Demonstration that Firefly-specific siRNA cause interference of a stably
expressed luciferase gene in CHO-LUC cells as compared with control siRNA.
Data-points are derived from single experiments and hence error bars have not
been applied. Comparison of the two sets of data (Firefly-specific siRNA versus
control siRNA over the dose range 0.01 to lOOOng/well) using a paired Student's
t-test reveals that this difference is statistically significant (p-value < 0.001).
Figure 4.17 Demonstration of the persistence of detectable luciferase interference observed in
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CHO-LUC cells following transfection of Firefly-specific siRNAs at two different
doses. Data-points are derived from single experiments and hence error bars have
not been applied.
Figure 4.18 Demonstration that transfection of high doses of RNA into CHO-LUC cells
results in paradoxical enhancement of the Firefly luciferase activity that is dose-
dependent. Statistically significant using paired Student's t-test (p-value < 0.001).
Figure 4.19 Demonstration that the paradoxical enhancement of luciferase activity following
transfection of siRNAs into CHO-LUC cells occurs irrespective of sequence
specificity, is dose-dependent, and apparent at 24 but not 48 hours post-
transfection. Data-points are derived from single experiments and hence error
bars have not been applied.
Figure 4.20 Comparison of chemically synthesised siRNAs with ones made using an in vitro
transcription method revealing greater potency of the former in terms of level of
knockdown of transient expressed luciferase in 3T3 cells. Data-points are derived
from single experiments and hence error bars have not been applied.
Figure 4.21 Demonstration that in vitro transcribed siRNAs, when transfected into CHO-LUC
cells at high dose, cause enhancement of Firefly luciferase similar to chemically
synthesised siRNAs. This is irrespective of sequence specificity. Data-points are
derived from single experiments and hence error bars have not been applied.
Figure 4.22 Analysis of the effect of adding the Tat peptide to the transfection mix on Firefly
luciferase interference as a measure of transfection efficiency. The result is
weakly statistically significant using a paired Student's t-test (p-value < 0.03).
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2.4.3 Statistical analyses: Results 3
Figure 5.1 Demonstration that homology of the siRNA antisense strand to the gene target is
more important than that of the sense strand in a transient transfection model.
Data-points are derived from single experiments (hence no error bars) but the
deviation from the overall experimental mean is statistically significant (p<0.001).
Figure 5.2 Demonstration that homology of the siRNA antisense strand to the gene target is
more important than that of the sense strand in a stable transfection model. Data-
points are derived from duplicate experiments to give range error bars and the
deviation from the overall experimental mean is statistically significant (p<0.001).
Figure 5.3 Demonstration that 5'-phosphoryation of the siRNA molecule does not alter the
previous result showing that homology of the antisense strand to the gene target is
more important than that of the sense strand in a stable transfection model. Data-
points are derived from duplicate experiments to give range error bars and the
deviation from the overall experimental mean is statistically significant (p<0.001).
Figure 5.4 Demonstration that Firefly-specific siRNA cause interference of plasmid-encoded
luciferase but not mRNA-encoded luciferase in a transient transfection model
over a range of different doses. Data-points are derived from single experiments
and hence error bars have not been applied but comparison of the two sets of data
by a paired Student's t-test confirm the result is statistically significant (p<0.001).
Figure 5.5 Demonstration that Firefly-specific siRNAs cause interference of plasmid-
encoded luciferase but not mRNA-encoded luciferase in a transient transfection
model in 3T3 cells for two out of three different siRNAs when assayed at 18
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hours post-transfection. Data-points are derived from single experiments and
hence error bars have not been applied and statistical analysis not performed.
Figure 5.6 Demonstration that partial interference ofmRNA-encoded luciferase by more
potent Firefly-specific siRNAs might be detectable in a transient transfection
model in 3T3 cells at the later time-point of 24 hours post-transfection. Data-
points are derived from single experiments and hence error bars have not been
applied and statistical analysis not performed.
Figure 5.7 Demonstration that Firefly-specific siRNA cause interference of plasmid-encoded
luciferase but not mRNA-encoded luciferase in a transient transfection model in
CHO cells for two out of two different siRNAs when assayed at 24 hours post-
transfection. Data-points are derived from duplicate experiments and error bars
represent the range. A paired Student's t-test has been performed to show that the
difference in observed interference of plasmid-encoded luciferase and mRNA-
encoded luciferase by duplex siRNA is statistically significant (p<0.001).
Figure 5.8 Demonstration that Firefly-specific siRNAs cause interference of plasmid-
encoded luciferase but not mRNA-encoded luciferase in a transient transfection
model in Drosophila S2 cells and similarly for mammalian 3T3 and CHO cells.
However, for Drosophila KC cells, Firefly-specific siRNAs cause interference of
both plasmid-encoded luciferase and not mRNA-encoded luciferase. Data-points
are derived from duplicate experiments and error bars represent the range. A
paired Student's t-test has been performed to show that this difference in siRNA-
induced interference ofmRNA-encoded luciferase between Drosophila S2 and
KC cells is statistically significant (p<0.001).
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Figure 5.9 Demonstration that prior 5'-terminal phosphorylation of the Firefly-specific
siRNAs does not affect the observed interference of luciferase in a transient
transfection model in CFIO cells. In addition, 5'-phosphorylated antisense RNA
strands do not yield interference using this model assay. Data-points are derived
from duplicate experiments and error bars represent the range.
Figure 5.10 Demonstration that prior 5'-terminal phosphorylation of the Firefly-specific
siRNAs does not affect the observed interference of luciferase in a transient
transfection model in Drosophila KC cells. In addition, 5'-phosphorylated
antisense RNA strands do not yield interference using this model assay. Data-
points are derived from duplicate experiments and error bars represent the range.
Figure 5.12 Comparison of luciferase interference observed in Drosophila KC and S2 cells
and mammalian CHO and 3T3 cells using 5'-phosphorylated versus mock-
phosphorylated siRNA-B2 in a transient transfection model. 5'-phosphorylation
enhances the level of knockdown ofmRNA-encoded luciferase in S2 cells. Data-
points are derived from single experiments and hence error bars have not been
applied and statistical analysis not performed. However, the result is consistent
with a similar finding in the parallel experiment using siRNA-C (Figure 5.12).
Figure 5.13 Comparison of luciferase interference observed in Drosophila KC and S2 cells
and mammalian CHO and 3T3 cells using 5'-phosphorylated versus mock-
phosphorylated siRNA-C in a transient transfection model. 5'-phosphorylation
enhances the level of knockdown ofmRNA-encoded luciferase in S2 cells. Data-
points are derived from single experiments and hence error bars have not been
applied and statistical analysis not performed. However, the result is consistent
with a similar finding in the parallel experiment using siRNA-B2 (Figure 5.11).
64
Chapter 2 - Methods
Figure 5.14 Compilation of all the data relating to 5'-phosphorylation of siRNAs and their
ability to interfere with either mRNA or plasmid-encoded luciferase according to
the four cell lines used and for two different siRNA molecules. Each data-point is
derived from a single experiment and the error bars shown represent the overall
standard error of the mean for all the experiments from that cell line.
Figure 5.15 Comparison of luciferase interference observed in Drosophila KC and S2 cells
and mammalian CHO and 3T3 cells using 5'-phosphorylated versus mock-
phosphorylated sense-mismatched heteroduplex siRNA in a transient transfection
model. 5'-phosphoryIation enhances the level of knockdown ofmRNA-encoded
luciferase, compared with plasmid-encoded luciferase, in KC and S2 cells. Data-
points are derived from single experiments and hence error bars have not been
applied and statistical analysis not performed.
Figure 5.16 Comparison of luciferase interference observed in Drosophila KC and S2 cells
and mammalian CHO and 3T3 cells using 5'-phosphorylated versus mock-
phosphorylated antisense-mismatched heteroduplex siRNA in a transient
transfection model. 5'-phosphorylation fails to enhance the level of knockdown
ofmRNA-encoded luciferase, compared with plasmid-encoded luciferase, in KC
and S2 cells. Data-points are derived from single experiments and hence error
bars have not been applied and statistical analysis not performed.
Figure 5.17 Compilation of all the data relating to 5'-phosphorylation of heteroduplex siRNAs
(both sense and antisense mismatched) and their ability to interfere with mRNA
or plasmid-encoded luciferase according to the four cell lines used. Each data-
point is derived from a single experiment and the error bars shown represent the
overall standard error of the mean for all the experiments from that cell line.
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2.4.4 Statistical analyses: Results 4
Figure 6.2 Demonstration that siRNA-induced interference in ES cells is maximal when
sense and antisense RNA strands are in 1:1 equimolar ratio. No formal statistical
analysis performed as data-points are derived from single experiments.
Figure 6.3 Flow-cytometric plots demonstrating the siRNA-induced knockdown ofGFP
expression in ES cells for three different incubation times. Comparison of the
GFP versus control experiment using a paired Student's t-test confirms that this
result is statistically significant (p=0.001).
Figure 6.4 Demonstration that repeated siRNA transfections in ES cells result in diminished
knockdowns ofGFP expression as compared with the control. This result does
not reach statistical significance using a paired Student's t-test (p=0.13).
Figure 6.6 Demonstration of dose-dependent siRNA-induced knockdown of a stably
expressed (3-galactosidase transgene targeted to the Oct4 locus in murine ES cells.
Each siRNA dose represents the result of a single experiment and hence error bars
have not been applied and formal statistical analysis has not been performed.
Figure 6.7 Demonstration of the effect of transfection of hTERT-specific siRNAs into
MDA435 tumour cells on levels of telomerase activity. Data-points are derived
from single experiments and hence error bars have not been applied.
Figure 6.8 Comparison of the number of ES cell colonies generated resistant to 6-
thioguanine following treatment with Hprt-specific and control siRNAs at two
different doses. Data-points are derived from single experiments and hence error
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bars have not been applied. However, cells treated with Hprt-specific siRNA fail
to yield more colonies than the background rate (control siRNA-treated cells).
Figure 6.9 Qualitative photographic image demonstrating the effect of Tk-specific siRNA on
CHO-LUC cells according to the colour change of the tissue culture medium and
compared against control single-stranded RNAs and double-stranded siRNAs.
Figure 6.10 Qualitative photographic image demonstrating the effect ofTk and Hprt-specific
siRNAs at two different doses on CHO cells according to the colour change of the
tissue culture medium and compared against control double-stranded siRNA.
Figure 6.11 Demonstration of the effect of Firefly-specific siRNA on the level of luciferase
activity of a transiently co-transfected Firefly plasmid in a number of different ES
cell lines either deficient in DNA methyltransferase activity or rescued thereof.
Error bars represent the range derived from duplicate experiments. While no
formal statistical analysis has been performed, it is apparent that there is siRNA-
induced interference in all these cell lines irrespective of methyltransferase status.
Figure 6.12 Demonstration of the effect ofDnmtl-specific siRNA on the level of cytosine
CpG methylation of ES cells following four serial transfections. Data-points are
derived from single experiments and hence error bars have not been applied.
However, comparison with control cells reveals evidence of siRNA-induced
knockdown resulting in a small reduction in global methylation (16.4%).
Figure 6.13 Qualitative representation of genomic CpG methylation: autoradiographs from
nearest neighbour analyses showing levels of cytosine methylation following four
serial transfections of ES cells with Dnmtl-specific or control siRNAs.
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2.4.5 Units ofmeasurement
In general, quantities of a given compound have been expressed in terms of moles. Where the
compound is in solution, quantities have been expressed as molar concentrations. The exception
to this rule is the concentration of siRNA molecules used in experiments of RNA interference.
Here, amounts of siRNA have been expressed in terms of absolute mass rather than mole
equivalents. This convention was adopted for two reasons. Firstly, to circumvent the fact that one
mole of siRNA duplex has twice the molecular mass of one mole of single stranded RNA and that
this situation might otherwise lead to confusion. And secondly, the practice of using absolute
mass followed the usual convention at the time of writing with many landmark papers in the field
using mass and moles interchangeably (Ref: Elbashir S.M. et al., 2001; see also "The siRNA User
Guide" at http://www.rockefeller.edu/labheads/tuschFsirna.html, Tuschl. T., 2002).
For a typical 21-nucleotide siRNA duplex, the approximate molecular weight is 14820.
Therefore, siRNA mass can be simply converted into mole equivalents by dividing by molecular
weight and hence to molar concentration by dividing by the volume of the transfection mix
(typically 200pl per well of a 24-well plate). These calculations are shown below:
Mass Moles Molar concentration
1 pg siRNA 0.067 fmoles 335 fM
1 ng siRNA 0.067 pmoles 335 pM
1 pg siRNA 0.067 nmoles 335 nM
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3.1 Introduction
Gene trap vectors, of which there are numerous designs, function by mutational insertion of a gene
trapping construct at random sites within the genomic DNA of a given cell (Ref: Evans M.J. et al.,
1997). This construct typically includes a selectable marker gene (usually neomycin) together
with a reporter gene (usually 0-galactosidase), which both fall under the transcriptional control of
the trapped upstream promoter, thereby facilitating the selection of clones in cell culture and the
monitoring of gene expression within these cells (Ref: Friedrich G. and Soriano P., 1991). A
splice acceptor site at the 5' end of the vector ensures the splicing of the RNA transcript to
generate a gene/(3-gal/neo fusion mRNA strand, thus achieving a functional disruption of the
trapped gene and subsequent identification of the gene sequence using established PCR methods.
The gene trap approach has already demonstrated its considerable potential, particularly as applied
to murine ES cells where it represents an efficient strategy for functional analysis of the mouse
genome (Ref: Skarnes W.C. et al., 1993; Forrester L.M. et al., 1996). ES clones derived from
gene trapping can be injected into early blastocysts to generate chimaeric animals, which can be
bred to generate mice both heterozygous and homozygous for the mutated gene locus. In many
cases, these animals might exhibit mutant phenotypes arising from functionally disrupted genes
(Ref: Townley D.J. et al., 1997).
However, few strategies have been described for identifying which of these gene trap clones merit
further analyses. This is because such clones, carrying single allele deletions, typically do not
exhibit any perturbation of cellular phenotype. The method described here represents a novel
variation on the conventional gene trapping approach that aims to permit in vitro screening of
clones of interest according to whether or not they exhibit a mutant phenotype. This is achieved
by employing a gene trap vector that possesses a powerful promoter inserted in reverse orientation
upstream of the splice acceptor site, thus allowing the transcription of an antisense RNA strand via
a secondarily transfected vector carrying a transactivating gene. This antisense RNA strand serves
to functionally disrupt expression of the counterpart allele, thereby generating a clone that is
effectively a functional "double knockout" for the locus. Such a strategy permits genotype and
phenotype to be directly correlated with one another and has demonstrated its potential in NIH3T3
cells where it has been employed to identify two putative tumour susceptibility genes (Ref: Li L.
et al. 1996; Liu K. et al. 1999).
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Figure 3.1: Schematic illustration of classical gene trapping strategy using basic vector design.
The gene trap vector "traps" the host promoter via a splice acceptor site generating a fusion mRNA
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3.2 Overview of the vector constructs
Three vectors are relevant to this chapter, namely pGSV and pTX, both a kind gift from Stanley
Cohen, Stanford University (Ref: Li L. & Cohen S., 1996), and pCRE (purchased commercially
from Invitrogen Inc. as pBS185™). The essential design features of these vectors are outlined
below (Figure 3.2).
Gene Search Vector GSV is a pHHAM-derived retroviral vector designed to insert randomly
within genomic DNA. It carries a P-geo reporter gene, which is transcribed only if insertion
occurs within the intron of a gene that is being actively expressed. Splicing of the fusion
transcript occurs via the upstream splice acceptor site resulting in juxtaposition of exonic and (3-
geo sequences and disruption of the gene. Therefore, neomycin-resistant clones (which should
concomitantly produce P-galactosidase and so stain dark blue with X-gal) represent those cells in
which there is a hemizygous deletion of the gene containing the search vector. The reversed
promoter sequence acts to initiate transcription of an antisense RNA strand in the presence of
transactivator LAP348, whose gene is contained in the vector TX.
Transactivating Vector. TX is derived from pHCMVLAP348. It contains a HyTK gene
expression cassette ligated into a Hind III site upstream of the transactivator gene, LAP348; this is
bracketed by loxP sites derived from pBS304. LAP348 carries the operator-binding domain of the
E. coli lacl repressor protein and the herpes simplex virus transactivation domain, VP 16, and acts
as a transcriptional activator in mammalian cells3. Activation of the reversed promoter in
pLLGSV by LAP348 occurs in trans and results in transcription of a RNA strand that is antisense
to the upstream portion of the trapped gene fusion transcript. Therefore, hygromycin-resistant
clones represent those cells carrying successful integration of the TX vector and will include cells
in which LAP348 expression has induced a functional disruption of both allelic copies of the
trapped gene, rendering a functional homozygous gene knockout.
Excision Vector. Cre carries a gene encoding for a recombinase, Cre, which acts specifically on
the lox-sites contained in TX. Therefore, integration of the excision vector into /zygro-resistant
cells results in deletion of the LAP348/HyTK segment located between these lox sites allowing
selection of ganciclovir-resistant clones. Thus, the function of the trapped gene partner allele is
restored resulting in return to a hemizygous state.
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Figure 3.2: Vectors used to derive functional knockouts via gene trap / antisense strategy.




5'LTR 3'dLTR 3'dLTR Ori Amp
Designations: LTR, retroviral long terminal repeats; SA, splice acceptor site; reversed
promoter, SV40 T antigen minimal early promoter linked to 14 tandemly repeated copies of
E. coli lac operator sequence (arrow indicates direction oftranscription); fi-geo, reporter gene
fusion ofE. coli lacZ and neo genes (arrow indicates sense direction of fusion gene).
B: Transactivating Vector (TX)
CMV Hyq TK CMV LAP348
lox polyA polyA Ori Amp Iox
Designations: CMV, cytomegalovirus promoter; HyTK, hygromycin resistance (hyg) and
thymidine kinase (TK) fusion gene; LAP348, transactivator gene; poly(A), signals
determining the site ofmRNA polyadenylation; lox (arrowheads indicate the orientation of
lox sites), recognition site for Cre recombinase encoded by segment depicted Cre figure.
C: Excision Vector (Cre)
Cre
RSV polyA Ori Amp
Designations: RSV, Rous sarcoma virus promoter; Cre, site-specific recombinase.
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3.3 Overview of the experimental strategy
The experimental strategy comprises three steps: step one yields neomycin-resistant single-
knockout gene trap clones; step two yields hygromycin-resistant functional double-knockout
clones; and step three yields ganciclovir-resistant single-knockout revertant clones (Figure 3.3).
Figure 3.3: Experimental strategy for deriving functional gene trap/antisense knockouts.
Step 1: GSV Transfection SINGLE GENE
KNOCKOUT
P SA B-gal neo
[~
P = reversed promoter;
SA = adenovirus splice acceptor;
B-gal = B-galactosidase;
neo = neomycin resistance gene;
E = exon; EP = electroporation
EP
Step 2: TX Transfection
lox Hyg TK LAP lox Ep
Hyg = hygromycin resistance gene;
TK = thymidine kinase;
LAP = LAP348 transactivating factor;
lox = lox excision site;
Anti-mRNA = antisense RNA strand
Step 3: Cre Transfection
Cre EP
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3.4 Overview of the experimental design
The three steps, that together comprise the experimental strategy outlined above, were performed
sequentially as illustrated below (Figure 3.4).
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3.5 Gene search vector (pGSV) traps active genes in ES cells
The gene search vector, pGSV, yielded approximately 10 neomycin-resistant colonies per 107 ES
cells when electroporated with 50pg circularised (uncut) plasmid DNA. A total of 33 CCE-
derived and 21 E14-derived gene trap clones were analysed.
The gene trap ES cell clones were assayed for LacZ expression and scored according to the pattern
and intensity of staining which reflects the activity of the trapped promoter. Three transfection
experiments were performed, the first two on CCE cells, termed C and D clones, and the third on
E14 cells, termed E clones. 15 out of a total of 33 (45%) CCE clones were positive for (1-
galactosidase expression, at variable levels, while 17 out of 21 (81%) E14 clones were positive.
The (3-galactosidase positive clones are listed below together with the intensity and pattern of
staining observed.
Clone Intensity of staining Pattern of staining
C1 ++++ Heterogenous
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El i i i i i Uniform
E2 +++ Uniform








El 1 +++ Heterogenous
E12 +++ Heterogenous (membrane)
El 3 +++ Uniform
E14 i i i i Heterogenous
El5 I I I I Heterogenous
El 6 ++++ Uniform
El 7 ++++ Uniform
El 8 + Scattered
El 9 ++ Heterogenous
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3.6 5' rapid amplification of cDNA ends (5'RACE) enables gene trap sequences
to be identified
5'RACE was performed on total RNA extracted from all (3-galactosidase positive clones listed
above (Refs: Frohman M.A., 1994; Townley D.J. et al., 1997). Out of a total of 32 clones, nine
produced discrete PCR bands that could be directly sequenced without resort to cloning (27%
success rate). All nine revealed gene trap integrations involving the 5' end of the p-galactosidase
sequence and the splice acceptor region fused in frame with the upstream exon of the trapped
gene. These are listed below:
Clone Trapped gene Homology
C2 Tsix (Xist antisense gene on X chromosome) 188bp
C16 X chromosome, clone RP23-43613 123bp
D1 chromosome 4, clone RP23-282N17 180bp
D2 chromosome 2, clone RP23-216D20 105bp
D4 chromosome 19, clone RP23-117H14 310bp
E3 Catns (catenin src gene, pi20) 146bp
E5 Rex2 (reduced expression gene) 145bp
E6 Nasp (somatic histone binding protein) 294bp
E12 Ctbp2 (C-terminal binding protein 2) 326bp
The 5'RACE methodology is shown schematically overleaf (Figure 3.5a) together with the
sequences of the nested primers (Figure 3.5b). The cDNA sequence of the 5'RACE product
derived from clone C2 is shown (Figure 3.6) for purpose of demonstrating homology alignment
with the Tsix gene. Finally, the raw cDNA sequence analyses for the four gene trap clones, E3,
E5, E6 and E12 is also included (Figure 3.7), for purpose of demonstrating the splice integration
site of the GSV gene trap vector via the splice acceptor sequence. Note that all four integrations
are shown in reversed orientation reflecting the 3' to 5' reading of the cDNA sequence from the
nested P-galactosidase primer through the adenoviral splice acceptor and into the upstream portion
of the endogenous gene. The actual site of insertion for each of these four gene trap integrations is
given below the respective sequence analysis. For clones E3 and E5, the integration is within the
5' untranslated region of the gene upstream of the start codon, whereas for clones E6 and E12, the
integration is juxtaposed to the gene's first coding exon downstream of the start codon.
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Figure 3.5a: Schematic diagram illustrating method of rapid amplification of cDNA ends.
5'RACE enables the amplification of gene sequences upstream of the gene trap insertion site.
The method is based upon the following steps: reverse transcription of the upstream mRNA
sequence, then homopolymeric tailing of the cDNA, and finally amplification through two cycles
of PCR using nested downstream primers.
Fusion mRNA Transcript








Second Round PCR CZZl ggggggi I
I Ir.r.r.r.ccci T
primer 3
Final PCR Product t=l gggggg l— ~t
i J ccccccci
Figure 3.5b: Sequence, notation and location of the two sets of primer triplets used for 5'RACE.
Two triplet sets ofprimers were used for amplification of gene trapped cDNA ends by the method of
5'RACE outlined in Figure 3.5a above. For each set, primer 1 was used for cDNA synthesis and primers 2
and 3 used with an anchor primer for the first round and nested round of PCR amplification respectively.
Primer 1: p-galRl ATTCAGGCTGCGCAACTGTTGG = bp 2023-2002
Primer 2: P-galR2 CTGCAAGGCGATTAAGTTGG = bp 1943-1924
Primer 3: (3-galR3 TAACGCCAGGGTTTTCCCAG = bp 1922-1904
Primer 1: LacRl TAATGGGATAGGTTACG = bp 2180-2164
Primer 2: LacR2 AGTATCGGCCTCAGGAAGATCG = bp 2107-2096
Primer 3: LacR3 ATTCAGGCTGCGCAACTGTTGG = bp 2023-2002
79
Chapter 3 - Results 1
Figure 3.6: Alignment of DNA sequence derived from 5'RACE analysis of clone C2 genomic DNA.
5'RACE analysis ofgenomic DNA extracted from the gene trap clone C2 reveals a PCR product whose
DNA sequence shows homology with the Tsix gene (testis-specific gene, on X chromosome). This gene
is the antisense version of the Xist gene (X-inactive transcripts, also on X chromosome) with which the
DNA sequence of the PCR product, as expected, also shares sequence homology. The 3' to 5' orientation
of the PCR product, whose DNA sequence is read through in the antisense direction from the upstream
neo gene, confirms that the site of the gene trap integration is within the Tsix gene and not the Xist gene.
1) gi|25137577|gb|AF541962.1 Mus musculus Tsix antisense RNA ... 6e-96
2) gi|13469702|gb|AF138745.1 AF138745 Mus musculus domesticus ... 6e-96
3) gi|21425583|emb|AJ421479.1 Mus musculus X-inactivation cen... 6e-96
4) gi|1673440|emb|X99946.1 MMTSXDNA M.musculus 94kb genomic se... 6e-96
5) gi|25004494|emb|AL669964.18 Mouse DNA sequence from clone ... 6e-96
6) gi|1150729|gb|U41396.1 MMMB414A3 Mus musculus X inactive sp... 6e-96
Mus musculus Tsix antisense gene (Tsix)
Query: 195 cgctccgctctggccacctgtctagctggctatcacgctcttcttccatcacgcgcttgccgcagc 260
llllllllllllllllllllllllllillllllllllllllllllllllllllllll
Sbjct: 250 cgctccgctctggccacctgtctagctggctatcacgctcttcttccatcacgcgcttgccgcagc 185
Query: 261 cgcctcccgggagtggatgcaggactcaagatgcgtggatatctcggaaagtgagaacagag 322
1111111111111111111111111111111111111111111111II11III 11111
Sbjct: 184 cgcctcccgggagtggatgcaggactcaagatgcgtggatatctcggaaagtgagaacagag 123
Query: 323 caagggcgccgagcgcaagtgtgtagcgcttgcaggtactttttgggaccgagtggagcac 383
llllllllllllllllllllllllllllllllllllllllllllllllllllllll
Sbjct: 122 caagggcgccgagcgcaagtgtgtagcgcttgcaggtactt-ttgggaccgagtggagcac 63
80
Chapter 3 - Results 1
Figure 3.7: 5'RACE cDNA sequence analysis reveals site of splice integration of the gene trap vector.
Sequence analysis of the 5'RACE cDNA products of four X-gal positive E14 clones reveals the splicing
integration sites of the gene trap vector for the four clones E3, E5, E6 and E12 (respectively genes Catns,
Rex2, Nasp and Ctbp2). Note that the splicing via the acceptor sequence is identical for each gene trap.
B-galactosidase (5'to 3') Splice acceptor (5'to 3') Gene (3'to 5')
< M ►
Clone E3 - Catns (catenin src gene, pl20): Intron 1 insertion, 95bp upstream of start codon (5'UTR).
B-galactosidase (5' to 3') Splice acceptor (5' to 3') Gene (3' to 5')
►
T XX5CT^<TMAAOS?n^^imm(TRT<3tfR£5A'rOi-(XAGr-T6iTCXSXlACCi}!'CG&"'COOCAC tX^AG*.C03CGW«SAG G CC CftACCGCGttJC' 'JGAICC "f'i'G GA6AG~C'
jftmrnrnMrnmrnm
OCttgjcc:t--aacci. ,iciwiacicri^aa\G&iY;ao»: irvtggrcmgttc»c^r.^cATAinrAnpccTTcrc/vncTaACAcx".?c.racxrTorrRAATPra: tft-carnccaaavc
130 140 1 s:; 170 130 190 2C0 22C 220 230 240
i IUL/UJ
Clone E5 - Rex2 (reduced expression gene): Intron 1 insertion, 209bp upstream of start codon (5'UTR).
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Clone E12 - Ctbp2 (C-terminal binding prot.): Intron 2 insertion, 53bp downstream of start codon (exon 1).
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3.7 Gene trap clones C2, E5 and E6 exhibit uniform X-Gal staining suggestive of
constitutive promoter activity in undifferentiated ES cells
B-galactosidase expression was assessed by X-gal staining of undifferentiated ES cells. Of those
clones listed above for which 5'RACE yielded the identity of the trapped gene, three exhibited a
uniform expression pattern, namely C2, E5 and E6, shown below (Figure 3.8). This result
suggests that the respective genes, Tsix, Rex2 and Nasp, are constitutively expressed in
undifferentiated ES cells.
Figure 3.8: Photomicrographs revealing uniform X-gal staining of gene trap clones C2, E5, E6.
Photomicrographs demonstrating (a) control wild-type CCE ES cells (phase contrast), (b) clone C2
(phase contrast), (c) clone E5 (bright field), and (d) clone E6 (bright field). All three gene trap clones,
C2, E5, E6 (respectively Tsix, Rex2, Nasp) exhibit uniform X-gal staining in undifferentiated ES cells.
a Wild type CCE ES cells b Clone C2 cells
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3.8 Clones E3 and E12 exhibit discrete X-gal staining patterns that may reflect
sub-cellular localisation of the respective gene trap fusion proteins
Clones E3 and E12 both exhibit non-uniform discrete X-gal staining. For clone E3, in which the
catenin-src gene is trapped, this is at discrete sites within each cell while for clone El2, in which
the C-terminal binding protein 2 gene is trapped, this is localised most intensely in the peri-
membrane region of the cell (Figure 3.9). If the transcribed p-galactosidase retains the localisation
signal of the trapped gene fused upstream via the splice acceptor site, then it is plausible that the
staining pattern reflects the sub-cellular localisation of the trapped gene product with implications
for gene function. Alternatively, this finding might represent staining artefact unrelated to the
trapped gene. Both these possibilities are discussed in relation to known gene function later.
Figure 3.9: Photomicrographs revealing discrete X-gal staining patterns for clones E3 and E12.
Photomicrographs revealing the P-galactosidase staining pattern for two gene trap clones: E3 (Catns
gene) at x20 (a) and x50 (c) magnification; and E12 (Ctbp2) at x20 (b) and x50 (d) magnification. For
E3 cells, P-galactosidase staining occurs in discrete peripheral foci, while for E12 cells, P-galactosidase
staining is principallymembranous, possibly reflecting localisation of respective fusion protein products.
a Clone E3 cells b Clone E12 cells
C Clone E3 cells d Clone E12 cells
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3.9 The gene trap genes, Rex2, Nasp, and Ctbp2, are not expressed in erythroid
cells, as assessed by LacZ staining, during haematopoietic differentiation
Ideally, the P-galactosidase staining should faithfully reflect the transcriptional activity of the
trapped promoter and thereby that of the endogenous gene during ES cell differentiation. In the
course of methylcellulose differentiation analysis of the three gene trap clones, E5, E6, and E12,
p-galactosidase expression was never evident in haemoglobinised erythroid cells despite relatively
strong staining in other haematopoietic and non-haematopoietic cells. By contrast, clone E3, in
which the trapped gene is the ubiquitously-expressed catenin-src, exhibited p-galactosidase
expression in all haematopoietic cells including those undergoing haemoglobinisation, thereby
serving as a useful experimental control. Thus, these findings suggest that there is lineage-
restricted expression of the three genes Rex2, Nasp and Ctbp2 during haematopoiesis, but not of
the gene Catns (Figure 3.10). Formal exclusion of the alternative explanation, namely that X-gal
staining fails to reveal P-galatosidase expression in haemoglobinised cells for reasons such as
changed pH, would require protein quantification by immunoblotting.
Figure 3.10: X-gal staining of haematopoietic embryoid bodies derived from ES gene trap clones.
Haematopoietic embryoid bodies derived from methylcellulose differentiation ofES cell gene trap clones:
(a) E5 (Rex2), (b) E6 (Nasp), and (c) E12 (Ctbp2) all fail to exhibit any X-gal staining of
haemoglobinised cells as contrasted with (d) E3 (Catns) which does exhibit ubiquitous X-gal staining.
a Clone E5 cells (Rex2) h Clone E6 cells (Nasp)
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3.10 "Enforced" expression of the gene trapped gene via maintained G418
selection pressure during ES cell differentiation induced by LIF-withdrawal
This experiment was designed to explore the effect of functionally "enforced" expression of the
trapped gene via maintenance of G418 antibiotic in the culture medium. The G418 prevents
down-regulation of the promoter driving the neomycin resistance gene, which would otherwise
result in cell death, and thereby results in concomitant constitutive expression of the homologous
(normal) copy of the trapped gene.
Experiments were performed on gene trap clones E3, E5, E6, El2 by plating individual cells at
low density (1OOcells/ml) on paired tissue culture plates (1,000 cells per 10ml plate) that either
contained G418 at a dose of lOOpg/ml or were G418 free. The cells were cultured in medium
lacking LIF and left for a period of one week to allow differentiation to occur.
For the three gene trap clones, E3, E6, El2 (respectively, trapped genes Catns, Nasp, Ctbp2), there
were no qualitative morphological discrepancies in differentiation between the paired plates (G418
100pg/ml versus G418 free). However, for the gene trap clone E5, in which the gene trap
insertion involved the gene Rex2, there was an obvious qualitative difference between the two
plates. Here, the G418 lOOpg/ml plate contained relatively few cells that were almost exclusively
undifferentiated while the G418 free plate contained ES cells undergoing normal differentiation
(Figure 3.11). This observation suggests that Rex2 expression, "enforced" by the presence of
G418, is incompatible with normal ES cell differentiation and results in the persistence of an
undifferentiated ES cell phenotype. This conclusion suggests that Rex2 is phenotypically
reminiscent of the unrelated gene Rexl. Rexl, which like Rex2 is so-named because of its
reduced expression in the presence of retinoic acid, is a well-recognised marker of undifferentiated
ES cells that undergoes rapid down-regulation once differentiation is induced via withdrawal of
LIF from the medium.
This observation raises the hypothesis that Rex2 is an important gene regulating ES cell
differentiation. However, the case is far from proven and the evidence presented here is
circumstantial and not conclusive. Further experiments to test this hypothesis would include the
introduction of the Rex2 gene into ES cells under a constitutive or conditional promoter and the
knockout of the gene using perhaps RNA interference, antisense approaches, or targeted
disruption. The latter could be used for blastocyst injection to derive chimaeras and generate
transgenic mice that could be bred to yield homozygous embryos and thereby true knockout ES
cells.
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Figure: 3.11: Gene trap clone E5 cells grown in the presence of G418 fail to differentiate.
ES cells of the E14 gene trap clone, E5, that carries the gene trap vector inserted into Rex2, were
cultured at low density in the absence ofLIF on paired G418 1OOpg/ml and G418 free plates. The
photomicrographs reveal undifferentiated ES cells growing on the G418 lOOpg/ml plate at x 20
(a) and x50 (b), but differentiated ES cells growing on the G418 free plate at x 20 (c) and x50 (d).
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3.11 B-galactosidase negative sub-clones are generated following introduction of
the transactivator vector (pTX) into gene trap ES cell clones
Generation of gene trap sub-clones carrying the transactivator vector, pTX, was attempted initially
on the four most strongly P-galactosidase positive CCE clones, CI, C2, C3 and CI6. Each clone
was grown to confluency on a T75, then trypsinised and divided equally into two cuvettes for
electroporation, one with 50pg of pTX plasmid DNA and the other with 50pg of a control
hygromycin vector, pPGK-hyg. Electroporated cells were plated onto duplicate plates and
selected with hygromycin at a concentration of 300pg/ml until colonies emerged. Colonies were
grown to day 12 when P-galactosidase expression was assessed by in situ staining using X-gal.
An independent arbiter, blinded to the identity of the plates, performed unbiased scoring of LacZ
expression by crude subjective assessment of the intensity of colony staining into strong, weak and
absent, thereby permitting comparison between the antisense and control plates. This revealed a
higher proportion of LacZ negative and weakly staining colonies on the pTX plate than for the
pPGK-hyg control plate (Figure 3.12). A total of 100 colonies were scored for each plate and the
results analysed statistically using Student's t-test for paired data. This demonstrated that the
observed reversal of P-galactosidase expression was statistically significant (p=0.003).
Thus, there is evidence that antisense transcription, initiated from the reversed promoter upstream
of the splice acceptor site, is able to knockdown expression of the p-galactosidase gene and, by
inference, presumably that of the trapped gene locus likewise. However, this effect was not
universal since some sub-clones remain LacZ positive implying that antisense knockdown has
variable penetrance due to factors not determined. These CCE clones were not analysed further as
attention was turned to E14-derived clones described below.
The four P-galactosidase-expressing E14 gene trap clones, E3, E5, E6 and El2, whose gene trap
integration sites were characterised by 5'RACE, were expanded and electroporated with the pTX
transactivator vector as described for the CCE clones above. On this occasion, hygromycin-
resistant sub-clones were picked individually onto duplicate wells and one well was subjected to
X-gal staining to assess P-galactosidase expression. Three of the four clones, E5 (Rex2), E6
(Nasp) and El2 (Ctbp2), yielded "antisense" sub-clones that were fully negative P-galactosidase
expression (Figure 3.13). These were assumed to represent clones in which the trapped gene,
together with the downstream P-geo fusion, had been functionally deleted by the antisense
mechanism. They were individually expanded for further phenotypic analysis and for "antisense
knockout reversal" through Cre-recombinase excision of the transactivator.
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Figure 3.12: Pie charts showing the loss of B-galactosidase expression in "knockout" sub-clones.
Four gene trap CCE ES clones were used to generate hygromycin-resistant sub-clones by insertion of
either a pPGK-hyg control vector (a) or the pTX transactivator vector (b). The sub-clones were scored
for level ofexpression of p-galactosidase, according to the accompanying key, to permit comparison.
Student's t-test for paired data was used to demonstrate that the observed reversal of P-galactosidase
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Figure 3.13: Photomicrographs demonstrating B-galactosidase negative "knockout" clones.
Hygromycin-resistant sub-clones were generated from the E14 gene trap clones using the pTX
transactivating vector and hygromycin selection. Putative "antisense knockout" p-galactosidase-
negative sub-clones were identified for (a) E5 (Rex2), (b) E6 (Nasp), and (c) E12 (Ctbp2). By
contrast, no p-galactosidase negative sub-clones were derived from the control experiments using a
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3.12 Comparative differentiation of gene trap clones with antisense knockout sub¬
clones fails to identify any differences using the methy(cellulose assay
The identification of genes important for normal differentiation represents the principal goal of the
current gene trap antisense knockout strategy. To this end, CCE-derived gene trap ES cell clones
(carrying the pPGK control vector) were compared with their corresponding "antisense" sub-clone
derivatives (carrying the pTX transactivator vector) using the methylcellulose assay to screen for
differentiation mutants. In total, 15 CCE-derived clones that were positive for p-galactosidase
expression (comprising seven C clones and eight D clones, as listed in section 3.5) were analysed.
Of this total, none of the "antisense knockout" clones was found to exhibit reproducibly abnormal
differentiation phenotypes when compared with their respective parental gene trap clones. In
large part, this result reflects the fact that the methylcellulose assay is a qualitative assay that is not
easily adapted for quantitative analysis. Moreover, it lacks the simplicity of classical phenotypic
screens being comparatively labour-intensive to perform and therefore poorly suited to the aim of
high-throughput screening of differentiation mutants. For these reasons, the methylcellulose
screening strategy was abandoned and an alternative approach was sought.
The alternative approach employed for selection of the E14-derived gene trap clones. Rather than
performing methylcellulose differentiation on all clones as previously, this was performed instead
on a restricted subset of P-galactosidase positive clones whose gene identity (revealed by 5'RACE
and cDNA sequence analysis) was suggestive of a possible role in differentiation. Such an
approach, which allowed a more detailed comparative analysis, was applied to the three clones E5
(Rex2), E6 (Nasp), and El 2 (Ctbp2), each of which had yielded LacZ positive NeoR gene trap and
LacZ negative Hy^ "antisense knockout" sub-clones. Methylcellulose differentiation assays were
performed in triplicate for each clone pair and the plates were assessed at 10-12 days. This was
done by scoring embryoid bodies qualitatively and quantitatively for recognisable features of
lineage differentiation, namely, erythroid, myeloid/macrophage, mixed haematopoietic, cardiac,
neuronal, and undifferentiated.
As for the CCE clones previously, this more refined differentiation analysis performed on the
three E14 clones, E5, E6, and E12, again failed to reveal qualitative or quantitative abnormalities
of differentiation when compared with their respective "antisense knockout" sub-clone derivatives
(data not shown). If these clones are indeed true functional knockouts of the trapped genes Rex2,
Nasp and Ctbp2, then this result suggests that none is required for normal in vitro differentiation.
However, confirmation of successful antisense deletion by immunoblotting and further functional
analyses of each of these three genes are warranted to corroborate this finding.
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3.13 Generation of Cre recombinase sub-clones leads to the reappearance of p-
galactosidase expression putatively via excision of the transactivator vector
Reversal of antisense knockout was achieved by Cre-excision of the pTX transactivator vector in
P-galactosidase negative clones via transfection of the pBS185™ vector. Sub-clones were
selected using ganciclovir at a concentration of 2pM. Ganciclovir is metabolised into a toxic
product by the thymidine kinase that is expressed from the HyTK cassette carried on the pTX
vector in Hyg11 antisense knockout clones. Cells in which the pBS185™ vector has successfully
carried out Cre-excision of the pTX vector no longer express thymidine kinase and are therefore
resistant to the effects of ganciclovir (like wild-type ES cells). Moreover, these hygromycin-
sensitive / ganciclovir-resistant sub-clones no longer carry the transactivator gene and have
therefore reverted to the original gene trap state. Note that formal demonstration of successful
genomic excision of the lox-flanked pTX vector by Southern blot analysis was not performed but
inferred from the reappearance of P-galactosidase expression indicated by positive X-gal staining.
This is demonstrated for the two gene trap clones C2 and C16 and their derivative LacZ-ve/HygR
knockout and LacZ+ve/GcvR revertant sub-clones below (Figure 3.14)
Figure 3.14: Cre excision of pTX transactivator vector leads to B-galactosidase reappearance.
X-gal staining of the CCE-derived C2 and C16 clones reveal p-galactosidase expression: positive
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3.14 Technical problems relating to the gene trap antisense knockout strategy for
identification of differentiation genes in ES cells
The original aim of using antisense knockout of gene-trapped genes in ES cells was the
identification of genes important to the differentiation process. However, two major impediments
to this goal became apparent in the course of experimentation. These are listed below:
1) The identification of differentiation mutants amongst the "antisense knockout" clones,
by comparative methylcellulose differentiation with the parental gene trap clones,
proved excessively labour-intensive and inefficient as a screening strategy. Moreover,
the methylcellulose assay lacked the qualitative and quantitative sensitivity necessary
for adequate discrimination of subtle abnormalities of ES cell differentiation. For both
these technical reasons, the methylcellulose assay was poorly suited to the purpose of
reliable and reproducible high-throughput analysis of ES cell clones.
2) Both the gene trap clones and the "antisense knockout" sub-clones typically exhibited a
broad degree of heterogeneity of P-galactosidase expression at the cellular level. This
was true of all trapped genes not ubiquitously expressed and resulted in a mosaic
population of X-gal negative and X-gal positive cells. Consequently, at the level of the
individual cell, it is difficult to conclude that the absence of P-galactosidase expression
is attributable to an antisense mechanism rather than the alternative explanation of
spontaneous silencing of the trapped locus for stochastic reasons unrelated to the
transactivator. Instead, knockdown of gene expression can only be inferred from an
overall effect of P-galactosidase staining on the whole population of cells. In view of
this technical difficulty, the formal proof of gene knockout using Western or Northern
blot analysis was not pursued. Attempts to overcome the problem using redesigned
gene trap and transactivating vectors that permitted inducible antisense knockout of the
trapped locus were unsuccessful and data is not presented here.
On account of both these technical shortcomings of the overall experimental strategy, the primary
goal of identifying novel genes involved in ES cell differentiation was not achievable. In terms of
the secondary goal of demonstrating proof-or-principle of the antisense gene trap methodology to
derive knockout ES cell clones, this was achieved only by measure of a surrogate reporter gene
rather than the trapped gene itself. These conclusions are explored in greater detail in the
discussion.
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3.15 Conclusion
The primary objective of this chapter was the proof-of-principle demonstration that antisense gene
trapping represents an experimentally legitimate and technically viable method for the
identification of putative differentiation genes in murine ES cells. The secondary objective was
the functional characterisation of these genes through analysis of the gene trap and antisense
knockout clones.
The gene search vector traps active genes in ES cells
A total of 54 ES cell gene trap clones were generated, through genomic integration of the gene
search vector, of which 32 demonstrated P-galactosidase expression. Amongst these, there was
considerable variability of staining intensity, likely reflecting differences in the transcriptional
activity of the trapped promoter. Similarly, there was considerable heterogeneity of staining
patterns with some clones exhibiting diffuse uniform staining, likely reflecting constitutional
promoter activity in all cells, and others exhibiting discrete patchy staining, likely reflecting
stochastic loss of transcriptional activity in some cells.
5'RACE analysis enables identification of gene trap sequences
Identification of the trapped gene sequences, using the technique of 5'RACE, was possible in a
total of nine out of 32 P-galactosidase gene trap clones. Of these nine, five yielded known genes
and four yielded unknown gene sequences. The five genes, whose functional characterisation is
discussed later, are Xist, Catns, Rex2, Nasp, and Ctbp2.
The transactivating vector yields B-galactosidase negative gene trap sub-clones
"Antisense knockout" sub-clones were generated from the four CCE-derived (3-galactosidase
positive gene trap clones, CI, C2 (Tsix), C3 and CI6, via introduction of the transactivating
vector. This resulted in overall reduction of P-galactosidase expression, by LacZ staining assay,
compared with a control vector that lacked the transactivating gene. Similarly, for the four El 4-
derived P-galactosidase positive gene trap clones, E3 (Catns), E5 (Rex2), E6 (Nasp), and E12
(Ctbp2), P-galactosidase negative transactivator sub-clones were derived following integration of
the transactivating vector. The transactivator recognises the reversed promoter sequence upstream
of the splice donor site positioned at the 5' end of the gene trap construct, thereby generating an
antisense RNA strand that includes upstream exon sequence. Thus, the observation of reduced p-
galactosidase expression reflects some degree of loss of expression of the trapped gene, putatively
via the mechanism of antisense inhibition. However, it is also possible for reduced expression of
P-galactosidase to be explained in terms of promoter interference and this issue is discussed later.
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Deficiencies in the above methodology for inferring "gene knockout"
The formal demonstration of reduced expression of the trapped gene in the transactivator sub¬
clones would require quantification of either the mRNA transcript or the protein level using
northern or western blotting respectively. However, the high degree of clone-to-clone variability,
as reflected by heterogeneity of P-galactosidase expression, meant that demonstration of reduced
gene expression in a single clone might not be generalisable to all the other clones. Moreover, it is
difficult to exclude the possibility that reduced mRNA or protein levels might simply reflect the
stochastic loss of expression of the trapped gene rather than any antisense process. Hence, this
direct evidence of antisense inhibition was not attained but rather the indirect evidence of reduced
P-galactosidase expression as described above. This level of evidence sufficed in the original
publication using antisense gene trapping in NIH3T3 cells (Ref: Li L. and Cohen S.N., 1996)
where it was termed random homozygous knockout. Of course, reduced P-galactosidase
expression can only reflect the events happening in cis at the site of the gene trap locus and not
those in trans at the site of the homologous allelic copy of the gene. Therefore, in strict terms it is
not possible to conclude that there has been actual bi-allelic antisense knockout (or knockdown) of
the trapped gene or simply monoallelic loss of the reporter gene.
"Promoter interference" as an alternative explanation of loss of reporter gene expression
Promoter interference represents an alternative explanation to antisense inhibition that could
account for the observation of reduced P-galactosidase expression following introduction of the
transactivating vector. Here, the transactivator initiates antisense transcription leading to the
recruitment of RNA polymerases and other components of the transcriptional machinery that
advance in reverse direction along the DNA strand. Inevitably, this would impede the generation
of mRNA transcripts from sense direction transcription and moreover interfere with the upstream
promoter by disrupting assembly of the transcriptional complex. Such a mechanism would result
in reduced expression of the P-galactosidase gene trapped downstream of the promoter without
resort to any antisense inhibition. Critically, this mode of gene/promoter interference would
operate only in cis and not in trans and thus the knockout would be monoallelic and not biallelic.
In other words, unlike the putative antisense inhibition mechanism, there would be no true
knockout of the trapped gene.
In order to determine which of the two mechanisms described above, namely antisense or
promoter interference, might explain the derivation of P-galactosidase negative transactivator sub¬
clones, it would be necessary to quantity the level of mRNA transcript (by northern blot analysis
or by RT-PCR) or that of the translated protein (by immunoblotting). The reasons these
experiments were not done are explored in the overview section of this conclusion.
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The Cre recombinase vector results in restoration of P-galactosidase expression
The introduction of the Cre recombinase into P-galactosidase negative transactivator sub-clones of
the gene trap clones C2 (Tsix) and C16 resulted in the restoration of P-galactosidase expression.
This observation suggests that transactivator excision is accompanied by reversal of antisense
inhibition (or promoter interference) of the trapped gene, thereby supporting the foregoing
conclusion that loss of P-galactosidase expression is a reliable measure of expression of the
trapped gene. Moreover, it concludes the primary objective of demonstration of the experimental
legitimacy of the antisense gene trapping approach.
Shortcomings of the methylcellulose differentiation assay as a screening strategy
However, the use of antisense gene trapping as a technically viable means of identifying genes
involved in the regulation of ES cell differentiation was contingent upon the use of a suitable
screening strategy. Here, the methylcellulose differentiation assay was used to compare single
knockout gene trap clones with functional antisense double knockout sub-clones to identify any
phenotypic differences. The assay was tailored in particular to assess haematopoietic
differentiation through the use of specific haematopoietic growth factors (erythropoietin,
interleukin-1, interleukin-3, and stem cell factor). However, the identification of differentiation
mutants in this manner proved excessively labour-intensive for the purpose of high throughput
screening on account of the inherent inefficiency of the methylcellulose assay, which lacks the
qualitative and quantitative sensitivity necessary for discrimination of subtle abnormalities. Out of
a total of 15 CCE-derived P-galactosidase negative antisense knockout sub-clones, none exhibited
any gross abnormality of differentiation as compared with the respective P-galactosidase positive
parental gene trap clones. Similarly, using a more refined methodology, none of the four E14-
derived p-galactosidase negative antisense knockout sub-clones, E3 (Catns), E5 (Rex2), E6
(Nasp), and El2 (Ctbp2), exhibited any significant abnormality of differentiation. Hence, the
primary objective of demonstrating technical viability of the antisense gene trapping strategy to
identify differentiation genes in ES cells was not achievable. However, a limited functional
analysis of the genes trapped in clones C2, E3, E5, E6 and El 2 was performed as outlined below.
Functional analysis of the Tsix (antisense to Xist) gene trapped in clone C2
The gene trapped in clone C2 was Tsix. This gene is antisense to the Xist gene and both Tsix and
Xist reside on the murine X chromosome. The DNA sequence derived by 5'RACE analysis
therefore exhibited homology with both these genes, but the corrected 5' to 3' orientation of the
sequence confirmed the integration of the gene trap vector into the Tsix gene and not its antisense
counterpart. Tsix is a 40-kb RNA originating 15kb downstream of the Xist which is known to
regulate X chromosome dosage compensation by controlling X inactivation in collaboration with a
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cw-acting element called the X inactivation centre (Ref: Lee J.T. et al., 1999). At the onset of X
inactivation, Tsix expression becomes monoallelic, is associated with the future active X and
persists until Xist is turned off. Tsix is not found on the inactive X once cells enter the X
inactivation pathway suggesting that it plays an important role in regulating the early steps of X
inactivation. This is supported by the observation that targeted deletion of Tsix gene in female
mouse ES cells results in non-random inactivation of the mutant X chromosome (Ref: Lee J.T. and
Lu. N., 1999). Thus, in the mouse it appears that Tsix regulates Xist in cis and thereby determines
which X chromosome is to become silenced (Ref: Sado T. et al., 2002). By contrast, in whole
mouse embryos, deletion of Tsix results in disruption of the normal paternal imprinting in the
extra-embyronic tissues suggesting that Tsix regulates this process also (Ref: Lee J.T., 2000).
The C2 gene trap clone was derived from CCE cells that are a karyotypically male ES cell line
with a normal male complement of single X and Y chromosomes. Consequently, it is self-evident
that the integration of the gene search vector into the Tsix gene on the single X chromosome
results in insertional mutagenesis of the only copy of Tsix in the cell. Thus, the single knockout
clone represents a complete gene knockout rendering the antisense knockout sub-clone redundant
in this instance. On the other hand, if the role of the Tsix gene is purely antisense inhibition of
Xist, then arguably the insertion of the gene trap vector does little to diminish its functionality.
Either way, neither the single knockout clone nor antisense knockout sub-clone exhibited any
significant abnormality of ES cell differentiation.
Perhaps the most notable insight from this gene trap clone is rather counterintuitive and that is the
fact the [3-galactosidase gene is expressed at all. Since Tsix is an RNA gene whose putative
function is mediated via antisense binding of the RNA molecule to Xist, there is no translation of
the gene into protein (Ref: Ogawa Y. and Lee J.T., 2004). Hence, it is unclear why the (3-
galactosidase of the gene search vector, or for that matter the neomycin phosphotransferase that
confers G418 resistance, should be expressed. The fact that it is suggests that the mRNA, either
despite the gene trap integration or because of it, is indeed translated into protein resulting in
ubiquitous expression of (3-galactosidase in all cells. If this is attributable to upstream sequence
elements within the mRNA transcript, then it suggests that Tsix RNA is able to translocate to
ribosomes in the cytoplasm and is not solely contained within the nuclear compartment.
Future experiments would seek to address both these issues. Firstly, confirmation that gene trap
insertion into Tsix does indeed result in loss of function of the gene and secondly functional
studies to investigate how this leads to alteration in the ability of Xist to initiate X chromosome
silencing.
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Functional analysis of the Catns (Catenin-src) gene trapped in clone E3
The gene trapped in clone E3 was Catns, or catenin-src (also referred to as pi20), that is located
on the murine chromosome 2. This is a novel tyrosine kinase substrate with armadillo homology
that is implicated in ligand-induced signalling via a number of growth factor receptors and also in
cell transformation by p60v-src (Ref: Reynolds A.B. et al., 1992). Catns associates with the cell-
cell adhesion protein complex containing E-cadherin and its cytoplasmic co-factors alpha-catenin,
beta-catenin, and plakoglobin, and like other components of the cadherin/catenin complex, defects
in Catns have been implicated in tumourigenesis (Ref: Reynolds A.B. et al., 1996). More
recently, Catns exists in a membrane-associated cadherin-bound pool, a cytosolic pool that affects
Rho GTPases, and a nuclear pool that is thought to associate with the methylation-relevant
transcriptional repressor Kaiso (Ref: Yanagisawa M. et al., 2004). The cytosolic Catns has been
shown to associate with microtubules and this binding is inversely related to its ability to regulate
Rho GTPases (Ref: Franz C.M. and Ridley A.K., 2004).
In the gene trap clone E3, the gene trap integration within the Catns gene occurred within the first
intron, which is located in the 5' untranslated region approximately 95 base pairs upstream of the
predicted start codon. P-galactosidase expression in undifferentiated ES cells was apparent within
the majority of cells but the pattern of staining revealed discrete foci. Typically each cell
possessed only a single focus of P-galactosidase staining that was located peripherally. It is
tempting to speculate that this reflects localisation of the Catns protein within either the cytosolic
or membrane-associated pool, but this possibility is tempered by the fact that the P-geo fusion
protein cannot carry any upstream localisation sequence tag (although it could conceivably carry a
downstream localisation tag). It is possible however that the fusion mRNA, rather than the
protein, carries upstream sequence information to target the transcript to one portion of the cell
thereby accounting for the discrete nature of the P-galactosidase expression. Introduction of the
transactivator vector into the E3 gene trap clone failed to generate P-galactosidase negative sub¬
clones implying either that the antisense inhibition failed on this occasion, possibly due integration
occurring within the first intron, or was insufficient to overcome the high level of expression of
the gene. Methylcellulose differentiation of the E3 gene trap clone was unremarkable and P-
galactosidase expression occurred ubiquitously without any evidence of cell lineage restriction.
Future experiments would seek to determine whether the P-galactosidase expression pattern
observed in the gene trap clone truly reflects the intracellular localisation of the Catns protein
using fluorescently labelled antibodies and to functionally characterise the gene using more
established knockout technologies such as RNA interference, antisense of targeted deletion.
97
Chapter 3 - Results 1
Functional analysis of the Rex2 (retinoic acid repression) gene trapped in clone E5
The gene trapped in clone E5 was Rex2, a gene that was originally identified using differential
hybridisation on account of its reduced expression during retinoic acid-induced differentiation of
F9 teratocarcinoma cells (Ref: Faria T.N. et al., 1998). Rex2 has also been identified in a large-
scale screen of mammalian proteins and their nuclear sub-compartments (Ref: Sutherland H.G. et
al., 2001). ft is not clear, despite its name, that Rex2 bears any functional or evolutionary ties with
Rexl, which is a zinc finger gene also regulated by retinoic acid and a commonly-used marker of
undifferentiated ES cells.
In the gene trap clone E5, the gene trap integration within the Rex2 gene occurred within the first
intron, which is located in the 5' untranslated region approximately 209 base pairs upstream of the
predicted start codon. p-galactosidase expression was uniform throughout all undifferentiated ES
cells but without any specific intracellular staining pattern. Upon ES cell differentiation in
methylcellulose, P-galactosidase expression was apparent within the embryoid body but never
within cells undergoing haemoglobinisation. Thus, it would appear that Rex2 is down regulated
during erythroid differentiation. This conclusion is supported by the observation above that the
trapped gene Catns is expressed in erythroid cells, thus serving as a convenient positive control
(note that the alternative explanation, namely that haemoglobinised cells stain poorly with X-gal
substrate, was not excluded). Apart from this finding, the methylcellulose differentiation of E5 ES
cells was otherwise unremarkable both for the P-galactosidase gene trap clone itself and also for
the derived P-galactosidase negative antisense knockout sub-clone.
When E5 clone ES cells were induced to undergo differentiation by seeding at low density on
tissue culture plates and removal of LIF from the medium, an interesting observation was made.
The presence of G418 at low dose (lOOpg/ml) resulted in failure of the normal fibroblastic
differentiation seen on the G418-free plate and also in control plates that used other G418-resistant
gene trap clones. Instead, the presence of low dose G418 caused the E5 ES cells to remain in
small colonies of undifferentiated cells even despite the absence of LIF in the medium. Thus, it
would appear that G418, either through enforced expression of the trapped Rex2 gene and the
downstream neo that confers resistance or through antibiotic-induced death of those cells that
switch off Rex2 and neo expression, results in persistence of the undifferentiated ES state in clone
E5 cells.
The rationale for this experiment was based upon previously published work showing that ES cells
carrying a transgenic neo gene, driven by the a-cardiac myosin heavy chain promoter, produced a
homogenous population of cardiomyocytes when differentiated in the presence of G418 due to
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selection of cardiac lineage-restricted cells (Ref: Klug M.G. et al., 1996). In the case of the E5
gene trap clone, where the neo is under the control of the Rex2 promoter, it appears that G418
selection restricts the ES cells to the undifferentiated state even in the absence of LIF.
Thus, Rex2 arguably represents a candidate stem cell gene in ES cells. This conclusion is
consistent with published data showing that induction of differentiation in teratocarcinoma cells,
using retinoic acid, results in down-regulation of Rex2 (Ref: Faria T.N. et al., 1998) and leads to
the testable hypothesis that enforced expression of Rex2 is able to maintain the pluripotent ES
state in a LIF-independent fashion.
Functional analysis of the Nasp (histone-binding protein) gene trapped in clone E6
The gene trapped in clone E6 was Nasp, or nuclear autoantigenic sperm protein. This is a histone-
binding protein that is a homologue of the N1/N2 gene expressed in oocytes of Xenopus laevis
(Ref: Richardson R.T. et al., 2000). It is expressed in both murine ES cells and somatic cells and
is carried on the mouse chromosome 4 (Ref: Richardson R.T. et al., 2001). Nasp has been shown
to be complexed with HI linker histone, suggesting a role as a histone transport protein, and
evidence points to its involvement in regulating the cell cycle (Ref: Alekseev O.M. et al., 2003).
In the gene trap clone E6, the gene trap integration within the Nasp gene occurred within the
second intron, which is located approximately 106 base pairs downstream of the predicted start
codon. P-galactosidase expression was evident throughout nearly all undifferentiated ES cells but
without any specific intracellular staining pattern. Upon ES cell differentiation in methylcellulose,
p-galactosidase expression was apparent within the embryoid body but never within cells
undergoing haemoglobinisation. Thus, as for the Rex2 gene previously, it would appear that Nasp
is down-regulated during erythroid differentiation (although again the alternative explanation that
staining with X-gal substrate is unusually weak within haemoglobinised cells has not been
excluded). Apart from this finding, the methylcellulose differentiation of E6 ES cells was
otherwise unremarkable both for the P-galactosidase gene trap clone itself and also for the derived
P-galactosidase negative antisense knockout sub-clone.
Functional analysis of the Ctbp2 (C-terminal binding protein) gene trapped in clone E12
The gene trapped in clone El 2 was Ctbp2, or C-terminal binding protein 2. This gene, which
resides on the mouse chromosome 21, was originally identified on the basis of its sequence
similarity to the Ctbpl gene whose protein product is known to associate with the C-terminus of
the adenoviral oncoprotein El A via a Pro-X-Asp-Leu-Ser motif (Ref: Katsanis N. and Fisher
E.M., 1998). Unlike Ctbpl, which is expressed from embryo to adult, Ctbp2 is expressed mainly
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during embryogenesis (Ref: Furusawa T. et al., 1999) and appears to be critical for axial
patterning leading to embryonic lethality in mutant null mice (Ref: Hildebrand J.D. and Soriano
P., 2002). The characterisation of the CtBP2 protein has revealed that it functions as a potent co-
repressor for a number of transcriptional factors including the Basic Kruppel-like factor (BKLF)
that is highly expressed in erythroid cells (Ref: Turner J. and Crossley M., 1998), and that this
action is mediated via binding to a minimal repression domain (Ref: Thio S.S. et al., 2004). Ctbp2
has also been shown to interact with the hematopoietic, zinc-finger protein FOG1 that is essential
for the development of the erythroid and megakaryocytic lineages (Ref: Katz S.G. et al., 2002).
In the gene trap clone El2, the gene trap integration within the Ctbp2 gene occurred within the
second intron, which is located approximately 53 base pairs downstream of the predicted start
codon. p-galactosidase expression was apparent in nearly all undifferentiated ES cells and
exhibited a specific staining pattern that was strongest in the peri-membrane region with
occasional sub-membrane foci. However, given the fact that this protein is known to act within
the nucleus as a transcriptional co-repressor, this unusual staining pattern is unlikely to indicate
physiological localisation of the protein within the cell and perhaps more likely to represent
staining artefact.
Upon ES cell differentiation in methylcellulose, P-galactosidase expression was apparent within
the embryoid body but never within cells undergoing haemoglobinisation. Thus, as for both Rex2
and Nasp genes previously, it would appear that Ctbp2 is down-regulated during erythroid
differentiation (although once again it is not possible to exclude the possibility that staining with
X-gal substrate is inexplicably weak within haemoglobinised cells). Apart from this finding, the
methylcellulose differentiation of El2 ES cells was otherwise unremarkable both for the P-
galactosidase gene trap clone itself and also for the derived P-galactosidase negative antisense
knockout sub-clone.
The apparent absence of expression in cells undergoing erythroid differentiation is in interesting
contrast with a related gene called FOG1. This gene is highly expressed in erythroid cells and acts
in concert with the transcriptional factor GATA1 to regulate erythropoiesis. In view of the known
interaction between CtBP2 and FOG1 (Ref: Katz S.G. et al., 2002), this reciprocal expression
pattern in erythroid cells suggests a model in which the lifting of CtBP2-mediated repression of
FOG1 is an important step during haematopoietic differentiation that leads to normal
erythropoiesis.
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Overview
As stated previously, the primary objective of this chapter was the proof-of-principle
demonstration that antisense gene trapping represents an experimentally legitimate and technically
viable method for the identification of putative differentiation genes in murine ES cells with the
secondary objective being the functional characterisation of these genes through analysis of the
gene trap and antisense knockout clones. Gene trapping in ES cells represents a powerful form of
random mutagenesis that has been used to reveal insights into the expression patterns of many
genes and to generate transgenic mice with the potential for breeding knockout offspring.
However, the inherent weakness of gene trapping lies in the fact that the gene-trap clones are only
hemizygous knockouts and therefore unlikely to yield a mutant cellular phenotype. Antisense
gene trapping represents a refinement of the established methodology designed to overcome this
shortcoming by enabling generation of functional double-knockout ES cell clones through
transactivation of a reversed promoter contained upstream of the gene-trap site. The RNA strand
thus generated would then inhibit gene expression via antisense hybridisation with the mRNA
transcript.
However, as explained previously, this trans inhibition is not the sole mechanism able to account
for the resulting p-galactosidase negative transactivator sub-clones. The alternative explanation is
that of promoter interference operating in cis via processes of mechanical hindrance of the
transcriptional complex. In order to discern which of these explanations best accounts for the
reversal of P-galactosidase expression, it would have been necessary to quantify either the level of
mRNA transcript or alternatively that of the translated protein. For mRNA levels this would be by
northern blot analysis or by RT-PCR, while for protein levels this would be by western blot
analysis. In the case of antisense inhibition operating in trans, there should be complete biallelic
knockout of gene expression resulting in minimal or absent levels of mRNA or protein. By
contrast, in the case of promoter interference operating in cis, the knockout would only be
monoallelic and therefore the mRNA and protein levels should only fall by approximately half
compared with wild-type ES cells and not at all compared with the mother gene-trap clone that is
already a hemizygous knockout.
In view of this alternative mechanistic explanation of the observed results, and the failure to
discern experimentally between them, it is arguably the case that the primary objective of this
chapter was not met. However, it should be borne in mind that the primary objective was not the
proof-of-principle demonstration of the antisense gene-trap methodology but rather its ability to
yield phenotypically mutant ES cell clones. This after all was the manner in which antisense gene
trapping originally proved its worth in NIH3T3 cells as a screen for tumour susceptibility genes
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(Ref: Li L. and Cohen S.N., 1996). Moreover, in this original demonstration of the methodology,
those mutant 3T3 clones selected for anchorage independence by an agar assay did indeed show
knockout of the trapped gene with loss of mRNA expression via northern blot analysis. In other
words, there already exists a proof-of-principle of the antisense gene trapping methodology, albeit
in 3T3 cells, and for this reason further experiments to prove the worth of the methodology in ES
cells were not pursued. Rather, the difficulty encountered in applying this strategy to ES cells was
that of failure to derive mutant clones due to a shortcoming of the methylcellulose differentiation
assay. Indeed, it is the screening strategy, rather than the knockout methodology, that represents
the major weakness of the whole forward genetics approach. This is particularly true in the case
of identifying differentiation genes in ES cells where the screening strategy must exhibit attributes
of discrimination, accuracy and reproducibility as well as being both high-throughput and non-
labour intensive.
Despite the failure to fulfil the primary objective of this chapter and derive mutant ES cell clones,
the secondary objective of functional characterisation of the gene-trap clones was arguably
achieved. However, the failure of any of the |3-galactosidase-negative transactivator sub-clones to
yield aberrant differentiation meant abandonment of the antisense gene trapping methodology in
favour of a new strategy for achieving gene knockout in ES cells, namely RNA interference.
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4.1 Introduction
RNA interference (RNAi) refers to the process whereby double-stranded RNA molecules are
processed into short interfering RNAs (siRNAs) able to induce knockdown of expression of genes
sharing complementary sequences. RNAi appears to represent an evolutionarily ancient cellular
process whose primary role is probably that of defence against foreign transposable elements but
may also have a secondary role in gene regulation. The principal aim of this chapter was to
explore the biology of the interference effect using a simple and tractable experimental model,
namely the knockdown of expression of a Firefly luciferase reporter plasmid using sequence-
specific siRNAs that are transiently co-transfected with the plasmid into the cell. This aim
comprises a number of goals:
To establish what is necessary and sufficient for induction of siRNA-induced gene knockdown
To demonstrate the importance of sequence-specific fidelity in the interference process
To investigate the potency and dose-dependency of siRNA-induced gene knockdown
To establish the stoichiometric ratio of sense and antisense RNA strands for interference
To investigate the effect of additional siRNAs on the potency of the interference effect
To establish whether there is differential functionality between the sense and antisense strands
To study the dynamics of the interference reaction by analysing the time course of knockdown
To study the kinetics of the interference reaction with regard to competitive reversibility
To study the magnitude and persistence of the interference knockdown effect
To confirm that knockdown of a transient gene can be recapitulated against a stable gene
To compare the efficacy of chemically synthesised siRNAs with in vitro transcribed siRNAs
To explore methods of enhancing delivery of siRNAs molecules into cells
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4.2 Sequence-specific short interfering RNA molecules suppress Firefly luciferase
expression in a potent and dose-dependent manner
Chemically synthesised siRNAs, sharing sequence homology to the Firefly luciferase gene
(position 154-172 from start codon), result in a potent knockdown of gene expression using a
transient transfection experimental system in both NIH 3T3 cells and murine ES cells. Here, the
siRNAs were co-transfected together with the Firefly luciferase reporter plasmid (pGL3) and a
Renilla luciferase internal control (pRL-CMV) into 3T3 cells and ES cells. This resulted in a
highly specific and dose-dependent suppression of Firefly luciferase expression in both cell lines
that was maximally potent at the highest concentration tested. The specificity of the interference
was evident from the observation that there is no knockdown of expression of the Renilla internal
control (except at very high doses of siRNAs where plasmid transfection itself is likely to be
compromised). This experiment highlights the potency and specificity inherent to the RNAi
process in 3T3 and ES cells, both of which exhibit remarkably similar knockdown profiles
illustrated in the graph below (Figure 4.1).
Figure 4.1: Sequence-specific siRNAs result in potent and specific gene interference.
Graph demonstrating the potent and specific nature of the knockdown effect resulting from
transient transfection of Firefly-specific siRNAs together with a Firefly luciferase target
plasmid and Renilla luciferase internal control plasmid in NIH 3T3 and murine ES cells.
Error bars represent the range derived from duplicate experiments.
0 0.1 1 10 100 1000
Dose of siRNA (ng per well)
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4.3 Interference ofFirefly luciferase expression is dependent upon the presence of
both sense and antisense RNA oligonucleotide strands
Transfection of either sense of antisense oligonucleotide strands alone is insufficient to induce
knockdown of Firefly luciferase expression, compared with a non-specific siRNA control, in a
repeat of the 3T3 transient transfection experiment above. However, if both sense and antisense
strands are transfected in an equimolar ratio, then there is potent knockdown of Firefly expression
irrespective of whether or not these have been pre-annealed by cooling slowly from 95°C. Hence,
both sense and antisense RNA 21mer strands, sharing 19bp of homology to each other and the
target gene, would appear to be necessary and sufficient for RNAi knockdown in mammalian cells
as illustrated graphically below (Figure 4.2).
Figure 4.2: Both sense and antisense RNA strands are required for gene interference.
Sense and antisense RNA molecules, irrespective of a prior explicit annealing step, appear to
be necessary and sufficient for knockdown ofFirefly luciferase in this experimental system.
Data-points are derived from single experiments and hence error bars have not been applied.
buffer nonsense oligo sense antisense sense + antisense GL3 dsRNA
(LacZ dsRNA) (non-annealed) (pre-annealed)
RNA oligonucleotides
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4.4 The interference effect is maximal when sense and antisense RNA strands are
in equimolar proportions suggesting a stoichiometry of 1 to 1
When the molar ratio of sense and antisense RNA strands are varied relative to one another, it is
apparent that the interference effect is maximal when they are present in equal amounts (Figure
4.3). The result of this experiment, performed in both 3T3 and ES cells, implies that the
interference process has an underlying stoichiometry of 1 to 1 (Figure 4.4). This observation
strongly suggests that hybridisation of the two RNA molecules, to form a double-stranded RNA
intermediary species, is a key step in the interference mechanism.
Figure 4.3: Gene interference is maximal when sense and antisense strands are equimolar.
[Note that the "interference" seen at either extreme might be attributable to the non-equal delivery of
the Firefly and Renilla plasm ids due compromised transfection on account of the high siRNA dose.]
Data-points are derived from single experiments and hence error bars have not been applied.
4000 1000 250 64 16 4 1 0.25 0.064 0.016 0.004
Dose of sense / antisense siRNA (ng per well)
Figure 4.4: The 1:1 stoichiometry of RNA interference is apparent at all concentrations
Double-stranded RNA yields more interference than sense (p<0.001) or antisense (p<0.001) alone.
Sense siRNA
1 4 16 64 250 1000
Dose of siRNA (ng per well)
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4.5 The specificity of the interference effect is critically dependent upon sequence
fidelity of the siRNA molecule with its target region
The RNAi knockdown effect is largely abrogated if the siRNA carries a three-nucleotide
mismatch with the target gene sequence. Thus, if instead of the pGL3 Firefly plasmid the
interference experiment is performed using the pGL2 plasmid, which carries discrepancies at three
discrete sites within the region of homology, then the level of knockdown is much reduced.
Conversely, if siRNA specific for pGL2 is co-transfected with the pGL3 plasmid, then likewise
the level of knockdown is much reduced by comparison with co-transfected pGL2 plasmid. This
reaffirms the specificity of the RNAi mechanism and highlights the importance of complete
sequence fidelity within the region of homology as illustrated below (Figure 4.5). Moreover, these
findings were borne out in both 3T3 cells and ES cells and thus appear to be intrinsic properties of
the RNAi process and not dependent upon the cell line used.
Figure 4.5: Gene knockdown via RNAi is critically dependent upon sequence fidelity.
Potent knockdown ofFirefly luciferase is observed in 3T3 cells when the siRNA used is specific for the
target gene (siRNA-B2/plasmid-pGL2 or siRNA-B3/plasmid-pGL3). However, this is largely abrogated
when the siRNA carries a three-nucleotide mismatch (siRNA-B3/plasmid-pGL2 or siRNA-B2/plasmid-
pGL3). Data-points are derived from single experiments and hence error bars have not been applied.
No siRNA siRNA GFP siRNA B3 siRNA B2 siRNA B2 siRNA B3
(buffer only) (control) (plasmid pGL2) (plasmid pGL2) (plasmid pGL3) (plasmid pGL3)
blank nonsense mismatch specific mismatch specific
siRNA - B3 (pGL3) CUUACGCUGAGUACUUCGAdTdT
1*11111*1 1*11111111 I I
siRNA - B2 (pGL2) CGUACGCGGAAUACUUCGAdTdT
siRNA control (GFP) GUUCAGCGUGUCCGGCGAGdTdT
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4.6 siRNA molecules that have sequence specificity for different regions within
the target gene exhibit differential interference potency
When the potency of different siRNAs are compared, each one sharing a different region of
homology within the target gene sequence, there are clear differences in potency of the
knockdown observed. Thus, for the pGL3 Firefly luciferase plasmid, siRNA sharing homology
with the region 154-172 (siRNA-B3) gives 99% knockdown, whereas siRNA sharing homology
with the upstream region 23-41 (siRNA-A) gives only 61% knockdown, and siRNA sharing
homology with the downstream region 195-213 (siRNA-C) gives 89% knockdown (Figures 4.6,
4.7 and 4.8). Therefore, it is apparent that the potency of the interference effect is dependent upon
a combination of both the sequence of the siRNA and also the site of homology within the target
gene. These findings appear to be largely independent of cell line used being broadly similar for
both 3T3 cells and ES cells.
Figure 4.6: Table and schematic diagram showing the site and sequence of various siRNAs.
Locations of the siRNA target sites within the Firefly gene: A) 26-46; B) 153-173; and C) 193-213.
Note that siRNA-B3 is mismatched at three sites with pGL2 and vice versa for siRNA-B2 and pGL3.
NAME POSITION SEQUENCE pGL2 pGL3
siRNA - A 26-46 bp GAAAGGCCCGGCGCCAUUCdTdT Specific Specific
siRNA -B3 153-173 bp CUUACGCUGAGUACUUCGAdTdT Mismatch Specific
siRNA - B2 153-173 bp CGUACGCGGAAUACUUCGAdTdT Specific Mismatch
siRNA-C 193-213 bp GCUAUGAAACGAUAUGGGCdTdT Specific Specific
SV40 promoter pGL3 luciferase gene polvA
siRNA - A siRNA - B3 siRNA - C
SV40 promoter pGL2 luciferase gene nolvA
siRNA - A siRNA - B2 siRNA - C
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Figure 4.7: Graph showing the differential effects of three siRNAs against pGL2 and pGL3.
For the Firefly luciferase on plasmid pGL3, knockdown potency is greatest for siRNA B3 > C > A.
For plasmid pGL2, knockdown is greatest for siRNA C > B3 > A. Note B3 is a mismatch for pGL2.
Transfections performed in 3T3 cells. Error bars represent the range derived from duplicate experiments.
Bufferonly siRNA-A siRNA-B3 siRNA-C
Figure 4.8: Graph showing same experiment performed over a range ofsiRNA concentrations.
For the Firefly luciferase on plasmid pGL3, knockdown potency is greatest for siRNA B3 > C > A.
For plasmid pGL2, knockdown is greatest for siRNA C > B3 > A. Note B3 is a mismatch for pGL2.
Data-points are derived from single experiments and hence error bars have not been applied.
Firefly luciferase plasmid pGL2
Firefly luciferase plasmid pGL3
siRNA-A —♦
siRNA - B3 —■—
siRNA-C
r
100 1000 0 1
Dose of siRNA (ng per well)
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4.7 Combinations of interfering siRNA molecules yield gene knockdown effects
that approximate to the summation average of each individual siRNA
To determine the gene knockdown effects of using multiple siRNA molecules in combination,
transient co-transfection experiments were performed using equimolar amounts of three siRNA
species, A, B3, and C, to target Firefly luciferase in 3T3 cells. The results demonstrate that the
observed level of knockdown of either the pGL2 or pGL3 Firefly gene is an approximate
summation average of each siRNA used individually without any appreciable loss of the
interference effect. This is illustrated in the graph below (Figure 4.9).
Fieure 4.9: Graph showing the effect of different combinations of siRNAs on Firefly knockdown.
Combinations of siRNAs yield a knockdown effect that is the summation average of each individual
siRNA. Here, the total siRNA is maintained at 1 OOpg/well for each experiment and thus the interference
observed for two or three siRNAs is a weighted average of each used individually. [Note that B3 is a
mismatch for pGL2], Error bars represent the range derived from duplicate experiments.
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4.8 The combination of the sense strand of one siRNA with the non-homologous
antisense strand of another siRNA fails to generate an interference effect
In order to explore the possibility that non-homologous pairs of sense and antisense RNA strands
might be able to induce an interference response, incorrectly matched sense/antisense RNAs were
co-transfected with either pGL2 or pGL3 plasmids in 3T3 cells and tested for their ability to
knockdown luciferase expression. The results reveal that when the sense strand of one siRNA is
used in conjunction with an equimolar amount of the antisense strand of a different siRNA, no
discernible gene knockdown effect is observed (Figure 4.10). Thus, failure to generate a double-
stranded RNA molecule due to non-homology between the sense and antisense strands appears to
abrogate the interference phenomenon. This experiment was predicated on the possibility that
sense and antisense RNA strands might serve as RNA primers for an endogenous RNA-dependent
RNA polymerase resulting in secondary generation of double stranded RNA that could then
mediate gene interference. A similar process, termed "transitive RNAi", has been reported to
occur in C. elegans. However, this experiment is a poor model of transitive RNAi since the non¬
homologous RNA strands fail to form siRNA duplexes and the only conclusion that might be
drawn is that such duplex formation appears to be an obligatory step in the interference process.
Figure 4.10: Graph showing effect of non-matched sense/antisense pairs on gene expression.
Mismatched sense and antisense combinations of the siRNA molecules A, B3, or C, in order to
generate a non-homologous pair, results in the complete abrogation of the gene interference effect.
The notation in the graph uses "s" to denote sense strand and "a" to denote antisense strand. Note
that the positive experimental control, using paired siRNA A, B3 and C, is shown in the previous
graph. [Total siRNA used was lOOpg/well for each experiment. Note that B3 is a mismatch for
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4.9 siRNA-mediated interference of co-transfected Firefly luciferase is apparent
as soon as luminescence is detectable
In order to explore the dynamics of the interference knockdown effect in 3T3 cells, luciferase
activity was assayed at early time-points following plasmid/siRNA co-transfection. As
previously, this experiment used the potent siRNA, B3 (homologous to region 154-172 of the
Firefly luciferase gene), transfected at varying concentrations together with the pGL3 plasmid.
The results demonstrate an unequivocal dose-dependent knockdown of Firefly luciferase as early
as four hours post-transfection, which represents the earliest time-point for detection of
luminescence (Figure 4.11). Thus, in transient co-transfection, there does not appear to be any
discernable lag period for the induction of the siRNA-induced interference effect, which rather
becomes evident commensurate with expression of the target luciferase. Using a paired Student's
t-test to compare the knockdown induced by siRNA at lOOOngAvell with that of the control for all
four time-points, this result is shown to be statistically significant (p=0.02).
Figure 4.11: Graph showing gene knockdown effects of siRNA-B3 at various time-points.
siRNA-B3, co-transfected together with pGL3, exhibits a dose-dependent knockdown of Firefly
luciferase expression (compared with Renilla internal control), as soon as luminescence is detectable
(four hours). This suggests that RNA interference acts commensurately with luciferase expression.
Data-points are derived from single experiments and hence error bars have not been applied. There
is a statistically significant difference between lOOOng/well siRNA-B3 and the control using a paired
Student's t-test (p=0.02) consistent with a dose-dependent knockdown throughout the experiment.
4 hours 5 hours 6 hours 7 hours
Time elapsed post-transfection of siRNA/plasmid
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4.10 siRNA-mediated knockdown of a co-transfected plasmid-borne gene exhibits
first order competitive reaction kinetics
In order to explore the kinetics of the interference phenomenon, the level of knockdown of Firefly
luciferase mediated using a fixed amount of siRNA co-transfected with varying concentrations of
target plasmid was assayed. This reveals that the level of luciferase knockdown observed for a
fixed amount of siRNA is proportional to the logarithm of the concentration of the target gene
implying that siRNA-induced interference obeys first order reaction kinetics. Moreover, it can be
overcome by using greater amounts of plasmid suggesting that interference is reversibly
competitive. This is illustrated by the exponential curves of the knockdown profiles plotted on
log-linear graphs (Figure 4.12) that become parallel when plotted on log-log graphs (Figure 4.13).
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4.11 The magnitude of siRNA-mediated gene knockdown is diminished if siRNA
transfection is delayed relative to transfection of the luciferase plasmid
This experiment was designed to address the question of whether plasmid DNA, following
transfection in 3T3 cells, might undergo changes that render it less susceptible to the effects of
siRNAs. The pGL3 target plasmid and pRL internal control plasmid were transfected at time zero
while siRNA-B3 (homologous to region 154-172) was transfected at time-points 0, +1, +24, and
+48 hours later for concentrations covering five orders of magnitude (0.1 to lOOOng per well).
The Firefly!Renilla luciferase activity was then assayed at +24, +25, +48 and +72 hours later
(Figure 4.14). At the highest concentration of lOOOng per well siRNA, the results reveal that the
level of Firefly luciferase knockdown to be 97% at 0 hours, at 95% at 1 hour, at 60% at 24 hours,
and 64% at 48 hours, relative to the Renilla control. The facile explanation for this observation is
simply the persistence of luciferase that is already produced prior to transfection of the siRNA
(approximate half-life of Firefly luciferase is 6 hours; source Promega™ product literature). The
alternative explanation, that the plasmid DNA undergoes qualitative changes that render it less
susceptible to subsequent siRNA-induced gene knockdown, appears less plausible.
Figure 4.14: Graph showing how delayed siRNA transfection affects level of gene knockdown.
When transfection of the siRNA-B3 is delayed relative to that of the pGL3 plasmid carrying the target
gene, the level of observed luciferase knockdown is diminished at all siRNA concentrations tested.
Data-points are derived from single experiments and hence error bars have not been applied.
Dose of siRNA (ng per well)
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4.12 Premature transfection of the siRNA up to two days prior to transfection of
the luciferase plasmid results in robust gene knockdown
This experiment was designed to address the question of whether siRNAs can lead to gene
knockdown in 3T3 cells if transfection of the luciferase plasmid is delayed by a period up to two
days. siRNAs, at two different concentrations, were transfected at time zero, while the plasmids
pGL3 and pRL, were transfected at times +1, +24, and +48 hours. Luciferase assays were
performed at +24, +48, and +72 hours to generate a time course knockdown profile (Figure 4.15).
The results reveal that the level of knockdown for a given dose of siRNA is approximately the
same irrespective of whether the Firefly plasmid transfection is delayed by 24 or 48 hours relative
to the siRNA. This implies that there is persistence within the cell of either the siRNA molecules
themselves or their interference effects over at least this time period of 48 hours (Figure 4.15).
Note that the data-points are from single experiments and hence error bars have not been applied
and statistical analysis has not been performed. However, the dosage effect and time-dependency
provides credibility to this conclusion.
Figure 4.15: Graph showing luciferase gene knockdown up to 48 hours post siRNA transfection.
When transfection of the siRNA-B3 precedes that of the pGL3 plasmid carrying the target gene by a
period up to 48 hours, specific and dose-dependent knockdown of the Firefly luciferase is still observed.
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4.13 siRNAs can mediate suppression of a stably integrated Firefly luciferase gene
The siRNA-B2 that induces potent knockdown of the pGL2 Firefly luciferase (homologous to
region 154-172) were tested for its ability to suppress expression of the same gene target stably
integrated in a CHO cell line. The cell line used for this experiment is the CHO-LUC cell line
(commercially available from Clontech Inc.) that has been generated from the CHO-AA8 tTA-
expressing cell line by insertion of the GL2 Firefly luciferase gene under the TRE promoter
(pRev-TRE-LUC). In the CHO-LUC cell-line, the GL2 luciferase is expressed constitutively (in
the absence of doxycycline) and at high level making this a suitable cell line for studying the
knockdown effects ofGL2-specific siRNAs.
As for the transient transfection experiment, the GL2-specific siRNA-B2 results in specific
knockdown of the stably integrated luciferase gene as compared with a non-specific siRNA
control (Figure 4.16). This achieves 93% knockdown at the highest concentration tested and is
highly statistically significant by Student's t-test (p<0.001). Even ignoring the fact that siRNA
delivery to CHO-LUC cells is likely to be sub-maximal, this level of gene knockdown approaches
the level seen for the pGL2 plasmid-encoded luciferase in the 3T3 transient transfection
experiment. Moreover, neither sense nor antisense RNA strands alone, nor the three-nucleotide
mismatched siRNA-B3, produce any significant knockdown whatsoever. This result confirms that
the siRNA-induced interference of stably integrated endogenous genes is qualitatively similar, in
terms of potency and specificity, to that of transiently expressed plasmid-borne epigenes.
Figure 4.16: Graph showing siRNA knockdown of an integrated Firefly luciferase in CHO-LUC cells.
siRNA-B2 transfection yields potent and specific knockdown of a stably integrated transgene. Data-points
are derived from single experiments and hence error bars have not been applied. Comparison ofthe two sets
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4.14 The interference-related gene knockdown effect persists for at least ten days
post-siRNA transfection
Using CHO-LUC cells, it was possible to determine the longevity of the interference effect. Cells
transfected with siRNA-B2 (homologous to region 154-172) resulted in over 90% knockdown
compared with a non-specific control siRNA until day 6 and around 80% until day 10 (Figure
4.17). This demonstrates the remarkable persistence of the interference phenomenon. Moreover,
it should be emphasised that the cells were serially diluted through passaging approximately 1 in
10 every third day. The doubling time of CHO-LUC cells is 16-20 hours and hence it is expected
that they would undergo at least ten cell divisions over this period (equivalent to an expansion of
210, or approximately 1,000 fold). It follows, therefore, that siRNA-induced gene knockdown can
persist through ten cell divisions despite dilution of the cytosolic siRNA concentration at each cell
doubling. This conclusion ignores the possibility that there exists either an amplification process
or an inherited epigenetic process that underpins the propagation of the knockdown effect from
cell generation to cell generation.
Figure 4.17: Graph showing the persistence of siRNA-induced luciferase knockdown.
CHO-LUC cells carrying a stably integrated Firefly luciferase were transfected with siRNA-B2
at two different doses and the level of luciferase knockdown measured thereafter up to ten days.
The knockdown is measured comparative to cells transfected with a non-specific control siRNA.
Data-points are derived from single experiments and hence error bars have not been applied.
Number of days post-transfection of luciferase-specific siRNA-B2
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4.15 RNA oligonucleotides in high dose provoke a non-specific transient
enhancement of luciferase expression in CHO-LUC cells
In the course of experiments designed to study siRNA-induced knockdown of the GL2 luciferase
gene in CHO-LUC cells, an unexpected observation was made. This was the paradoxical
enhancement of luciferase expression under some circumstances. These included the transfection
of all RNA oligonucleotides irrespective of whether they were single or double stranded and
irrespective of any shared luciferase sequence homology (Figure 4.18). The enhancement was
only apparent at concentrations in excess of lpg per well, and was not apparent at lower
concentrations (Figure 4.19). Finally, the enhancement was only observed over a time window of
24 to 48 hours, causing up to a 10-fold increase in Firefly luciferase activity, after which its
magnitude waned and true interference-mediated gene knockdown became apparent (Figure 4.19).
Thus, this phenomenon is qualitatively distinct from the RNAi effect. Firstly, it arises in response
to challenge with all RNAs, rather than just double-stranded RNA as for genuine interference;
secondly, it is completely non-specific, rather than the sequence-specific homology demanded of
siRNA-mediated gene knockdown; thirdly, it results in enhancement rather than knockdown;
fourthly, it is not apparent at lower concentrations where siRNAs retain their gene-interfering
effect; and finally, it results in an effect that is relatively short-lived compared with true RNAi.
These features are more consistent with the well characterised "interferon response". This view is
strengthened by the observation that at high doses of RNA, where significant luciferase
enhancement is seen to occur, this is accompanied by widespread cellular death (data not shown),
presumably via apoptosis. However, the interferon response is typically associated with
translational arrest rather than enhanced gene expression as seen here. A possible explanation of
this apparent paradox is the release of oxidative radical species during cellular apoptosis that are
capable of accelerating the luciferase reaction used to assay Firefly expression. In this case, the
apparent gene "enhancement" would simply reflect an artefact arising as a consequence of
assaying luciferase activity in apoptotic cells, rather than an actual increase in the expression of
the gene. However, this remains untested speculation.
Note that the "enhancement" phenomenon might quite easily mask any specific siRNA-related
knockdown effect with a superimposition of both occurring at higher siRNA concentrations. For
this reason, all experiments involving siRNA-induced knockdown were performed at
concentrations well below the enhancement-trigger threshold (i.e.: lOOng siRNA per well or less)
and were assayed at 48 rather than 24 hours post-transfection.
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Figure 4.18: Graph showing non-specific RNA-induced enhancement of luciferase activity.
CHO-LUC cells transfected with RNA oligonucleotides, whether single or double-stranded, induce
enhanced luciferase activity, irrespective of sequence specificity, at concentrations above lpgAvell.
Knockdown is measured comparative to control cells that had not undergone siRNA transfection. Data-
points are derived from single experiments and hence error bars have not been applied. The difference
between the two siRNA doses is statistically significant using a paired Student's t-test (p<0.001).
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Figure 4.19: Non-specific enhancement of luciferase activity occurs at 24 but not 48 hours.
CHO-LUC cells were transfected with either non-specific (LacZ) or luciferase-specific (B2) siRNA.
Increased luciferase activity is recorded at 24 hours post-transfection and at doses above lOOng/well.
However, by 48 hours post-transfection, and at doses below lOOngAvell, RNA interference prevails.
The knockdown is measured comparative to control cells that had not undergone siRNA transfection.
Data-points are derived from single experiments and hence error bars have not been applied.
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4.16 siRNA molecules generated by in vitro transcription exhibit less gene
knockdown potency than siRNA molecules generated by chemical synthesis
siRNA molecules generated by in vitro transcription, using the Silencer™ siRNA Construction Kit
(Ambion Inc.), were compared with identical sequence chemically synthesised siRNAs (Xeragon
Inc.). This revealed that the in vitro transcribed siRNAs were consistently less potent and more
erratic in their ability to knockdown transiently transfected luciferase in 3T3 cells than chemically
synthesised siRNAs (Figure 4.20). In CHO-LUC cells, when used at high doses over lmg/well,
enhanced luciferase expression was found similar to that described in Section 4.15 (Figure 4.21).
Figure 4.20: In vitro transcribed siRNAs are less potent than chemically synthesised siRNAs.
Knockdown oftransient luciferase in 3T3 cells using in vitro transcribed siRNAs is up to two orders of
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Figure 4.21: In vitro transcribed siRNAs yield luciferase enhancement in CHO-LUC cells.
High doses of in vitro transcribed siRNAs result in enhanced luciferase activity in CHO-LUC at 24
hours similar to chemically synthesised siRNAs. Data-points are derived from single experiments.
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4.17 Using short basic peptides derived from the transduction domain of the HIV
TAT protein to enhance liposomal delivery of siRNA molecules
The improved delivery of siRNA molecules into cells represents one of the major hurdles in
bringing the RNAi technology to in vivo applications. The latter includes the generation of
models of disease in mice and the treatment of disease in humans. The strategy chosen to enhance
siRNA delivery was based upon preliminary data generated by X. Nan and colleagues (Molecular
Medicine Centre, Edinburgh University) who have used peptide fragments derived from the
human immunodeficiency virus transcriptional activator TAT protein, in combination with
cationic liposomes, to facilitate the transfer of plasmid-borne reporter genes into cells (Ref:
Hyndman L. et al., 2004). These so-called transduction peptides, of which HIV TAT is the best
studied, were originally discovered by the serendipitous observation that some proteins are able to
enter cells in an apparently passive manner (Ref: Becker-Hapak M. et al., 2001). Such proteins,
which include the Drosophila homeotic transcription factor Antennapedia (Antp) and the herpes
simplex protein VP22, as well as HIV TAT protein, all contain short embedded basic peptide
sequences of around 9-16 amino-acids in length that are able to mediate the transduction of the
whole protein across the plasma membrane (Ref: Wadia J.S. and Dowdy S.F., 2002). Structurally
dissimilar to one another, their common feature appears to be the presence of numerous positively
charged lysine and arginine residues, as exemplified by the TAT sequence of nine amino acids
(RKKRRQRRR).
The transduction process, which remains poorly defined, appears to operate via a mechanism that
is independent of receptors, transporters, or endocytosis, occurring at 4°C and in the presence of
cellular transport process inhibitors (Ref: Schwarze S.R. and Dowdy S.F., 2000). The potency of
this mechanism to deliver functional proteins to cells in vivo is well illustrated in mice by the
demonstration that intraperitoneal injection of a TAT-coupled P-galactosidase reporter results in
rapid uptake of the protein throughout all tissues of the animal (Ref: Schwarze S.R. et al., 1999).
These results have been extended to therapeutic ends in a mouse model of terminal peritoneal
carcinomatosis successfully treated by TAT-mediated delivery of a transducible p53-activating
peptide (Ref: Snyder E.L. et al., 2004). In a similar fashion, TAT has also been shown to be able
to deliver large DNA molecules into cells (Ref: Snyder E.L., and Dowdy S.F., 2001) and it this
evidence, together with the preliminary data kindly provided by X. Nan and colleagues (not
shown), that provided the experimental rationale for exploring its use for delivery of siRNAs into
cells.
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4.18 Tat-derived transduction peptides appear to enhance liposomal-mediated
delivery of siRNA molecules into cells
Based on preliminary data showing how a short ten amino-acid peptide sequence derived from the
HIV tat gene is able to enhance the liposomal-mediated transfection of reporter plasmids (personal
communication, X. Nan), experiments were designed to explore this approach for delivery of
interfering siRNAs in CHO-LUC cells. siRNA-C, which has homology to region 195-213 of the
GL2 luciferase gene, was chosen for this purpose at a dose of lOOng per well that would permit
greatest sensitivity of detection of enhanced gene knockdown effect. Luciferase knockdown was
compared for low dose liposome (0.15pl Lipofectin™ or Oligofectamine™), with and without
2pg Tat added, and also high dose liposome (lpl Oligofectamine™ only), with and without 2pg
Tat added. The results revealed that Tat enhances the transfection efficiency of liposomal the
reagents, Lipofectin™ and Oligofectamine™ (Figure 4.22). However, this finding exhibited a
variable consistency and requires further methodological refinement. Comparison of Tat+ve and
Tat-ve transfection mixes using a paired Student's t-test reveals statistical significance (p=0.03).
Figure 4.22: Tat peptides enhance liposomal delivery of siRNA as assessed by gene knockdown.
The ability ofTat (2pg/well) to improve delivery of siRNA-C (lOOng/well) by either Lipofectin™
(Lipo) at low dose (LD=0.15|ig/well) or Oligofectamine™ (Oligo) at low dose (LD=0.15gg/well)
and high dose (HD=lng/well) was tested by assessing knockdown of luciferase in CHO-LUC cells.
The knockdown is measured comparative to control cells that had not undergone siRNA transfection.
Data-points are derived from single experiments and hence error bars have not been applied. The
finding of enhanced knockdown when using Tat is weakly statistically significant using a paired
Student's t-test to compare transfection mixes +Tat versus -Tat (p=0.()3).
o — mam mam ..)
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4.19 Conclusion
The primary objective of this chapter was to characterise the nature of the RNA interference effect
in mammalian cells using an experimental system that yielded robust and reproducible results.
This system employed siRNA molecules to knockdown a Firefly luciferase reporter gene
transiently expressed in NIH3T3 cells. A secondary objective was the demonstration that siRNA-
mediated knockdown operates in a similar fashion against a stably integrated Firefly luciferase in
a transgenic CHO cell line.
Double-stranded siRNA molecules cause dose-dependent knockdown of target epigenes
Co-transfection of the Firefly luciferase reporter plasmid together with sequence-specific siRNA
oligonucleotides in 3T3 cells resulted in the potent and dose-dependent knockdown of luciferase
expression. This knockdown effect was dependent upon the presence of both sense and antisense
RNA strands, although explicit annealing of these strands at high temperature prior to transfection
appeared to be unnecessary. The complementary strands were designed to form an RNA duplex,
via hybridisation over 19 base pairs with 3' dinucleotide thymidine overhangs, and this was shown
to be the physiologically relevant species by the 1:1 stoichiometry of the interference effect.
Neither sense nor antisense alone yielded any significant effect.
siRNA-iuduced knockdown requires sequence fidelity with the target gene
The sequence specificity of the interference effect was demonstrated by the fact that three discrete
sequence discrepancies between the siRNA and its target largely abrogated any significant
knockdown of the luciferase target. Moreover, sequence homology of the siRNA is not sufficient
for effective interference since different siRNA molecules yield considerable variability of
knockdown potency. Hence, for the three siRNAs used here to knockdown transiently expressed
Firefly luciferase, siRNA-B (153-173 bp from start codon) was more potent than siRNA-C (193-
213 bp from start codon), which was more potent that siRNA-A (26-46 bp from start codon).
The level of gene knockdown is determined by key siRNA design criteria
Based upon the above findings, together with those from siRNA knockdown experiments in
subsequent chapters, it is possible to derive a number of broad conclusions regarding successful
siRNA design. These are listed below:
• Site of siRNA sequence homology approximately 150 base pairs from start codon
• Ratio of G/C nucleotides to A/U nucleotides close to unity
• Absence of long runs of G/C base pairings
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• Absence of contained palindromic sequences
• Presence of one or more G/C nucleotides at the 5' end of the sense strand
• Presence of one or more A/U nucleotides at the 5' end of the antisense strand
In particular, high G/C content within the siRNA, especially where this generates a palindromic
sequence (such as GGCGCC in siRNA-A), which would lead to erroneous sense-sense and
antisense-antisense strand pairings, appears to significantly lessen the interference effect.
Conversely, the presence of one or more G/C nucleotides at the 5' end of the sense strand together
with one or more A/U nucleotides at the 5' end of the antisense strand appears to significantly
enhance the interference effect. We can speculate that these generally applicable features of
effective siRNA design, which have also been validated in other comparative analyses of siRNA
potency (Ref: Holen T. et al., 2002), reflect the importance of suitable annealing/melting
properties of the RNA duplex which appear to be different at the two opposite ends of the
molecule. It is possible that this reflects aspects of the basic interference mechanism. This
requires incorporation of the siRNA molecule into the RISC machinery, unwinding of the duplex
siRNA into single RNA strands, and hybridisation of the relevant strand to its target sequence.
The use of siRNA molecules in combination provides useful mechanistic insights
When siRNA molecules were used in combination with one another, it was shown that the overall
knockdown is approximately equivalent to the average of each siRNA used individually. In other
words, the interference effect of two or more siRNAs appears to be additive and not multiplicative
such that the knockdown potency of a 50:50 mix of weak and strong siRNA is midway between
each siRNA used alone. Based upon this assessment, one could envisage that destruction of the
target mRNA by two siRNAs might result in cleavage at two different sites, although clearly a
single cleavage site on its own will suffice in preventing mRNA translation.
An alternative model of RNA interference, termed "transitive RNAi", argues that guide siRNAs
can serve as primers for RNA-dependent RNA polymerisation of the mRNA template. In this
way, a pair of non-overlapping siRNAs could produce a long double-stranded RNA molecule
from which new siRNAs are secondarily generated through the action of Dicer. In order to test
this possibility in mammalian cells, mismatched non-complementary pairs comprising the sense
strand of one siRNA and the antisense strand of another siRNA, were tested and shown to be
incapable of any significant knockdown compared with the non-specific control. However, while
this is an interesting negative result, it does not rule out transitive RNAi in mammalian cells since
the experiment is arguably based upon the wrong model. This is because the RNA strand pairs
fail to form duplexes that previous experiments have shown to be necessary for RNA interference.
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Analysis of the temporal and dosage aspects of siRNA-induced gene knockdown
Analysis of temporal and dosage aspects of the siRNA-induced knockdown effect was performed
in order to provide insight into the dynamic and kinetic nature of the interference process. The
results of these experiments, and their interpretations, are as below.
Firstly, the time-course of the knockdown effect is commensurate with that of Firefly expression
such that there is a dose-dependent reduction of luciferase activity even at the earliest moment this
is detectable (four hours post-transfection of siRNA/plasmid mix). Thus, in a transient
transfection setting, there appears to be no significant lag period, between gene expression and
gene interference, required for the initiation or amplification of the siRNA-induced knockdown
effect. Rather, the level of observed interference is directly related to the amount of siRNA that is
co-transfected with the reporter plasmid.
Secondly, for a fixed amount of siRNA, the effect of increasing the amount of co-transfected
plasmid results in an exponential-shaped "knockdown curve" on a linear-log plot that becomes a
straight line on a log-log plot that is indicative of first order reaction kinetics. Different amounts
of siRNA result in parallel straight lines on the log-log plot consistent with reversible competitive
behaviour. In other words, the level of knockdown observed following siRNA/plasmid co-
transfection in 3T3 cells is determined solely by the amount of siRNA transfected and can be
overcome by adding excess plasmid.
Thirdly, if the transfection of the siRNA is delayed relative to transfection of the plasmid by an
interval of 24 to 48 hours, then the level of observed knockdown is reduced by approximately 30-
50% over a range of siRNA doses by comparison with that observed for co-transfection. In other
words, if the plasmid is transfected a significant while before the siRNA, then the ability of the
siRNA to knockdown the target gene is diminished. However, these findings most easily
explained in terms of the persistence of luciferase protein translated prior to transfection of the
siRNA, thereby limiting interpretation of this result.
Fourthly, in a reversal of the previous experiment, if the transfection of the siRNA precedes
transfection of the plasmid by an interval of 24 to 48 hours, then the level of observed knockdown
for a given dose of siRNAs is approximately the same as if the siRNA and plasmid were co-
transfected. In other words, there is persistence of the siRNA molecules themselves, or their
interference effect, within the cell over this time period without significant loss of the potency of
the observed knockdown. Thus, RNA interference exhibits intracellular molecular stability over
at least 48 hours even in the absence of the gene target.
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siRNA molecules are able to induce knockdown of a stable transgene in CHO cells
The demonstration of siRNA-induced knockdown of a stably integrated Firefly luciferase
transgene, using a CHO cell line termed CHO-LUC, confirmed that RNAi operates against an
endogenous gene just as for an exogenous gene. The knockdown effect exhibits the same
hallmark features of dose-dependent potency and sequence-directed specificity as identified in the
transient co-transfection experiments previously, thereby providing the experimental basis
whereby siRNA molecules might be used as tools for analysing the function of native genes.
The siRNA-induced knockdown of the Firefly luciferase in CHO-LUC cells showed evidence of
persistence up to ten days post-transfection. This result demonstrates that the interference effect is
able to persist through multiple rounds of cell division. Given that cellular division in this cell line
occurs every 16-20 hours and the cells were passaged regularly throughout the experiment, then a
conservative approximation for the persistence of the interference effect is ten cell divisions. This
is equivalent to a population expansion of 210, or approximately 1,000 fold. Thus, siRNA-induced
gene knockdown can persist despite a halving of the cytosolic concentration of the siRNA at each
cell doubling, equivalent to a 1,000-fold overall dilution. This demonstration is most simply
explained in terms of the remarkable potency of the siRNA molecules in mediating knockdown of
their target gene. However, it is also compatible with two alternative possibilities, namely either
the presence of an amplification process or an inherited epigenetic process, both of which would
lead to the propagation of the knockdown effect from cell generation to cell generation.
Excess siRNA induces paradoxical luciferase enhancement and apoptosis of CHO-LUC cells
In the course of experiments aimed at knocking down expression of stable Firefly luciferase in
CHO-LUC cells, it was shown that RNA oligonucleotides, under certain circumstances, provoke a
paradoxical enhancement of luciferase activity, on occasion up to ten-fold. This was observed
with all RNA oligonucleotides transfected irrespective of whether they were single or double
stranded and irrespective of any shared luciferase sequence homology. The enhancement was
only apparent at the highest doses of RNA in excess of lpg per well and not below. Finally, the
enhancement was transient, occurring over 24 to 48 hour time window after which its magnitude
waned and true interference-mediated gene knockdown became apparent.
Thus, this phenomenon is qualitatively distinct from that of RNA interference. Firstly, it arises in
response to all RNA oligonucleotides, rather than just double-stranded RNA; secondly, it is
completely non-specific, rather than the sequence-specific; thirdly, it results in enhancement rather
than knockdown; fourthly, it is not apparent at lower concentrations where siRNAs retain their
physiological activity; and finally, it results in an effect that is relatively short-lived.
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These features are more consistent with the well characterised "interferon response" that is typical
of mammalian cells. Such a view is strengthened additionally by the observation that at high
doses of RNA, where significant luciferase enhancement is seen to occur, there is widespread
cellular apoptosis (data not shown). However, the interferon response is typically associated with
translational arrest rather than enhanced gene expression as seen here. A plausible explanation of
this apparent paradox might be the fact that apoptotic death is accompanied by release of oxidative
radicals that are capable of accelerating the luciferase reaction used to assay Firefly expression. If
so, then the apparent gene "enhancement" simply reflects an artefactual result, caused by assaying
luciferase activity in apoptotic cells, rather than a true increase in gene expression. However, this
explanation remains speculative and further characterisation of the effect would require proper
gene expression analysis, such as Southern of Northern blot assays, detection of interferon levels
and apoptosis markers, and testing against other reporter gene targets such as GFP.
Chemically svnthesised siRNAs are more potent than in vitro transcribed siRNAs
Two technical aspects of siRNA experimentation were addressed in the course of this chapter.
The first was a comparative assessment of chemically synthesised siRNAs with molecules having
identical nucleotide sequence but generated by in vitro transcription. This revealed that the in
vitro transcribed siRNAs were consistently less potent and more erratic in their action than their
chemically synthesised counterparts, whether used to knockdown transiently expressed luciferase
in 3T3 cells or stably integrated luciferase in CHO-LUC cells. Naturally, this finding does not
preclude technical shortcomings arising during the synthesis of the in vitro transcribed molecules,
which were prepared using a commercial kit. However, based upon this result, chemically
synthesised siRNAs were used for all subsequent knockdown experiments.
Liposomal delivery of siRNAs into cells can be improved using "transduction peptides"
The second technical aspect addressed in this chapter pertained to the delivery of siRNA
molecules into cells. The reason for exploring this issue is the fact that efficient siRNA delivery
represents one of the major hurdles in the translation of RNAi technology to in vivo applications.
The work was conducted in collaboration with X. Nan and colleagues who have demonstrated that
transduction peptides derived from the HIV-1 Tat protein, in combination with cationic liposomes,
are able to facilitate the transfer of plasmid-borne reporter genes into cells (Ref: Hyndman L. et
al., 2004). This nine amino-acid peptide was tested here for its ability to enhance liposomal
delivery of siRNAs using Firefly-specific molecules to knockdown luciferase expression in CHO-
LUC cells. The siRNA chosen for this purpose was of intermediate potency and used at low dose
with knockdown assayed after 48 hours to avoid any spurious enhancement artefact.
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The findings of the Tat-liposome experiment revealed that Tat peptide can significantly enhance
siRNA delivery by liposomes, as measured by luciferase knockdown, albeit with some
experimental variability. Because of this, the method was not used in other knockdown
experiments and remains to be more fully characterised. This would require refinement of the
methodology and doses. As for the mechanism of enhanced transfection, evidence from plasmid
transfection studies suggests that the liposomal reagent acts as a bridging molecule between the
oligonucleotide and the transduction peptide (Refs: Torchilin V.P. et ah, 2001; personal
communication X. Nan). However, this explanation remains speculative and the results presented
here in relation to siRNA transfection will require future work to clarify.
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5.1 Introduction
The molecular mechanism whereby siRNA molecules can induce knockdown of expression of
genes remains to be fully elucidated. Current evidence suggests that RNA interference operates
predominantly at a post-transcriptional level by sequence-directed destruction of the mRNA
transcript. However, other non-conflicting experimental data supports the conclusion that siRNAs
operate also at a transcriptional level that might induce local epigenetic modifications of the gene.
This possibility was addressed in this chapter using an elaboration of the transient transfection
model developed previously to dissect out aspects of siRNA action. Specifically, experiments
were designed to try to answer the following questions:
❖ Is one RNA strand pre-eminent over the other in directing interference?
❖ To what degree are discrete nucleotide mismatches tolerated within either strand?
❖ Is siRNA-induced knockdown of a plasmid reporter recapitulated using an mRNA reporter?
❖ What is the effect of 5'-terminal phosphorylation of the siRNA molecule on the interference?
❖ Are the foregoing findings consistent for stable gene targets as for transiently expressed ones?
❖ Are the features ofRNA interference in mammalian cells recapitulated in Drosophila cells?
❖ Are there qualitative inter-species differences (mammalianIDrosophila) with regard to RNAi?
❖ Are there qualitative intra-species differences between various cell lines with regard to RNAi?
❖ Is there evidence that siRNAs act at a transcriptional level as well as post-transcriptionally?
❖ If so, is it possible to experimentally dissect one mechanism of siRNA action from the other?
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5.2 The antisense strand is pre-eminent over the sense strand in directing siRNA-
mediated gene knockdown of transiently expressed Firefly luciferase
The siRNAs B2 and B3 differ from one another by three distinct nucleotides. Thus, by mixing the
sense of one with the antisense of the other, it is possible to generate "chimaeric" heteroduplex
siRNAs from B2 and B3 (termed either siRNA-B2/3 or B3/2) that are internally mismatched and
therefore impaired in their ability to undergo complementary base-pairing. This situation permits
insight into which RNA strand is responsible for directing gene knockdown specificity.
The potency of these heteroduplex siRNAs to yield Firefly luciferase gene knockdown was tested
experimentally using the transient transfection model in 3T3 cells. This reveals that if the sense
strand is mismatched but the antisense strand is correct, then there is potent gene knockdown
"comparable to that of the fully matched siRNA at 94%. If, conversely, the antisense strand is
mismatched but the sense strand is correct, then there is minimal gene knockdown at 22%. This
represents a statistically significant experimental difference (mean = 0.88, SD = 0.12, p<0.001).
Thus, it appears that antisense homology is paramount while sense strand mismatch is largely
tolerated (Figure 5.1). This result was corroborated similarly for ES cells (data not shown).
Figure 5.1: Graph showing Firefly luciferase knockdown using the siRNA-B2/B3 heteroduplex.
The knockdown of transiently expressed Firefly luciferase in 3T3 cells using lOOng/well heteroduplex
siRNAs reveals that antisense-strand fidelity is paramount while sense-strand mismatch is tolerated.
Data-points are derived from single experiments and hence error bars have not been applied.





































Chapter 5 - Results 3
5.3 The importance of antisense-strand fidelity for proper siRNA function is
recapitulated for knockdown of a stably integrated Firefly luciferase gene
The above experiment was performed in a similar fashion using the CHO-LUC cell line that
carries a stably integrated Firefly luciferase (GL2) gene. Heteroduplex siRNAs, comprising either
the sense strand of B2 and antisense strand of B3 (siRNA-B2/3) or vice versa (siRNA-B3/2), were
tested for their ability to knockdown expression of the Firefly luciferase in CHO-LUC cells
alongside a variety of controls (Figure 5.2). As for the transient transfection experiments in 3T3
cells previously, only those heteroduplex siRNAs that retained antisense strand fidelity yielded
gene knockdown, even if the sense strand carried a three-nucleotide mismatch. Once again this
points to the pre-eminence of the antisense strand in directing the interference process and is a
statistically significant finding (p<0.001).
Figure 5.2: Graph showing luciferase knockdown using the siRNA-B2/B3 heteroduplex.
Knockdown of a stably integrated Firefly luciferase in CHO cells, using lOOng/well heteroduplex siRNAs,
reveals that antisense-strand fidelity is paramount while sense-strand mismatch is tolerated. Error bars
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5.4 Phosphorylation of the 5' end of the siRNA molecule does not influence
knockdown of a stably integrated luciferase gene
In order to address the question of whether or not phosphorylation at the 5' end of the siRNA
molecule might influence the RNA interference process, the previous experiment was performed
in duplicate using both mock-phosphorylated and 5'-phosphorylated siRNAs (Figure 5.3). This
analysis holds relevance for experiments presented subsequently comparing the interference
potential of mock and 5'-phosphorylated siRNAs against transiently expressed Firefly luciferase.
The results reveal that there is no significant difference between the two siRNAs and, thus,
exogenous 5'-phosphorylation of the siRNA molecule appears to be unnecessary for the
knockdown of a stably integrated Firefly luciferase gene in CHO-LUC cells.
Figure 5.3: Graph showing effect ofS'-phosphorylation on siRNA-induced knockdown.
5'-phosphorylated siRNAs (lOOng/well) show no significant difference in their ability to
knockdown a stably integrated Firefly luciferase in CHO-LUC cells compared with mock-
phosphorylated controls. Error bars represent the range derived from duplicate experiments.
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5.5 Firefly-specific siRNAs fail to knock down luciferase expression following
transient transfection of a Firefly luciferase mRNA reporter molecule
The paradigm view of RNA interference argues in favour of a post-transcriptional mechanism in
which targeted binding of the siRNA to the messenger RNA transcript leads to cleavage of the
mRNA via an RNA-induced silencing complex (RISC). In order to challenge this hypothesis, the
ability of F/>e/7y-specific siRNAs to direct knockdown of a messenger RNA luciferase reporter
molecule was compared with knockdown of a DNA-encoded luciferase plasmid. The Firefly gene
sequence was identical for both the mRNA, denoted mGL2, and the plasmid, denoted pGL2, (both
products purchased from Promega Inc.). The mGL2 reporter is an uncapped mRNA molecule
containing a 30-base polyA tail that produces functional luciferase when translated, while the
pGL2 plasmid is a circular DNA molecule carrying a luciferase gene sandwiched between SV40
promoter and enhancer regions that control transcription.
All experiments comparing mGL2 Firefly knockdown with pGL2 Firefly knockdown were
performed, as for previous transient transfection experiments, using liposomal-mediated co-
transfection of the relevant siRNA together with either the mGL2 (mRNA) or the pGL2 (DNA
plasmid) luciferase target. Typically, experiments were internally controlled using the pRL
Renilla luciferase. Luciferase-specific siRNA molecules were compared with non-specific control
siRNAs (typically LacZ or GFP siRNAs) using maximal concentrations of lOOng/well, which is
below the threshold at which double-stranded RNA exhibits non-specific influences. The
experiments were performed on NIH 3T3 or CHO-AA8 cells and were assayed for luciferase
expression using a luminometer within 6-18 hours of transfection (except where otherwise stated).
In the initial experiment to compare knockdown of mGL2 luciferase expression with pGL2
luciferase expression using F/>e/7y-specific siRNA, the latter was used at a variety of
concentrations against a non-specific siRNA control. The findings demonstrate that when
luciferase expression is analysed within 18 hours post-transfection, there is no significant Firefly
knockdown when it is encoded as an mRNA reporter while there is robust Firefly knockdown
when it is encoded as a plasmid reporter. The results, which were internally controlled using
Renilla expression, are illustrated graphically overleaf (Figure 5.4). Here, the change in luciferase
expression resulting from the Firefly-specific siRNA at each dose has been calculated relative to
the change in expression seen for the non-specific control siRNA at the same dose. This lack of
efficacy of the B2 siRNA to knockdown the mGL2 target was also borne out for two other Firefly-
speeific siRNAs, A and C, that have previously been shown to knockdown pGL2 (Figure 5.5).
This finding is statistically significant using Student's t-test for paired data (p=0.002).
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Figure 5.4: Firefly-specific siRNA-B2 knocks down pGL2 but not mGL2 luciferase.
The Firefly-specific siRNA, B2, is able to knock down expression of luciferase when encoded on a DNA
plasmid, pGL2, but not an mRNA reporter, mGL2, when introduced into 3T3 cells by transient transfection.
This was apparent for all siRNA concentrations tested with luciferase expression being assayed at 18 hours
post-transfection. The quantities used were either 0.5ggAvell mGL2 or 2.0pg/ well pGL2, together with
lOOng/well pRL Renilla internal control. Data-points are derived from single experiments and hence error
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Figure 5.5: Firefly siRNAs fail to knock down mGL2 luciferase reporter within 18 hours.
Firefly-specific siRNAs generate knockdown of transiently transfected luciferase when it is encoded on a
plasmid, pGL2, but fail to generate any significant knockdown when it is encoded by a messenger RNA,
mGL2, reporter molecule. This experiment was performed on 3T3 cells using lOOng/well siRNA, either
0.5|ig/well mGL2 or 2.0jig/well pGL2, and lOOng/well pRL Renilla internal control. Luciferase levels
were assayed at 18 hours post-transfection. Data-points are derived from single experiments and hence
error bars have not been applied.
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5.6 Evidence suggesting partial siRNA-induced knockdown ofmRNA-encoded
Firefly luciferase after a period of 24 hours post-transfection
When the previous experiment comparing three Firefly-specific siRNA molecules (A, C and B2)
was assayed for luciferase expression after 24-36 hours post-transfection (rather than 12-18
hours), then a modest knockdown of the mGL2 Firefly luciferase is detectable. However, this is
quantitatively much smaller than the knockdown of the pGL2 Firefly luciferase (Figure 5.6). If
correct, then it suggests that the action of the siRNA at the level of the mRNA is a delayed one
that is unable to account for the earlier knockdown of the pGL2 luciferase. However, this finding
represents the only occasion that siRNA-induced mGL2 knockdown was observed and as such
might simply represent experimental variation rather than genuine result. Moreover, the data-
points are derived from single experiments and hence error bars and statistical analysis have not
been applied. As previously, this experiment was performed on 3T3 cells in 24-well plates using
lOOng/well siRNA, 0.5pg mGL2/well or 2.0pg/well pGL2, and lOOng/well pRL Renilla control.
Figure 5.6: Firefly-specific siRNAs generate a modest and late knockdown of mGL2 luciferase.
Firefly-specific siRNAs generate a modest knockdown of the mGL2 luciferase only if luciferase activity
is assayed after 24 hours post-transfection. This represents a late effect of the siRNA acting at the level
of the mRNA and is unable to account for the much larger knockdown of the pGL2 luciferase detectable
within 12 hours post-transfection. As previously, the experiment was performed on 3T3 cells using
lOOng/well siRNA, either 0.5jig/welI mGL2 or 2.0pg/well pGL2, and lOOng/well pRL Renilla internal
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5.7 Failure of Firefly-specific siRNAs to mediate knockdown ofmRNA-encoded
luciferase reporter confirmed likewise in CHO cells
Based upon the previous findings in 3T3 cells, revealing an unexpected inability of Firefly-
specific siRNA to mediate knockdown of an mRNA-encoded luciferase, experiments were
undertaken to extend this result to another mammalian cell line, specifically CHO cells. Here,
CHO-AA8 cells were co-transfected using either mGL2 reporter or pGL2 plasmid together with
the relevant siRNA (B2, C, or non-specific control), and pRL internal control. For each of the
three siRNAs, the following combinations were compared: sense alone, antisense alone,
sense/antisense equimolar mixture, and double-stranded annealed (Figure 5.7). The results
illustrate that for the two Fz>e/7y-specific siRNAs, B2 and C, but not the control, there is
unambiguous knockdown of the pGL2 luciferase for both the sense/antisense mixture and the
double-stranded annealed. However, there is no demonstrable knockdown of mGL2 luciferase in
the parallel experiment suggesting that siRNA-induced knockdown operates in CHO cells against
the DNA-encoded, but not the mRNA-encoded, Firefly reporter. This result is statistically
significant using Student's t-test for paired data (p=0.001).
Figure 5.7: Fi'rgffv-specific siRNAs fail to knockdown mGL2 luciferase in CHO cells at 24 hours.
In CHO-AA8 cells, Fz>e/7y-specific siRNAs yield knockdown ofpGL2 luciferase but not mGL2
luciferase (controlled by non-specific siRNAs). This experiment was performed using lOOng/well
siRNA, either 0.5pg/well mGL2 or 2.0pg/well pGL2, and lOOng/well pRL and luciferase levels were
analysed at 24 hours. Error bars represent the range derived from duplicate experiments. This finding
is statistically significant using a paired Student's t-test (p=0.001).
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5.8 Firefly-spccific siRNAs knock down expression of a co-transfected mRNA
luciferase reporter in Drosophila KC cells but not S2 cells
The foregoing results, showing failure of Firefly-specific siRNAs to knock down expression of the
mGL2 mRNA luciferase reporter, argues against the paradigm view that siRNA-induced
interference operates at a post-transcriptional mRNA level in mammalian cells. In order to
address this issue, it was necessary to demonstrate that the Firefly-specific siRNAs are able to
induce knockdown of the mGL2 reporter in a different cell system where a post-transcriptional
site-of-action is well established. The Drosophila cell lines, KC and S2, were chosen for this
purpose. These are immortal cell lines originally derived from embryonic haemocytes that have
been well characterised and were kindly provided by B. Baum. KC (Kel67) cells are small and
round with a high doubling rate and poor plastic adherence while S2 (S2R+) cells are large and flat
with a lower doubling rate and strong plastic adherence. Both cell lines exhibit robust RNA
interference and have been used in a functional RNAi-based genomic analysis of cell morphology
using double-stranded RNA mediated knockdown (Ref: Kiger A. et al. 2003).
The experiment performed was the same as for the 3T3 and CHO cells previously, namely the
direct comparison of Firefly-specific siRNAs (B2 and C) to knockdown pGL2 and mGL2
luciferase reporters using transient co-transfection. There are two clear findings:
1) In Drosophila KC cells, Firefly-specific siRNAs are able to knockdown both pGL2 and
mGL2 luciferase suggesting that the site of action is post-transcriptional (p<0.001).
2) However, in Drosophila S2 cells, as for mammalian 3T3 and CHO cells, Firefly-specif\c
siRNAs are able to knockdown pGL2 but not mGL2, luciferase (p<0.001).
Thus, there are qualitative differences not only between Drosophila and mammalian cells but also
between KC and S2 cells. The levels of statistical significance shown are calculated using
Student's t-test for paired data. The results are shown graphically overleaf (Figure 5.8).
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Figure 5.8: Firefly siRNAs knockdown mGL2 luciferase in KC but not S2 Drosophila cells.
Firefly-spec] f\c siRNAs (B2 and C) knockdown both pGL2 and mGL2 in Drosophila KC cells but
only pGL2 and not mGL2 in Drosophila S2 cells (similar to the pattern ofknockdown for mammalian
3T3 and CHO cells). The experiment was performed using lOOng/well siRNA, either 0.5pg/well
mGL2 or 2.0pg/well pGL2, and lOOng/well pRL. Luciferase levels were analysed at 24 hours. Error
bars represent the range derived from duplicate experiments. This qualitative difference between KC
and S2 cells is statistically significant using a paired Student's t-test (p<0.001).
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5.9 5'-phosphoiylation of the siRNA molecule does not affect level of knockdown
of Firefly luciferase expressed from a transiently transfected pGL3 plasmid
The influence of phosphorylation of the 5' terminus of the siRNA molecule on the level of target
gene knockdown was investigated in mammalian (CHO) and Drosophila (KC) cells. siRNA
molecules were either phosphorylated using the enzyme T4 polynucleotide kinase, which
catalyses the transfer of the y-phosphate from ATP to the 5'-terminus of polynucleotides bearing a
5'-hydroxyl group, or else mock phosphorylated (no enzyme added). The luciferase plasmid
pGL3 was used rather than pGL2 on account of its overall greater level of expression in cells.
Two Firefly-specific siRNAs (B3 and C) were tested for the knockdown potential (sense alone
versus antisense alone versus double-stranded) and these were compared with the three-nucleotide
mismatch siRNA (B2) and a non-specific control siRNA (LacZ). The experiment was performed
identically in both CHO and KC cells using co-transfection of the relevant siRNA together with
the pGL3 Firefly (target) and pRL Renilla (internal control) plasmids. Knockdown was assayed at
36 hours post-transfection in the conventional manner.
The results confirm the comparable magnitude of siRNA-induced knockdown in KC cells as for
CHO cells and also its exquisite sensitivity to contained sequence mismatch. More pertinently,
the results demonstrate that phosphorylation of the 5'-terminus of the oligonucleotide appears to
have no effect on the potency of the siRNA-induced knockdown, nor on the knockdown inactivity
of the single-stranded RNAs. Note however that no test to confirm successful 5'-phosphorylation
by T4 polynucleotide kinase was performed. These results are presented for CHO cells and KC
cells overleaf (Figures 5.9 and 5.10).
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Figure 5.9: S'-terminal phosphorylation is irrelevant to siRNA function in CHO cells.
Phosphorylation of the 5'-terminus of the siRNA molecule has no influence on the function of
the siRNA in CHO cells. Both mock and 5'-phosphorylated Firefly-specific siRNA molecules
yield pGL3 luciferase knockdown while control, mismatch and single-stranded forms are all
ineffective. The experiment used co-transfection of lOOngAvell siRNA (5'-phosphorylated, or
mock), l.Opg/well pGL3 and lOOngAvell pRL, and was analysed at 36 hours post-transfection.
Error bars represent the range derived from duplicate experiments.
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Figure 5.10: 5'-terminal phosphorylation is irrelevant to siRNA function in KC cells.
Phosphorylation of the 5'-terminus of the siRNA molecule has no influence on the function of
the siRNA in KC cells. Both mock and 5'-phosphorylated Firefly-specific siRNA molecules
yield pGL3 luciferase knockdown while control, mismatch and single-stranded forms are all
ineffective. The experiment used co-transfection of lOOngAvell siRNA (5'-phosphoryIated, or
mock), 1.0jig/well pGL3 and lOOngAvell pRL, and was analysed at 36 hours post-transfection.
Error bars represent the range derived from duplicate experiments.
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5.10 Overview of experimental strategy designed to assess the effect of 5'-terminaI
phosphorylation on siRNA-induced knockdown of transiently transfected mGL2 and
pGL2 Firefly luciferase reporters in mammalian and Drosophila cells
The previous experiment reveals that 5'-terminal phosphorylation of the siRNA molecule
apparently has no bearing on knockdown of a plasmid-borne Firefly luciferase target, pGL3, in
either mammalian CHO cells or Drosophila KC cells. To test the hypothesis that this is also true
of knockdown of the mRNA luciferase reporter, mGL2, in those cells that fail to show knockdown
with non-phosphorylated siRNAs (i.e.: CHO, 3T3 and S2 cells), the following experiment was
performed represented schematically below (Figure 5.11).
Figure 5.11: Schematic representation of experimental strategy to examine siRNA knockdown.
Experimental strategy to explore the effect of5'-terminal siRNA phosphorylation on knockdown of a
target mGL2 or pGL2 Firefly luciferase in mammalian (CHO & 3T3) and Drosophila (KC & S2) cells.




pRL (Renilla internal control)
Firefly luciferase reporter
oGL2 (DNA1 or mGL2 (mRNA)
sense vs. antisense vs. duplex




KC / S2 / CHO / 3T3 cells
(24 well plate format)





Chapter 5 - Results 3
5.11 Evidence suggesting that 5'-phosphorylation of the siRNA termini enhances
the knockdown ofmGL2, but not pGL2, luciferase in Drosophila S2 cells
The results of the foregoing experiments reveal that Firefly-specific siRNAs are unable to
knockdown luciferase expression in Drosophila S2 when the gene target is borne on an mRNA
molecule despite being able to knockdown the same gene target when it is borne on a plasmid
molecule, while in Drosophila KC cells, by contrast, Firejly-spec\f\c siRNAs are able to
knockdown both mRNA and plasmid-borne luciferase targets. Unexpectedly, when the same
experiment is performed using 5'-phosphorylated siRNAs in Drosophila S2 cells, there is
significant knockdown of the mRNA-borne luciferase suggesting that phosphorylation of the 5'-
termini of the siRNA molecule has "rescued" its interference activity. Thus, in S2 cells, siRNA-
induced knockdown of an mRNA-borne target is 5'-phosphate dependent while knockdown of a
plasmid-borne target is 5'-phosphate independent. This is qualitatively different from KC cells,
where knockdown of both mRNA and plasmid-borne targets operates in the absence of 5'-
phosphorylation. In the case of mammalian CHO and 3T3 cells, there remains failure of
knockdown of the mRNA-borne target, despite knockdown of the plasmid-borne target,
irrespective of 5'-phosphorylation of the siRNA.
The validity of this result, showing that knockdown of mRNA-encoded luciferase in S2 cells is
enhanced by 5'-phosphorylation of the siRNA molecule, is strengthened by the fact that it is
consistent for two different F/re/7y-specific siRNA molecules, namely siRNA-B2 (89% to 28%)
and siRNA-C (81% to 50%). However, it should be noted that data-points are derived from single
experiments and hence error bars and statistical analysis have not been applied. Consequently,
these results might simply reflect experimental variation rather than genuine finding. The results
are shown overleaf: the upper graph (Figure 5.12) shows the effect of 5'-phosphorylation of
siRNA-B2 on mGL2 versus pGL2 knockdown in KC, S2, CHO and 3T3 cells, while the lower
graph (Figure 5.13) does likewise for siRNA-C.
The set of eight graphs on the subsequent page (Figure 5.14) presents the complete set of
experimental data. Here, each cell line (KC, S2, CHO and 3T3) has been subjected to luciferase
knockdown experiments using a variety of siRNAs (F7re/7y-specific B2 and C, both single-
stranded and double-stranded, three-nucleotide mismatched B3, and control LacZ) that has been
either mock or 5'-phosphorylated. The results affirm the findings outlined above that 5'-
phosphorylation of the double-stranded F/>e/7y-specific siRNAs, B2 and C appears to "rescue" the
knockdown effect of the mRNA luciferase reporter, mGL2, in Drosophila S2 cells (but not
mammalian CHO or 3T3 cells).
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Figure 5.12: Effect of S'-phosphorylation on luciferase knockdown using Firefly siRNA-B2.
Luciferase knockdown was assessed for both mGL2 and pGL2 using either mock or 5'-phosphorylated
siRNA-B2 in Drosophila KC and S2 cells and mammalian CHO and 3T3 cells. 5'-phosphorylation
"rescues" the siRNA knockdown effect with mGL2 in S2 cells. This experiment was performed using
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Figure 5.13: Effect ofS'-phosphorylation on luciferase knockdown using Firefly siRNA-C.
Luciferase knockdown was assessed for both mGL2 and pGL2 using either mock or 5'-phosphorylated
siRNA-C in Drosophila KC and S2 cells and mammalian CHO and 3T3 cells. 5'-phosphorylation
"rescues" the siRNA knockdown effect with mGL2 in S2 cells. This experiment was performed using
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5.12 5'-phosphorylation of a sense-mismatched heteroduplex siRNA is necessary
for knockdown of pGL2 Firefly luciferase in Drosophila, but not mammalian, cells
Previous results in mammalian CHO cells have demonstrated that there are profound differences
in the ability of a mismatched heteroduplex siRNA to knockdown a target luciferase. Thus, if the
heteroduplex is comprised of a matching sense-strand but three-nucleotide mismatched antisense
strand, then there is complete abrogation of the knockdown effect. Conversely, if the
heteroduplex is comprised of a matching antisense strand but three-nucleotide mismatched sense
strand, then the level of knockdown is similar to that measured for the fully matched siRNA
duplex. In other words, sequence fidelity of the antisense strand is paramount in determining the
effectiveness of siRNA-induced target gene knockdown while minor infidelity of the sense strand
is relatively well tolerated. This finding was demonstrated both for transiently transfected pGL3
luciferase target in CHO-AA8 cells (Section 5.1) and also for stably integrated GL2 luciferase
gene target in CHO-LUC cells (Section 5.2). Moreover, the phenomenon was apparently
independent of 5'terminal phosphorylation of the siRNA (Section 5.3).
When the sense-mismatch heteroduplex was tested against the mGL2 mRNA luciferase reporter,
using transient co-transfection in CHO and 3T3 cells, it was not possible to demonstrate any
significant knockdown. This demonstration was consistent with previous findings revealing the
ineffectiveness of siRNAs against mRNA targets in mammalian cells and contrasts with a clear
knockdown of the pGL2 in the parallel experiment. Of greater significance was the demonstration
in Drosophila KC and S2 cells that the sense-mismatch heteroduplex siRNA fails to result in
knockdown of luciferase for both pGL2 and mGL2. In other words, there is a qualitative
difference between Drosophila and mammalian cells in regard to their ability to generate
knockdown of pGL2 luciferase in response to a sense-mismatch heteroduplex siRNA.
However, if the same sense-mismatch heteroduplex siRNA is 5'-terminally phosphorylated, then
there is enhanced luciferase knockdown in Drosophila cells, but only for the pGL2 luciferase
target and not the mGL2 luciferase target. Thus, pGL2 luciferase knockdown using sense-
mismatch heteroduplex siRNA is largely 5'-phosphorylation-independent in mammalian CHO and
3T3 cells but largely 5'-phosphorylation-dependent in Drosophila KC and S2 cells. However, it
should be noted that data-points are derived from single experiments and hence error bars and
statistical analysis have not been applied. Consequently, these results might simply reflect
experimental variation rather than genuine finding. The results are shown below according to the
siRNA heteroduplex (Figures 5.15 and 5.16) and thereafter are compiled according to each cell
line used (Figure 5.17).
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Figure 5.15: Effect of S'-phosphorylation on sense-mismatch heteroduplex siRNA function.
Firefly knockdown using the B3/B2 heteroduplex siRNA (sense-mismatch/antisense-correct)
occurs in CHO, and to a lesser degree 3T3, mammalian cells but not in KC or S2 Drosophila cells
unless there is 5'-terminal phosphorylation ofthe siRNA. This experiment was performed using
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Figure 5.16: Effect of 5'-phosphorylation on antisense-mismatch heteroduplex siRNA function.
Firefly knockdown using the B2/B3 heteroduplex siRNA (antisense-mismatch/sense-correct) is not
demonstrable in either mammalian or Drosophila cells irrespective ofsiRNA 5'-terminal phosphorylation
(i.e.: there is a total intolerance ofantisense-strand mismatch). This experiment was performed using
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Figure 5.17: Effect ofS'-phosphorylation of heteroduplex siRNAs on Firefly luciferase knockdown.
Same data as previous figures presented according to the cell line in which the experiment was performed.
The results demonstrate that luciferase knockdown occurs in mammalian CHO and 3T3 cells using sense-
mismatch, but not antisense-mismatch, heteroduplex siRNAs. However, in Drosophila KC or S2 cells there
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5.13 Conclusion
The primary objective of this chapter was the experimental dissection of the nature of RNA
interference in mammalian cells. This dissection was twofold: firstly, to define the key molecular
determinants for effective siRNA-induced knockdown; and secondly, to establish the site of action
of the siRNA molecule.
Antisense strand fidelity is obligatory for siRNA action
In order to determine which strand is pre-eminent in directing effective target knockdown,
"chimaeric" heteroduplex siRNA molecules were generated comprising three-nucleotide
mismatched sense or antisense strands. When the mismatch is within the antisense strand, there is
almost complete abrogation of the knockdown potency of the siRNA against transiently
transfected luciferase in 3T3 cells. Conversely, when the mismatch is within the sense strand,
then the siRNA retains similar potency to a fully matched siRNA. In other words, siRNA action is
intolerant of mismatch in the antisense strand while remarkably tolerant of the corresponding
mismatch in the sense strand. Thus, fidelity of the antisense strand of the siRNA molecule is
paramount in determining effective siRNA function. The same outcome was observed when the
experiment was performed in CHO-LUC cells using siRNA to knockdown a stably integrated
luciferase transgene. The clear mechanistic implication of this finding is that it is the antisense
strand that directs recognition of the target sequence probably through complementary base
pairing with the mRNA or, possibly, with the non-coding DNA.
5'-phosphorylation of the siRNA is irrelevant in mammalian cells
In the foregoing experiment using CHO cells, it was shown that phosphorylation of the 5'-ends of
the siRNA molecule prior to transfection (using polynucleotide kinase) had no influence on the
observed pattern or potency of the knockdown. Thus, either the presence of a terminal 5'-
phosphate is physiologically irrelevant for effective siRNA action or alternatively the cell contains
its own endogenous 5'- nucleotide kinase activity able to perform this function post-transfection.
This finding has relevance to results derived from subsequent experiments.
siRNA knockdown ofmRNA luciferase is weak or absent in 3T3 cells
The paradigm view of RNA interference argues in favour of a post-transcriptional mechanism in
which targeted binding of the siRNA to the mRNA transcript leads to cleavage of the latter via an
RNA-induced silencing complex (RISC). A direct prediction from this theory is that active
siRNAs should be able to knockdown a target gene irrespective of whether that gene is encoded
by a DNA molecule or an mRNA molecule. However, when this prediction was tested in 3T3
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cells, F/re/7y-specific siRNAs that could induce knock down of a plasmid-borne luciferase gene
failed to do likewise if the same luciferase gene was encoded on an mRNA molecule. This was
the case for two different Firefly-specific siRNAs and over all concentrations tested. Only if the
luciferase activity is assayed after 24 hours post-transfection was there any detectable knockdown
of mRNA-encoded luciferase but this was consistently much less than the knockdown of the
plasmid-borne luciferase. Thus, in 3T3 cells, siRNA-induced knockdown of mRNA luciferase
appears to be qualitatively distinct from that of DNA luciferase being at best rather weak and
delayed in its effect.
siRNAs show knockdown ofDNA luciferase but not mRNA luciferase in CHO cells
The same result was demonstrated likewise in CHO cells except that here it proved impossible to
detect any significant knockdown of the mRNA luciferase despite unequivocal knockdown of the
DNA luciferase for two different siRNAs tested. This result suggests that the siRNA-induced
knockdown measured in all the transient transfection experiments operates at the level of the DNA
and not the mRNA. Such an interpretation of the results is clearly at odds with the prevailing view
that siRNA operates primarily at a post-transcriptional level. However, it is possible that
alternative explanations could account for these results including experimental variation or
artefact, problems with the time-course of mRNA transfection and expression, and the non-
physiological nature of the experimental approach.
Reasons for failure of siRNA-induced knockdown ofmRNA luciferase in mammalian cells
It is possible to contrive alternative explanations for these unexpected findings. Firstly, if the
mRNA was rapidly translated into luciferase prior to incorporation of the siRNA into the silencing
complex, then clearly no knockdown would be detectable. However, luciferase activity was
apparent for at least 36 hours suggesting that mRNA translation must itself take place over several
hours allowing time for the siRNAs to exert their effect. Secondly, the siRNAs might operate in a
cellular compartment, such as the nucleus, that the exogenously introduced mRNA (but not the
plasmid DNA) is unable to access. However, this would be contrary to the established view that
interference takes place in the cytoplasm. Finally, the mRNA molecule used here, which lacks a
5'-cap but possesses a 30-nucleotide polyA tail, has not been generated via the normal
physiological route and may therefore bypass the RNA interference machinery.
KC and S2 cells are Drosophila haemocyte lines known to exhibit robust RNA interference
In order to determine if these findings were specific to mammalian cells, and in so doing exclude
alternative explanations suggested above, it was necessary to demonstrate that transiently
transfected mRNA luciferase could be successfully knocked down using Firefly specific siRNAs
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in non-mammalian cells instead. Two well-characterised Drosophila cell lines (kindly provided
by B. Baum) were chosen for this purpose, both derived by immortalisation of embryonic
haemocytes. KC (Kc167) cells are small and round with a high doubling rate and poor plastic
adherence while S2 (S2R+) cells are large and flat with a lower doubling rate and strong plastic
adherence. Both cell lines exhibit robust RNA interference and have been used in a functional
RNAi-based genomic analysis of cell morphology using double-stranded RNA mediated
knockdown (Ref: Kiger A. et al. 2003).
siRNAs show knockdown ofmRNA luciferase in KC cells but not S2 cells
The findings reveal an unexpected but clear qualitative difference between KC and S2 cells
Drosophila cells. Thus, in KC cells, Firefly-specific siRNAs are able to knockdown both DNA
luciferase and RNA luciferase in-keeping with the notion that the interference of gene expression
is operating post-transcriptionally at the level of the mRNA. However, in S2 cells, F/re/Zy-specific
siRNAs are only able to knockdown DNA luciferase and not RNA luciferase, which is the pattern
of knockdown seen in the mammalian cell lines, 3T3 and CHO, previously. Moreover, these
findings were corroborated for two different siRNA molecules that recognise different target
sequences within the luciferase gene. The demonstration that Firefly-specific siRNAs do indeed
knockdown RNA luciferase in KC cells confirms that the experimental design is robust and that
their failure to do so in mammalian cells is not attributable to trivial technical reasons.
S'-phosphorylated antisense siRNAs alone do not exhibit knockdown activity
Some evidence has suggested that single-stranded antisense siRNAs, particularly when S'-
phosphorylated, are sufficient on their own to induce target gene knockdown, at least in HeLa
cells (Ref: Martinez J. et al., 2002). However, this was not a finding in the experiments of the
previous chapter performed in 3T3 cells. In order to address this issue, sense alone, antisense
alone, and double-stranded versions of two different Firefly siRNAs were tested in both
mammalian CHO and Drosophila KC cells alongside a non-specific control and a three-nucleotide
mismatched control. The results reveal, both for unphosphorylated and 5'-phosphorylated
siRNAs, that only double-stranded siRNAs are able to yield significant luciferase knockdown. By
contrast, single-stranded antisense (and sense) siRNAs on their own, whether phosphorylated or
not, are unable to produce knockdown in either CHO or KC cells, thus confirming earlier
conclusions that both homologous strands, irrespective of prior 5'-phosphorylation, are necessary
for interference of a transiently expressed plasmid-borne gene. In addition, again confirming
previous findings, discrete mismatches at three disparate sites within the target sequence largely
abrogate this effect.
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5,-phosphorylation partially rescues siRNA action against mR.NA luciferase in S2 cells
In light of the above result using a DNA luciferase target, the effect of 5'-phosphorylation of
siRNAs on knockdown of RNA luciferase was similarly assessed in Drosophila and mammalian
cell lines. This revealed in S2 cells that, whereas previously the Firefly siRNA was unable to
induce knockdown of the RNA luciferase, the addition of a 5'-phosphate partially rescues the
knockdown effect of the siRNA. In other words, unlike in KC cells where siRNA knockdown of
RNA luciferase occurs irrespective of 5'phophorylation, in S2 cells the siRNA requires a 5'-
phosphate for effective knockdown of RNA luciferase. Thus, prior 5'-phosphorylation of the
siRNA molecule appears to rescue the knockdown effect against an RNA luciferase target in S2
cells resulting in an outcome similar to KC cells. However, this result is also subject to more
prosaic explanations including experimental variation and technical error. If on the other hand it
is a genuine finding, then it suggests that KC cells contain a high level of endogenous 5'
nucleotide kinase activity relative to S2 cells, a prediction that might be formally tested.
S'-phosphorylated siRNAs fail to knockdown mRNA luciferase in mammalian cells
Two additional salient negative findings from the foregoing experiment are also relevant. Firstly,
unlike for S2 cells, 5'-phosphorylation fails to rescue siRNA knockdown function against RNA
luciferase in either CHO or 3T3 cells, revealing an important qualitative difference between
Drosophila and mammalian cells. Secondly, there is no demonstrable knockdown of RNA
luciferase using antisense siRNAs alone, whether 5'-phosphorylated or not, in any of the cell lines
tested, confirming again that both sense and antisense strands are necessary for interference
against RNA, as well as DNA, gene targets.
S'-phosphorylation is able to rescue the knockdown activity of (antisense-fidelitous)
heteroduplex siRNAs in Drosophila cells against PNA luciferase but not mRNA luciferase
As presented previously, mismatched heteroduplex siRNAs are able to knockdown both plasmid-
borne luciferase and endogenous luciferase in CHO and 3T3 cells but only if the antisense strand
retains complete sequence fidelity with the target. In other words, siRNA knockdown in
mammalian cells appears to be relatively tolerant of sense strand mismatches. However, these
results are not reproducible in Drosophila cells. Instead, the same heteroduplex siRNAs that are
able to knockdown DNA luciferase in mammalian cells are unable to do likewise in KC and S2
cells. However, by 5'-phosphorylating these heteroduplex siRNAs, their knockdown action is
partially restored in both KC and S2 cells, but only against DNA luciferase and not against RNA
luciferase. Thus, the knockdown action of (antisense fidelitous) heteroduplex siRNAs against
DNA luciferase appears to be 5'-phosphate-independent in mammalian cells but 5'-phosphate-
dependent in Drosophila cells. In addition, there is no demonstrable knockdown effect against
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RNA luciferase in either mammalian or Drosophila cells irrespective of 5'-phophorylation status.
Once again, it is possible that more prosaic explanations of experimental variation and technical
error might account for these results.
Summary of findings
This chapter sought to define the key molecular determinants of effective siRNA-induced
knockdown and in so doing shed light on the site of action of the siRNA molecule. Some of the
findings in the two mammalian cell lines used were unexpected and, in view of this, efforts were
made to corroborate these findings by repeating the same experiments in two Drosophila cell
lines. The summary of all these results are listed below:
• siRNA knockdown activity in mammalian cells, as revealed by the use of heteroduplex
molecules, requires antisense strand fidelity but is tolerant of sense strand mismatch
• siRNAs that yield robust knockdown of a transiently transfected plasmid-borne DNA
luciferase in 3T3 or CHO mammalian cells fail to knockdown an mRNA-borne luciferase
• siRNAs produce knockdown of both DNA and mRNA luciferase in KC Drosophila cells
but only DNA and not mRNA luciferase in S2 Drosophila cells
• 5'-phosphorylation of the siRNA molecule appears to partially rescue its knockdown
activity against mRNA luciferase in S2 Drosophila cells
• 5'-phosphorylation of the siRNA moleculefails to rescue its knockdown activity against
mRNA luciferase in 3T3 or CHO mammalian cells
• Heteroduplex siRNAs that yield robust knockdown ofDNA luciferase in mammalian cells
fail to produce knockdown of either DNA or mRNA luciferase in Drosophila cells
• 5'-phosphorylation of the heteroduplex siRNA is able to partially rescue its knockdown
activity in KC and S2 Drosophila cells against DNA luciferase but not mRNA luciferase
• Antisense-strand molecules alone, whether 5'-phosphorylated or not, fail to exhibit any
knockdown activity against DNA or mRNA luciferase in either mammalian or Drosophila
cells
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Statistical considerations
This chapter contains a large amount of data that has been analysed using various quantitative
methods to determine levels of statistical significance. However, statistical significance alone
cannot prove that an observation is indeed experimentally genuine or biologically meaningful.
This is especially true where large numbers of data-points are being correlated with outcomes.
Moreover, while most these data-points were derived from replicated experiments, some were
derived from non-replicated experiments for which standard errors cannot be calculated. Where
this occurred, the validity of the results was considered according to whether the effect showed
dosage consistency or occurred similarly for two different siRNAs. However, inevitably, there is
the risk that results are over-interpreted leading to incorrect conclusions. For this reason, the
findings listed above are provisional and intended to serve as hypotheses that might be tested by
future experiments.
Future experiments
The most consistently reproducible finding from this chapter was the demonstration that Firefly-
specific siRNAs, when co-transfected with the target gene into CHO cells, are unable to induce
knockdown of mRNA-encoded luciferase. It was borne out similarly in 3T3 cells, except perhaps
for a weak delayed effect, and also Drosophila S2 cells. However, in KC cells, the siRNAs do
induce knockdown of the mRNA-encoded luciferase with similar potency as for DNA-encoded
luciferase. This observation served to strengthen the validity of the experimental model and
confirm that the lack of knockdown seen in CHO, 3T3 and S2 cells is indeed genuine. In order to
explore this finding further, future experiments are proposed below:
The key experiment to establish the precise site of action of siRNA interference in
these cells is the nuclear run-on transcription assay. This would allow a transcriptional
level of interference to be distinguished from a post-transcriptional/translational level via
incorporation of radio-labelled nucleotides into nascent mRNA strands in isolated nuclei
and subsequent autoradiography. In the former case, mRNA transcripts would cease to be
produced upon siRNA action while in the latter, they would continue to be produced and
then destroyed by siRNA-induced strand cleavage.
A second strategy would be to quantify the mRNA using immunoblotting or even
microarray analysis. However, neither of these approaches possesses the ability to
measure nascent transcripts and hence they would fail to distinguish between mRNA
transcriptional arrest and mRNA destruction.
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Finally, detection of mRNA cleavage products, by immunoblotting for size or
sequencing of 5'RACE products, would reveal whether the mRNA was cleaved within the
siRNA target site, yielding proximal and distal fragments, or alternatively interrupted
during transcription, when only a proximal fragment would result.
Of these experiments, the nuclear run-on experiment would be the most important in determining
whether siRNA knockdown in these cells operates predominantly at the transcriptional DNA level
or post-transcriptional mRNA level. It is conceivable that gene expression might be interrupted at
any point along this route, from accessibility of the DNA to the transcriptional machinery to
generation of an mRNA molecule and its translocation out of the nucleus. Finally, the possibility
that the non-physiological nature of the experimental model used in this chapter, which uses the
transient transfection of mRNA or DNA molecules into cells, might have resulted in artefactual
results should be considered. Undoubtedly, this strategy produces an artificial cellular situation
raising the possibility that this alone accounts for the unexpected outcome that co-transfected
siRNAs knockdown DNA but not mRNA genes. This is explored further in the forthcoming
discussion.
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6.1 General design of siRNA-mediated knockdown experiments against various
gene targets in different cell lines
The principal goal of this chapter was to demonstrate that siRNA knockdown can operate in
murine ES cells by targeting a number of different gene targets: transiently expressed Firefly
luciferase; randomly integrated GFP transgene; p-galactosidase gene targeted to an endogenous
locus (Oct3/4); and the endogenous DNA methyltransferase gene (Dnmtl). In addition, results are
presented from siRNA-mediated knockdown of the telomerase reverse transcriptase gene
(hTERT) in two human breast cancer cell lines (MDA and T47D) and of the pyrimidine salvage
pathway thymidine kinase gene (Tk) in CHO cells. Finally, the pertinent negative results from an
experiment designed to induce permanent silencing of the hypoxanthine phosphoribosyl
transferase gene (Hprt) by siRNA targeting and 6-thioguanine selection of ES cells are presented.
The basic design of all the siRNA knockdown experiments was essentially identical with gene
expression assayed either qualitatively, quantitatively, or functionally as appropriate (Figure 6.1).
Figure 6.1: Schematic illustration demonstrating the basic experimental strategy for studying
siRNA-induced knockdown ofvarious target genes in a number of different cell lines.
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6.2 Transfection ofFirefly-specific siRNAs result in dose-dependent knockdown
of transiently expressed luciferase in murine ES cells
Results presented in previous chapters have established that siRNA molecules bearing sequence
homology with a target reporter luciferase are able to mediate knockdown of gene expression in a
potent and dose-dependent fashion in mammalian CHO and 3T3 cell lines. Co-transfection of
Firefly-s\>Qc\f\c siRNAs with pGL3 luciferase plasmid in murine ES cells recapitulates these
findings and confirms that RNA interference operates in a similar fashion in ES cells as for CHO
and 3T3 cells. The results reveal that the step-wise increase of both sense and antisense siRNA
strands in the transfection mix leads to a dose-dependent knockdown of luciferase expression. By
comparison, variance of sense and antisense siRNA strands in inverse amounts results in a "V"-
shaped curve in which maximum knockdown occurs when sense and antisense strands are present
in equimolar amounts (Figure 6.2). This confirms that the stoichiometry of sense and antisense
strands in the interference process is 1:1 consistent with the view that the active intermediary
species is double-stranded RNA. Finally, the demonstration that RNA interference operates in ES
cells opens up the possibility of using siRNAs to functionally analyse differentiation genes.
Figure 6.2: Graph showing siRNA-mediated knockdown of Firefly luciferase in murine ES cells.
The knockdown of transiently expressed Firefly luciferase (from pGL3 plasmid) in murine ES cells using
specific siRNA molecules exhibits dose-dependent potency, sequence specificity and 1:1 stoichiometry.
The amount of antisense strand goes up in parallel or down inversely with the sense strand dose shown.
Dose of sense siRNA (ng per well)
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6.3 Sequence-specific siRNA molecules are able to suppress expression of a GFP
transgene stably integrated by random genomic insertion in ES cells
Sequence-specific siRNAs were tested for their ability to knockdown expression of enhanced GFP
in a genetically engineered ES cell line kindly donated by A. Medvinsky (Ref: Gilchrist D.S. et
al., 2003). Here, the GFP gene is expressed from a powerful constitutive promoter and carried on
a transgene stably integrated by random genomic insertion. siRNA molecules sharing sequence
homology with region 125 to 143 of the EGFP gene were transfected using Oligofectamine™
using a modified protocol in which cells were exposed for variable periods to the transfection
reagent containing siRNA at lOOng/ml. ES cells were then assessed for GFP expression by flow
cytometric analysis of fluorescence at 48 hours post-transfection and compared with ES cells
transfected with control (LacZ-specific) siRNAs. The results reveal a modest knockdown of
fluorescence level that is maximal (34%) for the two-hour siRNA incubation experiment (Figure
6.3). Comparison of the two sets of data using a paired Student's t-test confirms statistical
significance (p=0.001). The limited potency of the knockdown effect may reflect poor efficacy of
the siRNA molecule or inefficiency of the transfection process. In addition, demonstration of
EGFP knockdown is made more difficult given its prolonged intracellular stability with a half-life
of approximately 12-24 hours (personal communication A. Medvinsky).
Figure 6.3: Flow cytometric analysis showing siRNA-mediated knockdown of GFP in ES cells.
siRNAs sharing sequence homology with EGFP were tested against control LacZ siRNAs for their
ability to knockdown expression ofGFP in an ES cell line carrying a stably integrated GFP transgene.
The two keys indicate the lengths of time the GFP and LacZ siRNAs were incubated with the ES cells.
Fluorescence was assessed by flow cytometry at 48 hours for three different siRNA incubation times.
Analysis of the data using a paired Student's t-test demonstrates statistical significance (p=0.001).
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6.4 Repeated knockdowns of GFP expression, via serial transfection of siRNA,
result in diminished rather than enhanced knockdown effect
In order to test whether repeated knockdowns of GFP expression would result in an enhanced
cumulative effect, serial transfections of GFP-specific siRNA were performed at three-day
intervals on the same ES cells. At each passage, an aliquot of cells were analysed by flow
cytometry while the remainder were re-suspended directly into transfection mix for one hour prior
to re-plating on gelatin-coated wells. Contrary to expectation, this experiment revealed that the
magnitude of the knockdown was diminished at each passage from 28% to 14% to 4% relative to
the control ES cells that were transfected with non-specific (LacZ) siRNA (Figure 6.4). It is
possible that this apparent fall-off in magnitude of GFP knockdown at each transfection cycle
reflects a progressive depletion of the molecular components of the RNAi machinery. However,
the finding fails to reach statistical significance using Student's t-test for paired data (p=0.13) and
might be more easily explained in terms of experimental variation. Nonetheless, it is included
here as an observation that is worthy of further investigation.
Figure 6.4: Repeated cycles of siRNA transfection result in diminished levels of GFP knockdown.
Repeated cycles oftransfection ofES cells with GFP-specific siRNAs result in diminished, rather than
enhanced, levels ofGFP knockdown relative to the baseline cells transfected with control LacZ siRNAs.
Data-points are derived from single experiments and hence error bars have not been applied.
The result is not statistically significant using a paired Student's t-test (p=0.13).
Control LacZ siRNA IH
GFP-specific siRNA □ J
1st siRNA 2nd siRNA 3rd siRNA
knockdown knockdown knockdown
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6.5 LacZ-specific siRNAs can suppress expression of a p-galactosidase transgene
targeted to the Oct3/4 locus in murine ES cells
LacZ-specific siRNAs were tested for their ability to knockdown a P-galactosidase transgene that
had been targeted to the endogenous Oct3/4 locus in ES cells kindly provided by A. Smith (Ref:
Dani C. et al., 1998). This ES cell line, termed IOUD2, permits the testing of siRNAs against a
reporter gene integrated within a physiological gene locus rather than a random integration locus
as for the GFP cell line used in the previous experiments. The photomicrographs below illustrate
the unequivocal knockdown of p-galactosidase expression within discrete ES cell colonies (Figure
6.5). Here, ES cells have been seeded at low density following siRNA transfection to allow
colonies to form. The level of LacZ knockdown was then quantified after five days using X-gal
staining. This analysis reveals the persistence of p-galactosidase knockdown as the ES colonies
grow indicating clonal inheritance of the interference effect through repeated cell divisions.
Figure 6.5: LacZ-specific siRNAs knock
down expression of a stable B-galactosidase
targeted to the Oct3/4 locus in ES cells.
ES cells were transfected with LacZ-specific
siRNA and then re-plated at low dilution. At
five days, colonies were assessed for level of
expression of P-galactosidase using X-gal
staining. This revealed a dose-dependent
knockdown of p-galactosidase expression
compared with control (GFP) siRNA. The
level ofknockdown was highly variable and
colonies exhibited considerable heterogeneity
ofP-galactosidase expression (see Figure 6.6).
Control (GFP) siRNA at 4ug/well
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6.6 siRNA-induced knockdown of p-galactosidase expression in ES cells exhibits
dose-dependency and clonal heritability
B-galactosidase-expressing IOUD2 cells were transfected in suspension using either LacZ-specific
siRNAs or control (GFP) siRNAs, at varying doses, and seeded on 1 Ocm plates at a concentration
of 103 cells per plate. Colonies were allowed to emerge over the following five days after when
the plates were stained for |3-galactosidase activity using the X-gal assay. Colonies were scored
under light microscopy for the intensity of blue staining quantified according to the approximate
proportion of positive cells per colony. Each experiment was unique and hence statistical analysis
has not been performed. However, the dose-dependent nature of the effect supports the
conclusion that siRNA-induced knockdown of (3-galactosidase expression is genuine. Indeed, at
the highest siRNA dosage tested, a significant proportion of colonies showed negligible blue
staining five days post-transfection. This confirms that the RNAi effect can be propagated from
parental cell to daughter cell through several rounds of cell division. However, even at this dosage
there remain many colonies that do not exhibit any P-galactosidase knockdown suggesting either
failure of transfection of the siRNA into the original cell or alternatively incomplete knockdown
or even resistance of the cell to the interference effect.
Figure 6.6: Graph showing siRNA-induced knockdown of B-galactosidase expression in ES cells.
LacZ-specific siRNAs are able to knockdown expression of a p-galactosidase transgene in IOUD2 ES
cells in a dose-dependent fashion. Each experiment was unique and hence error bars have not
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6.7 siRNAs directed against the telomerase reverse transcriptase gene (hTERT)
fail to show significant functional knockdown of telomerase activity in human cancer
cell lines
Sequence-specific siRNAs were tested for their ability to knockdown expression of the reverse
transcriptase subunit of the telomerase enzyme (hTERT) in human breast cancer cell lines.
hTERT is an integral part of the telomerase complex required for the retention of telomeric
sequences present at the termini of the chromosomes. This involves the catalytic restoration of
hexanucleotide (TTAGGG) repeats that are otherwise eroded during DNA replication. Evidence
suggests that these are required for chromosomal stability in cells undergoing continual self-
renewal including both stem cells and cancer cells, both of which exhibit high levels of telomerase
activity (Ref: Cech T.R., 2004). In this experiment, which was part a collaborative project with A.
Tsakiridis (Honours student, Edinburgh University), hTERT-specific siRNAs were tested for their
ability to knockdown telomerase activity as measured by a functional PCR-based ELISA
telomerase assay (Telomerase PCR ELISA™, Roche Inc.).
Two human breast cancer cell lines were used, namely MDA435 and T47D. These were serially
transfected four times, as per the suspension method described previously, using two different
siRNAs homologous to distinct regions of the hTERT gene and a non-specific control siRNA.
The cells were then lysed and telomerase activity assayed using the TRAP method (Telomeric
Repeat Amplification Protocol) and quantified via a sensitive photometric enzyme immunoassay.
However, the results fail to demonstrate a consistent and dose-dependent knockdown of
telomerase activity. Only at the highest level of 1 pg siRNA was there any evidence of loss of
telomerase activity (77% for the upstream hTERT siRNA, 63% for the downstream hTERT
siRNA, 86% for both hTERT siRNAs combined, and 99% for the control siRNA) although these
results are derived from single experiments and hence statistical analysis is not possible
Besides technical failure of the experiment itself, or of the siRNA molecules used, other reasons
for the absence of interference effect on telomerase activity include the following:
1) hTERT may not be the rate-limiting step determining telomerase activity within a cell
2) hTERT protein may persist causing sustained telomerase activity
3) the PCR-based assay may be poorly sensitive to low levels of activity.
Finally, any functional assay of telomerase activity will inevitably under-measure the true level of
gene knockdown compared with an RNA-based assay such as northern blot analysis or RT-PCR.
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Figure 6.7: Graph showing effect of transfection of hTERT-specific siRNAs in MDA435 cells.
siRNAs specific for the hTERT gene fail to demonstrate knockdown of telomerase activity when
transfected into MDA435 breast cancer cells. Data-points are derived from single experiments and
hence error bars have not been applied. The apparent lack of telomerase knockdown might be
attributable to a number ofproblems including technical and biological issues.
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6.8 siRNA-induced knockdown in ES cells of the purine salvage pathway enzyme,
Hprt, fails to generate surplus mutant clones by negative selection in 6-thioguanine
Hypoxanthine phosphoribosyl transferase (Hprt), which resides on the X chromosome and hence
is present in a single copy in male ES cells, is a key enzyme involved in purine synthesis via the
salvage pathway. ES cells that are mutant for the Hprt locus, whether arising spontaneously or via
a genotoxic insult, can be isolated using the purine analogue 6-thioguanine. This is converted by
Hprt into a cytotoxic metabolite that kills wild-type cells and thereby allows negative selection of
Hprt deficient cells. In order to test the hypothesis that Hprt-specific siRNAs might be able to
produce permanent silencing of the Hprt locus, for instance via methylation or some other
epigenetic change at the gene locus, ES cells were selected with 6-thioguanine post-knockdown to
see if this yielded surplus mutant clones above the background rate.
A total of 106 ES cells were transfected with siRNA specific for Hprt gene or a non-specific
control siRNA. The cells were then re-plated on a total of six 1 Ocm dishes and allowed to recover
for 36 hours. Selection was then commenced in medium containing 6-thioguanine at two different
doses, 2pg/ml or 4pg/ml. Colonies resistant to 6-thioguanine emerged at 8-10 days and these
were counted and compared (Figure 6.8). The results demonstrate that cells treated with Hprt-
siRNA fail to generate fewer 6-thioguanine-resistant clones, as hypothesised above, than the
spontaneous background rate for cells treated with the control siRNA. A parallel experiment to
derive thymidine kinase deficient ES cells, via siRNA-induced knockdown of the Tk locus
followed by negative selection in 5-bromodeoxyuridine, yielded a similar result (data not shown).
Figure 6.8: Hprt-specific siRNAs fail to
generate surplus 6-thioguanine resistant
ES clones compared with control siRNA.
10 ES cells were transfected with either Hprt
siRNA or control GFP siRNAs and then re-
plated on 10cm dishes. The graph shows the
number ofES colonies emerging after one-
week selection with 6-thioguanine at toxic
concentrations of2pg/ml and 4pg/ml. Data-
points are derived from single experiments
and hence error bars have not been applied.
Cells treated with Hprt-siRNA fail to
generate fewer 6-thioguanine-resistant clones
than the spontaneous background rate
(control-siRNA treated cells).
Hprt-specific siRNA □
Control GFP siRNA H
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6.9 CHO cells can be efficiently killed by targeting the pyrimidine salvage
pathway using siRNA-directed knockdown of thymidine kinase (Tk)
When CHO cells were transfected with siRNAs specific for the pyrimidine salvage pathway
enzyme, thymidine kinase (Tk), widespread cell death was observed. This occurred even at very
low siRNA doses of lOng/weil (which represents only 1% of the concentration used in most other
siRNA knockdown experiments) and was never observed using a variety of control siRNAs (GFP,
LacZ and Firefly). At lOng/well, Tk-specific siRNA induced death of over 99% of cells
(estimated according to the ratio of surviving colonies to cells plated < 0.01) while at higher
concentrations of lOOng/well and lpg/well there was absolute cell death (no surviving colonies).
This result was qualitatively reproducible on a number of occasions and occurred in the absence of
any selective toxic agent. By comparison, there was no significant toxic effect on murine ES cells
and only a minor toxic effect on 3T3 cells suggesting that the salvage pathway is functionally
redundant in these cells relative to CHO cells.
The above observation was exploited further to address the question of whether cells surviving
Tk-siRNA knockdown were either spontaneously arising Tk mutants or otherwise resistant to the
effects of RNA interference. CHO-LUC cells were selected using Tk-specific siRNA at lOng/well
and surviving cells were pooled and expanded. These were then subjected to repeat transfection
with Tk-specific siRNA and shown to be equally susceptible to cell death as the original cells,
thereby confirming that they were not mutant at the targeted Tk locus. Similarly, surviving CHO-
LUC cells were subjected to transfection with Fz>e/Zy-specific siRNA-B2 and shown to exhibit an
expected knockdown of luciferase expression, thereby excluding any intrinsic resistance to the
RNA interference process.
The observation of CHO cell toxicity arising from transfection with low dose Tk-specific siRNAs
suggests a specific mechanism such as functional depletion of thymidine kinase activity leading to
cellular apoptosis. If this is the case however, it is not clear why CHO cells should be peculiarly
susceptible to targeting of the Tk gene within the pyrimidine salvage pathway given the
redundancy of this enzyme to nucleotide synthesis. Nonetheless, it is of interest perhaps that the
drug, 5-bromodeoxyuridine, acts as a chemosensitising agent via its action on thymidine kinase.
In a similar fashion, but to a tenfold lesser degree, Hprt-specific siRNA were also found to be
toxic to CHO cells (data not shown). The cellular toxicity of both the Tk and Hprt siRNAs are
demonstrated by the photographs overleaf showing the relevant wells of a 24-well plate in which
the colour of the medium is a crude measure ofmetabolic cell activity (Figures 6.9 and 6.10).
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Figure 6.9: Transfection of Tk-specific siRNA (sense + antisense) is toxic to CHO-LUC cells.
Transfection of lOng/well of Tk-specific siRNA is toxic to CHO cells only when both sense and
antisense are used (either mixed in 1:1 ratio or pre-annealed double-stranded) while sense alone,
antisense alone, and control siRNA are innocuous to the cells. This finding is evident here from
failure of 1ml ofmedium to change colour from pink to yellow after 24 hours incubation indicating
reduced metabolic activity. That this is a Tk-specific phenomenon is supported by the observation
that the control Firefly siRNA-B2, which yields potent knockdown of the stably integrated GL2














Figure 6.10: Transfection ofHprt-siRNA is also toxic in CHO cells but tenfold less than Tk-siRNA,
Hprt-specific siRNA was shown to induce cell death following transfection in CHO cells but to a tenfold
lesser degree than Tk-specific siRNA. The toxicity ofboth siRNAs is indicated here by failure of 1ml of
medium to change from pink to yellow after 24 hours incubation reflecting reduced metabolic activity.
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6.10 siRNA-induced knockdown in ES cells is not contingent upon the presence of
either Dnmtl or Dnmt3a/3b DNA methyltransferase activity
RNA interference in plants occurs initially via a post-transcriptional mechanism followed by
transcriptional silencing mediated via DNA methylation and epigenetic change at the site of the
targeted gene locus (Ref: Baulcombe D., 2004). Similarly, in mammalian cells, recent evidence
has suggested that siRNAs can induce DNA methylation and epigenetic change likewise here also
(Refs: Kawasaki H. and Taira K., 2004; Morris K. et al, 2004). In view of this, the relevance of
DNA methyltransferase activity to the RNA interference process was tested. siRNA-B3,
homologous to region 154-172 of the GL3 gene, was tested for its ability to knock down luciferase
expression from a transiently transfected pGL3 plasmid in ES cells defective in either maintenance
methyltransferase activity (Dnmtl"'") or de novo methyltransferase activity (Dnmt3a"/"3bv) using
cells kindly provided by B. Ramsahoye (Refs: Li E. et ah, 1992; Xie S. et ah, 1999; Okano M. et
ah, 1999).
The results demonstrate that there is no significant compromise of knockdown efficacy in either
Dnmtl"'" or Dnmt3a~'"3b"'" ES cells. This indicates that the presence ofmethyltransferase activity is
not necessary for suppression of a transiently expressed epigene (Figure 6.11). Moreover, since
Dnmtl"'" and Dnmt3a"'"3b"'" ES cells both have hypomethylated genomes (approximately 20-30%
CpG methylation in Dnrntl"'" cells and <1% in late-passage Dnmt3a"'"3b"'" cells compared with
>70% in wild-type ES cells, Refs: Li E. et ah, 1992; Jackson M. et al, 2004), then this result also
demonstrates that RNA interference is not contingent upon a normally methylated genome. The
control experiments using Dnmt3a"'"3b"/" ES cell lines rescued for either Dnmt3a or Dnmt3b also
show normal siRNA-induced luciferase knockdown.
This finding, namely that methyltransferase activity is not necessary for siRNA-induced
knockdown of an epigene, contrasts with the claim mentioned previously that siRNAs can bring
about methylation of the gene promoter (Refs: Kawasaki H. and Taira K., 2004; Morris K. et al,
2004). While the two results are not wholly mutually exclusive, it does suggest that the DNA
methylation is not the primary mechanism of siRNA-induced gene silencing. This conclusion is
supported by the result of other investigators who have employed a similar strategy of using cells
deficient in de novo methyltransferase activity and shown that double-stranded RNAs can induce
transcriptional repression with appropriate chromatin changes independently of DNA methylation
(RefTing A.H. et al., 2005).
169
Chapter 6 - Results 4
Figure 6.11: siRNA-induced knockdown is not contingent upon DNA methyltransferase activity.
There is no significant difference in the potency of siRNA-induced knockdown ofFirefly luciferase
transiently transfected into ES cells deficient in maintenance methyltransferase activity (Dnmtl) or de
novo methyltransferase activity (Dnmt3A/3B) compared with wild-type or 3A/3B rescue ES lines.
Error bars represent the range derived from duplicate experiments.
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6.11 siRNAs directed against Dnmtl result in a functional deficit of maintenance
methyltransferase activity in ES cells
Wild-type ES cells exhibit approximately 70-80% methylation of CpG sites compared with
approximately 20-30% for targeted knockout Dnmtl'1' ES cells (Ref: Li. E. et al., 1992; Lei H. et
al., 1996). Dnmtl-specific siRNAs were tested for their ability to knockdown expression of
maintenance DNA methyltransferase activity in wild-type ES cells resulting in an overall loss of
methylated CpGs within the genome. ES cells were transfected using Dnmtl-specific siRNAs and
seeded at low density on 10cm plates (105 cells per plate). The cells were cultured for four days to
allow several rounds of cell division to occur with passive loss of methylated CpGs that are not
maintained in the absence Dnmtl. This process was repeated serially four times over two weeks
alongside a control experiment using a non-specific siRNA. Genomic DNA was then harvested
for subsequent measurement of global CpG methylation level using the nearest neighbour analysis
kindly performed by B. Ramsahoye.
The results are presented as raw data in the form of autoradiograph images (Figure 6.13).
Quantification of CpG methylation (ratio of mCpG to total CpG) was performed by densitometry
using the Scion Image™ software (available from www.scioncorp.com). This reveals that the
proportion of methylated CpG dinucleotides is lower for the Dnmtl knockdown (67.8%) than for
the control knockdown (81.1%) and the non-treated pre-passaged (83.7%) and post-passaged ES
cells (80.0%). Each methylation analysis was derived from a single experiment and hence error
bars cannot be applied. However, the three control experiments yield a mean CpG methylation of
81.6% with standard deviation of 1.9% suggesting that Dnmtl knockdown is indeed statistically
significant and can produce partial genomic DNA demethylation (Figure 6.12).
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Figure 6.12: siRNA-induced knockdown of Dnmtl results in loss of genomic methylation in ES cells.
Nearest neighbour quantification ofgenomic CpG methylation levels in wild-type ES cells as follows: pre-
passaged (83.7%), post-passaged (80.0%), control GFP siRNA knockdown (81.1%), and Dnmtl-specific
knockdown (67.8%). This represents an overall loss of genomic CpG methylation attributable to Dnmtl
siRNA knockdown of 16.4%. Data-points are derived from single experiments and hence error bars have not
been applied. The difference in CpG methylation is statistically significant (mean 81.6, SD 1.9 p<0.001).
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Figure 6.13: siRNA Dnmtl knockdown leads to loss of cvtosine methylation in wild-type ES cells.
Dnmtl was knocked down by serial siRNA transfection ofwild-type ES cells. Genomic DNA was
harvested and assayed for cytosine methylation using the nearest neighbour method. Autoradiograph
densitometry studies shown below were analysed using Scion Imaging™ software and reveal a
reduction ofmethylated CpG dinucleotides of 16.4% relative to control siRNA knockdown cells.
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6.12 Conclusion
The primary objective of this chapter was to demonstrate that siRNA molecules are able to
generate gene interference in murine embryonic stem cells by targeting various reporter genes
expressed either transiently or stably in the cell. The secondary objective was to extrapolate these
findings to various endogenous genes in ES cells, and other cell lines, with the goal of yielding an
informative knockdown phenotype. Finally, results are presented from experiments designed to
investigate a putative link between siRNA-induced gene interference and induction of epigenetic
silencing of that gene in the cell.
siRNAs induce knockdown ofa transiently expressed Firefly epigene in ES cells
The initial experiment sought to recapitulate the findings of earlier experiments in 3T3 and CHO
cells, namely the demonstration of knockdown of a transiently expressed Firefly luciferase gene
by sequence-specific siRNAs. This confirmed, as expected, that siRNA molecules co-transfected
with the Firefly plasmid result in the dose-dependent knockdown of luciferase activity with a
sense to antisense strand stoichiometry of 1 to 1. Thus, RNAi in ES cells, as for other mammalian
cells, requires equimolar amounts of matching oligonucleotide strands which base pair to yield a
double-stranded RNA molecule that shares obligatory sequence homology with the target gene.
siRNAs induce knockdown of a stable randomly integrated GFP gene in ES cells
Subsequent experiments in ES cells sought to extrapolate these findings from the setting of a
transiently expressed target gene to that of a stably expressed one. A transgenic ES cell line
carrying a randomly integrated enhanced green fluorescent protein (EGFP) reporter gene was
chosen for this purpose. The results reveal that GFP-specific siRNA yields a modest but definite
knockdown of fluorescence activity compared with non-specific control siRNA. The limited
potency of this knockdown effect, compared with that of transiently expressed luciferase, can be
explained in terms of the considerable stability of green fluorescent protein in the cell.
In an attempt to produce a more substantial GFP knockdown, through serial transfections of
siRNA into the same cells, it was found that each round of transfection yielded a diminished
knockdown effect compared with the previous round. In other words, the cells appear perversely
less susceptible to the gene interference effect of the siRNA following prior exposure to the same
siRNA, possibly due to exhaustion of the molecular constituents of the RNAi machinery.
However, this result was not amenable to statistical analysis on account of non-replicated
experimental data and the finding requires verification against other endogenous gene targets.
Further exploration of this phenomenon was not pursued here.
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siRNAs induce knockdown of a B-galactosidase gene targeted to the Oct3/4 locus in ES cells
The next logical experiment, building on the previous result, was the demonstration that siRNA
molecules can mediate the knockdown a reporter gene located within a physiological gene locus.
A P-galactosidase expressing ES cell line, IOUD2, in which the transgene construct has been
targeted to the Oct3/4 locus, was used for this purpose. Expression of the Oct3/4 gene is critical
for maintaining an undifferentiated ES state. In the IOUD2 cell line, which by necessity is
hemizygous for the native Oct3/4 gene, expression from a single allele appears to suffice for this
purpose. The knockdown of the P-galactosidase gene in these ES cells, using LacZ-specific
siRNAs, resulted in the dose-dependent reduction of expression of the reporter gene by X-gal
staining analysis, while non-specific siRNA had no significant effect. Of note is the fact that this
knockdown was not associated with any observable ES cell differentiation implying that silencing
of the P-galactosidase gene targeted to the Oct3/4 locus did not result in the concomitant silencing
of the homologous Oct3/4 locus.
siRNA-induced P-galactosidase knockdown is clonaHy inherited through many cell divisions
By seeding the IOUD2 ES cells at low density following transfection of LacZ-specific siRNAs, it
was possible to observe the staining pattern of discrete colonies emerging after five days, each one
typically derived from a single ES cell. This revealed considerable heterogeneity of staining from
mostly negative colonies at high siRNA doses to mostly mosaic colonies at low siRNA doses.
Thus, it is appears that the RNAi effect is clonally propagated from parent cell to daughter cell
through several rounds of cell division and the permanence of this effect is determined by siRNA
dosage. At all siRNA doses, however, there were some colonies that remained completely
positive for p-galactosidase. This implies either that the transfection process is incomplete or that
the interference process is not universally effective; reasons for the latter might include those of
siRNA dosage, RNAi resistance, or stochastic knockdown failure.
hTERT-specific siRNAs fail to knockdown telomerase activity in human cancer cells
A number of endogenous genes were chosen as candidate targets for siRNA-induced knockdown.
The first of these was the human telomerase reverse transcriptase (hTERT) gene that is highly
expressed in both stem cells and transformed cells (Ref: Weinberg R.A., 1998), and which appears
to play a key role in the process of tumourigenesis (Ref: Hahn W.C. et al., 1999a). A specific
telomere terminal transferase activity was originally identified in Tetrahymena extracts (Ref:
Greider C.W. and Blackburn E.H., 1985). This so-called telomerase activity was subsequently
shown to be required form maintaining the integrity of the telomeric structures that reside at the
ends of chromosome (Ref: Blackburn E.H., 1991). It comprises an RNA subunit (TER) and a
reverse transcriptase subunit (TERT), with the latter providing the rate-limiting catalytic activity
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(Ref: Poole J.C. et al., 2001). The selective activation of the hTERT gene in the vast majority of
human tumours has highlighted this gene as a promising target for cancer therapy (Ref: Hahn
W.C. et al., 1999b). To date, a variety of diverse strategies for inhibiting telomerase have been
proposed (Ref: Kelland L.R., 2000). However, most of these suffer from problems of potency,
specificity or delivery.
RNA interference, using sequence-specific siRNAs, represents an obvious means for achieving
targeted knockdown of telomerase activity in the cell. This proposal was tested here using two
different siRNA molecules, sharing sequence homology with the hTERT gene. siRNA-induced
knockdown was examined in two immortalised cell lines, derived from human breast cancer, using
a functional assay of telomerase activity. However, each siRNA on its own failed to demonstrate
consistent and dose-dependent knockdown of telomerase activity although both siRNAs combined
did possibly yield a small but non-statistically significant knockdown effect. Apart from reasons
of technical failure, the explanation for the lack of success in this experiment is not clearly
apparent. However, persistence of the pre-translated hTERT protein following siRNA transfection
may be partly to blame. In order to test such a possibility, quantification of hTERT mRNA, by
northern blot analysis or quantitative RT-PCR, rather than a functional assay of telomerase
activity would be required.
Hprt-specific siRNAs fail to induce permanent silencing the Hprt locus in ES cells
While cells are able to synthesise nucleotides de novo, these are generally acquired exogenously
by the cell from the environment. However, when purines and pyrimidines are in short supply, so-
called salvage pathways become a major source of nucleotides. The enzyme hypoxanthine
phosphoribosyltransferase (Hprt), which is carried on the X chromosome and therefore exists as a
single copy in male ES cells, catalyses a key step in the salvage of purines. ES cells that are
mutant for the Hprt locus, whether arising spontaneously or via a genotoxic insult, can be isolated
using the purine analogue 6-thioguanine. This is converted by Hprt into a cytotoxic metabolite
that kills wild-type cells and thereby allows negative selection ofHprt deficient cells.
In order to test the hypothesis that Hprt-specific siRNAs might occasionally produce permanent
silencing of the Hprt locus, for instance via methylation or epigenetic modification, ES cells were
selected with 6-thioguanine post-knockdown. However, this strategy failed to generate 6-
thioguanine resistant clones in excess of the background rate using a control siRNA. Thus, Hprt-
specific siRNAs targeting the coding region of the Hprt gene are apparently unable to produce a
permanent silencing of the gene locus. Naturally, this assumes that there was no technical failing
of the experiment.
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The relevance of this result is placed in context by two recent papers that have demonstrated that
gene knockdown can indeed lead to permanent gene locus silencing via CpG methylation (Refs:
Kawasaki H. and Taira K., 2004; Morris K.V. et al., 2004) associated with histone methylation
(Ref: Kawasaki H. and Taira K., 2004) and histone deacetylation (Ref: Morris K.V. et al., 2004).
This notable difference between the current Hprt knockdown experiment and these papers above is
that while the former used siRNAs directed against the coding sequence of the gene, the latter
used promoter-directed siRNAs. However, the comparison is nonetheless noteworthy.
Tk-specific siRNAs fail to induce permanent silencing the Tk locus in ES cells
The salvage of pyrimidines involves the key enzyme thymidine kinase whose activity varies with
the cell cycle being particularly important for the replication of DNA shortly prior to cell division.
In an analogous fashion to previously, mutant cells lacking the enzyme can be selected using the
nucleotide analogue in 5-bromodeoxyuridine, which is converted by thymidine kinase into a toxic
compound leading to death of normal cells. Attempts to generate thymidine kinase deficient ES
cells via siRNA-induced knockdown of the gene followed by 5-bromodeoxyuridine selection
failed to produce resistant colonies in excess of the spontaneous background rate, thereby
supporting the previous conclusion that siRNAs directed at the coding region of a gene are unable
to produce permanent silencing of that locus.
siRNA-induced knockdown of key salvage pathway genes in CHQ cells causes apoptosis
The targeted knockdown in CHO cells of the Tk and Hprt nucleotide salvage pathway genes,
using Tk-specific and Hprt-specific siRNAs, unexpectedly resulted in widespread cellular
apoptosis compared with non-specific control siRNAs. Crude measurement of the relative
toxicities of these siRNAs, using semi-quantitative methods of counting surviving colonies,
showed that Tk siRNA had lOOx and Hprt siRNA had lOx the toxicity of control GFP siRNA on
CHO cells. The possibility of non-specific toxicity arising as a by-product of the interference
process itself was excluded by the fact that F/>e/7y-specific siRNAs were not associated with any
significant death of CHO-LUC cells. Assuming then that this toxicity reflects a gene specific
effect, then it would appear both pyrimidine and purine nucleotide salvage pathways are critical
for CHO cell survival, perhaps because of its high rate of cell division, although it is not clear why
this is not the case for ES and 3T3 cells likewise.
siRNA-induced epigene knockdown is not dependent upon methyltransferase activity
It is well recognised in plants that post-transcriptional gene silencing is able to lead to the
methylation of the targeted gene leading to epigenetic silencing of the locus (Ref: Baulcombe D.,
2004). Similarly, and as alluded to previously, it has also been claimed in mammalian cells that
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siRNAs directed at gene promoter sequences are able to initiate cytosine methylation within and
around the targeted region (Refs: Kawasaki H. and Taira K., 2004; Morris K.V. et al., 2004).
However, it is not clear that this process is relevant for gene knockdown by coding sequence
directed siRNAs. In order to test this, siRNA-induced gene knockdown was assessed in cell lines
kindly provided by B. Ramsahoye (Ref: Jackson M. et al., 2004) that were deficient either in
maintenance methyltransferase activity (Dnmt 1 A) or de novo methyltransferase activity (Dnmt3a /_
3b~'~). The results reveal that there is no significant compromise of knockdown efficacy in either
Dnmtl"'" or Dnmt3a"/"3b"/" ES cells, thereby confirming that methyltransferase activity is not
necessary for suppression of a transiently expressed epigene. However, the possibility that
siRNA-induced knockdown of endogenous genes is compromised in methyltransferase-deficient
cells was not tested.
Dnmtl-specific siRNAs result in significant genomic demethylation in wild-type ES cells
It is known that murine ES cells carrying a targeted knockout of the Dnmtl maintenance
methyltransferase are deficient in genomic methylation with only 20-30% of CpG dinucleotides
methylated compared with 70-80% in wild-type ES cells (Ref: Li E. et al., 1992). This was the
rationale for testing the demethylating potential of Dnmtl-specific siRNAs in wild-type ES cells.
Using serial knockdowns to induce a cumulative effect, genomic DNA showed an overall
reduction of cytosine methylation of approximately 16% compared with control cells. Thus, it is
possible using this strategy to induce partial genomic demethylation similar to that seen with
nucleotide analogues such as azadeoxycytidine. It is predicted that the combined knockdown of
both maintenance and de novo methyltransferase activity, by targeting all three Dnmt genes active
in mammalian cells, would have a much greater aggregate demethylating effect.
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Chapter 7 - Discussion
7.1 Introduction
The overarching goal of this thesis was the exploration of two novel strategies for elucidating gene
function in mammalian cells. The first strategy, termed antisense gene trapping, was applied using
a classical forward genetics approach to screen for differentiation genes in murine embryonic stem
cells, while the second strategy, RNA interference, was applied using a reverse genetics approach
to manipulate discrete genes both in ES cells and other cell lines. Arguably, while quite distinct
from one another, both strategies share in common a key dependence upon double-stranded RNA
to mediate silencing of a sequence-homologous gene. In antisense gene trapping, the double-
stranded RNA is generated endogenously by hybridisation of the messenger RNA with an
antisense RNA strand (produced through the action of the transactivator on the reversed gene trap
promoter). By contrast, in RNA interference, the double-stranded RNA is introduced exogenously
in the form of small RNA duplexes termed short interfering RNAs. The main results from the
foregoing results chapters in regard to these two methodologies are discussed below.
7.2 Antisense gene trapping
The primary objective of chapter three, termed "antisense gene trapping in embryonic stem cells",
was the demonstration that such a methodology might permit the identification of putative
differentiation genes in murine ES cells. The secondary objective was the functional
characterisation of these genes through analysis of the gene trap and antisense knockout clones.
It should be stated that the formal proof-of-principle demonstration of the antisense gene trapping
methodology was not explicitly sought at the outset of this work. The reason for this was simply
the fact that antisense gene trapping is already established as a viable experimental strategy for
achieving the functional deletion of random genes. The evidence for this is derived from a
number of publications (Refs: Li L. and Cohen S.N., 1996; Xie W. et al., 1998; Liu K. et al.,
180
Chapter 7 - Discussion
1999; Liu K. et al., 2000a; Liu K. et al., 2000b) that have used antisense gene trapping to induce
homozygous functional knockout of allelic loci in NIH3T3 cells for the purpose of identifying
tumour susceptibility genes. Moreover, the primary objective as stated above was to use the
methodology of antisense gene-trap to yield phenotypically mutant ES cell clones using a suitable
differentiation assay. Only if and when such mutant ES cell clones were isolated was it intended
to confirm knockout of the trapped gene in order to show that the phenotype was attributable to
the mutation. Further confirmation could then be sought by restoring the ES clone to the wild type
state through Cre excision of the transactivator.
The major failure of the methodology therefore lay not in the shortcomings of antisense gene
trapping to knockout genes but rather those of methylcellulose differentiation as a screening
strategy for identifying mutant ES cell clones. This failed to identify any mutant clones either
through deficiencies of the screening method itself or simply due to too few "knockout" clones
being analysed. Indeed, herein lies one of the key problems of forward genetics, namely the
dependency upon an optimal mutant screen. Such a screen should exhibit attributes of
discrimination, accuracy and reproducibility as well as being both high-throughput and non-labour
intensive. These are not features ofmethylcellulose differentiation of ES cells.
Despite this being the case, it did prove possible to isolate a number of P-galactosidase positive
gene trap clones that clearly became P-galactosidase negative upon introduction of the
transactivator and then positive again upon introduction of the Cre recombinase. However, it is
not clear that these results are necessarily attributable to antisense knockout of the trapped gene
locus though binding with mRNA transcript. An equally plausible explanation for these results is
that of promoter/transcriptional interference due to the movement of reverse-direction RNA
polymerase moving counter to forward-moving RNA polymerase. Such a situation would result
in loss of expression of the trapped gene, and therefore its p-galactosidase marker, due to
interference with gene transcription or promoter initiation. The major difference between these
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two alternative explanations for the observed loss of expression of P-galactosidase lies in the fact
that while antisense knockout operates in trans to functionally delete the trapped gene, promoter
interference operates in cis and will not therefore lead to gene knockout.
In order to discern experimentally between antisense knockout and promoter interference, it would
be necessary to quantify either the level of mRNA transcript or alternatively that of the translated
protein. For mRNA levels this would be by northern blot analysis or by RT-PCR, while for
protein levels this would be by western blot analysis. In the case of antisense inhibition operating
in trans, there should be complete biallelic knockout of gene expression resulting in minimal or
absent levels of mRNA or protein. By contrast, in the case of promoter interference operating in
cis, the knockout would only be monoallelic and therefore the mRNA and protein levels should
only fall by approximately half compared with wild-type ES cells and not at all compared with the
mother gene-trap clone that is already a hemizygous knockout. It is worth noting perhaps that in
the original use of the antisense gene trapping technology (Ref: Li L. and Cohen S.N., 1996) the
mutant 3T3 clones selected for anchorage independence by an agar assay did indeed show
knockout of the trapped gene with loss of mRNA expression via northern blot analysis. In other
words, antisense gene trapping appears to have been the correct explanation at least in this
particular case using 3T3 cells.
As stated already, the feasibility of using antisense gene trapping to identify genes important for
differentiation of ES cells was undermined by the inefficiency of the chosen phenotype screen.
The methylcellulose differentiation assay, while well characterised for the analysis of
haematopoietic and other lineage differentiation of ES cells, is largely a qualitative assay that is
good for identification of gross abnormalities of differentiation but poor at picking up subtle ones
requiring precise quantitative analysis. Moreover, the methylcellulose assay is highly labour
intensive making it less practical from an experimental perspective as a screening strategy for
mutant clones, especially in the context of comparing gene trap clones with antisense knockout
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sub-clones that each need to be performed in triplicate for purposes of statistical validation. By
contrast, in the original application of the antisense gene trapping approach, for identification of
putative tumour susceptibility genes in NIH3T3 cells, the screening strategy was growth in simple
agar allowing for the emergence of knockout clones that had lost anchorage dependence.
What alternative screening strategies might be applicable to the task of identifying mutant ES cell
clones? In essence, there are two possible approaches. Either to use a phenotypic screen, of
which methylcellulose despite its drawbacks is arguably the best characterised, or else to use a
genotypic screen. This would seek to show altered expression levels, for instance by RT-PCR, of
key genes known to be important for ES cell pluripotency, of which Oct3/4 is perhaps the best
such candidate. Alternatively, genes known to up-regulated by induction of differentiation could
be analysed perhaps by micro-array analysis of clones. However, of the two approaches, the
phenotypic screen is undoubtedly more powerful and one that allows selection of ES cell clones
exhibiting a newly acquired phenotypic trait. Unfortunately, for the purpose of the current study,
such a screen remained an elusive goal.
In an attempt to circumvent the lack of an effective screen, the original strategy was modified
thus. Instead of subjecting all clones to methylcellulose differentiation, only those clones for
which the trapped gene yielded to 5'RACE analysis and were deemed suitable candidates for
further study were scrutinised. This avoided needless assays on "dead-end" clones and at the
same time allowed for a more thorough assessment of differentiation. Moreover, is took
advantage of the rapid completion and annotation of the murine genome that was occurring
throughout the project. However, as previously, this approach also failed to identify
differentiation mutants. It did nonetheless allow for a more refined phenotypic analysis of a
number of gene trap clones. The major findings of interest arising from these clones are
summarised below.
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7.3 Analysis of gene trap genes
Using the modified approach described above, whereby genes-of-interest were selected according
to 5'RACE identification of the trapped gene sequence, a total of five gene trap clones were
selected for closer functional analysis. These were Tsix, Catns, Rex2, Nasp, and Ctbp2. It should
be noted that the possibility of multiple insertions of the gene search vector in any of these clones
was not explored. It is known that gene trap vectors are prone to integrate at multiple genomic
sites leading to problems of interpretation of phenotypic outcomes. While such a situation can
only be formally ruled out by Southern blotting of genomic DNA, the finding of a single 5'RACE
band on gel electrophoresis would appear to argue against multiple insertions in the case of these
particular five clones listed above. However, multiple insertions of the vector do represent a
genuine possibility that could potentially affect the interpretation of phenotypic findings described
here.
All five of the clones exhibited P-galactosidase positivity, and four out of five yielded derivative
P-galactosidase negative knockout sub-clones; the Catns gene trap clone failed to do so for reasons
not apparent. The most significant findings arising from analysis of these clones are listed below:
(1) The gene trap insertion into the Tsix gene results in insertional mutagenesis of the only copy
of this gene in male ES cells. It is not clear, however, that Tsix performs any specific function
in male cells that are not required to undergo X chromosome inactivation. Tsix is a 40-kb
RNA originating 15kb downstream of the Xist which is known to regulate X chromosome
dosage compensation by controlling X inactivation in collaboration with a cis-acting element
called the X inactivation centre (Ref: Lee J.T. et al., 1999). At the onset of X inactivation,
Tsix expression becomes monoallelic, is associated with the future active X and persists until
Xist is turned off. Tsix is not found on the inactive X once cells enter the X inactivation
pathway suggesting that it plays an important role in regulating the early steps of X
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inactivation. This is supported by the observation that targeted deletion of Tsix gene in female
mouse ES cells results in non-random inactivation of the mutant X chromosome (Ref: Lee J.T.
and Lu. N., 1999). Thus, in the mouse it appears that Tsix regulates Xist in cis and thereby
determines which X chromosome is to become silenced (Ref: Sado T. et al., 2002).
Perhaps the most interesting insight from this gene trap clone comes from the P-galactosidase
expression. Since Tsix is an RNA gene whose putative function is mediated via antisense
binding of the RNA molecule to Xist, there is no translation of the gene into protein (Ref:
Ogawa Y. and Lee J.T., 2004). Hence, it is unclear why the p-galactosidase of the gene search
vector, or for that matter the neomycin phosphotransferase that confers G418 resistance,
should be expressed at all. The fact that it is suggests that the mRNA, either despite the gene
trap integration or because of it, is indeed translated into protein resulting in uniform and
ubiquitous expression of P-galactosidase in all cells. If this is attributable to upstream
sequence elements within the mRNA transcript, then it suggests that Tsix RNA is able to
translocate to ribosomes in the cytoplasm and is not solely contained within the nuclear
compartment. However, this conclusion remains speculative.
(2) The three genes, Rex2, Nasp, and Ctbp2, all exhibited specific loss of P-galactosidase
expression within erythroid cells during haematopoietic differentiation of embryoid bodies. It
is not clear whether this is simply an artefact of the assay, possibly related to failure of the X-
gal substrate to act properly in haemoglobinised cells, or reflection of true lineage restricted
expression of these genes. In support of the latter is the fact that Catns is expressed in
erythroid cells and serves here as a convenient positive control to the experiment. In addition,
in the case of Ctbp2, it is known that this is a negative regulator of the Gatal-associated
transcription factor Fogl that is highly expressed in erythroid cells. Thus, down-regulation of
Ctbp2, as reflected by the absence of P-galactosidase activity in haemoglobinised cells, may
allow up-regulation of Fogl leading to normal erythropoiesis.
185
Chapter 7 - Discussion
C-terminal binding protein 2 resides on the mouse chromosome 21 and was originally
identified on the basis of its sequence similarity to the Ctbpl gene whose protein product is
known to associate with the C-terminus of the adenoviral oncoprotein El A via a Pro-X-Asp-
Leu-Ser motif (Ref: Katsanis N. and Fisher E.M., 1998). Unlike Ctbpl, which is expressed
from embryo to adult, Ctbp2 is expressed mainly during embryogenesis (Ref: Furusawa T. et
al., 1999) and appears to be critical for axial patterning leading to embryonic lethality in
mutant null mice (Ref: Hildebrand J.D. and Soriano P., 2002). The characterisation of the
CtBP2 protein has revealed that it functions as a potent co-repressor for a number of
transcriptional factors including the Basic Kruppel-like factor (BKLF) that is highly expressed
in erythroid cells (Ref: Turner J. and Crossley M., 1998), and that this action is mediated via
binding to a minimal repression domain (Ref: Thio S.S. et al., 2004). CtBP2 has also been
shown to interact with the hematopoietic, zinc-finger protein FOG1 that is essential for the
development of the erythroid and megakaryocyte lineages (Ref: Katz S.G. et al., 2002).
Interestingly, FOG1 is highly expressed in erythroid cells and acts in concert with the
transcriptional factor GATA1 to regulate erythropoiesis. Given the known interaction
between CtBP2 and FOG1 (Ref: Katz S.G. et al., 2002), this reciprocal expression pattern in
erythroid cells is perhaps not surprising and suggests that the lifting of CtBP2-mediated
repression of Fogl is an important step in the initiation of normal erythropoiesis.
(3) Expression of the Rex2 gene, during LIF-withdrawal differentiation, appears to result in
persistence of the undifferentiated ES state. This conclusion is inferred from the fact that
maintenance of G418 selection pressure on the gene trap cells, thereby "enforcing" expression
of the Rex2 locus carrying the gene trap vector, prevents normal ES differentiation. Instead of
fibroblasts emerging, the presence of low dose G418 causes the ES cells to remain in small
colonies of undifferentiated cells even despite the absence of LIF in the medium. Thus, it
appears that G418, either through enforced expression of the trapped Rex2 gene and the
downstream neo that confers resistance or through antibiotic-induced death of those cells that
186
Chapter 7 - Discussion
switch off Rex2 and neo expression, results in persistence of the undifferentiated ES state.
The rationale for this experiment was based upon previously published work showing that ES
cells carrying a transgenic neo gene, driven by the a-cardiac myosin heavy chain promoter,
produced a homogenous population of cardiomyocytes when differentiated in the presence of
G418 due to selection of cardiac lineage-restricted cells (Ref: Klug M.G. et al., 1996).
Thus, Rex2 arguably represents a candidate stem cell gene in ES cells. This conclusion is
consistent with published data showing that induction of differentiation in F9 teratocarcinoma
cells, using retinoic acid, results in down-regulation of Rex2 (Ref: Faria T.N. et al., 1998).
Indeed, this was the basis by which the gene was originally identified using differential
hybridisation. Rex2 has also been identified in a large-scale screen of mammalian proteins
residing in nuclear sub-compartments (Ref: Sutherland H.G. et al., 2001). Note that despite
its name, Rex2 does not appear to bear any functional or evolutionary ties with Rexl, which is
a zinc finger gene also regulated by retinoic acid and a commonly-used marker of
undifferentiated ES cells.
Thus, Rex2 appears to represent a candidate differentiation gene whose expression correlates
with an undifferentiated state in ES cells. Such a claim is obviously contentious but consistent
with the data presented. Alternatively, it is possible that the findings are artefactual and arise
due to the artificial nature of the experimental conditions in which ES cells are induced to
differentiate in the presence of G418 that might otherwise limit cell proliferation.
Nonetheless, the hypothesis that Rex2 is indeed an important gene whose expression helps to
maintain ES cells in an undifferentiated state is a testable one. For instance, it predicts that the
targeted knockout of Rex2 is not compatible with ES cells or their derivation from the inner
cell mass of the embryo. The converse prediction that down-regulation of Rex2 might lead to
initiation of differentiation might be similarly tested using RNA interference to knockdown
expression of the Rex2 gene.
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7.4 RNA interference
The use of antisense gene trapping to achieve functional gene knockout was originally described
in 1996. This pre-dates the discovery of RNA interference in 1998 and the first application of
short interfering RNAs in mammalian cells in 2001. With hindsight, it is intriguing to speculate,
as suggested previously, that both processes share a common molecular mechanism that requires
the presence of double-stranded RNAs. In the case of antisense gene trapping, these are generated
endogenously within the cell, while in the case of RNA interference, they are introduced
exogenously into the cell.
Methods of genetic analysis are necessarily contingent upon the timing of biological discoveries
and this is reflected in this thesis by the eventual abandonment of antisense gene trapping in
favour of the emerging technology of RNA interference for the purpose of knocking down gene
expression. The major rationale for switching methodologies was the realisation that antisense
gene trapping was fatally undermined by the lack of an effective screening strategy and that the
goal of gene knockdown could be more easily achieved using RNA interference. One additional
factor that cannot be overlooked in this decision process was the rapid completion and annotation
of both the human and mouse genomes that is necessary for the sequence data required for
designing short interfering RNAs. However, as emphasised previously, it is important not to
overlook the fact that while both antisense gene trapping and RNA interference aim to discover
gene function through gene knockdown, they are conceptually very different approaches with the
former being phenotype-driven and the latter genotype-driven. As such, this change of direction
of the thesis was driven as much by experimental pragmatism as it was by the original aims of the
research to identify key differentiation genes. In addition, given the infancy of RNA interference
at the time of embarking upon this work, particularly in relation to its applicability to ES cells, it
was recognised that preliminary groundwork in other cell lines would be necessary to establish
key aspects of this new methodology.
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7.5 Gene knockdown using siRNAs
The experimental results presented in this thesis provide useful insights into the nature of the RNA
interference mechanism and shed light on some of the molecular determinants of siRNA-induced
gene knockdown in mammalian cells. For instance, the requirement for equimolar amounts of
complementary sense and antisense oligonucleotide RNA strands testifies to the fact that gene
interference is mediated via a double-stranded RNA molecule, although an explicit annealing step
prior to siRNA transfection does not appear to be obligatory (see figures 4.1, 4.2, 4.3 and 4.4).
The potency of gene knockdown appears to be partly dependent upon the actual sequence of the
siRNA and also upon the site of binding within the target gene, and this exhibits dose-dependency
with sigmoid-shaped response curve (see figures 4.5, 4.6, 4.7 and 4.8). It is worth commenting
that while these findings are now well established, at the time of embarking on this work most
aspects of siRNA function in mammalian cells was simply inferred from earlier work using long
dsRNA molecules in non-mammalian organisms.
While key design features for effective siRNA action were not fully explored, some tentative
conclusions can be drawn from the results of these experiments presented in this thesis. Many, if
not all, of these findings have been corroborated by other published analyses (Refs: Tomari Y. and
Zamore P.D., 2005) and also by commercially available resources (see Dharmacon Inc. and
Xeragon Inc. company websites). They include the avoidance of high G/C content or runs of G/C
within the siRNA sequence and also the avoidance of palindromic sequences that might allow
same strand base pairing or intra-strand folding. The presence of a pair of G/C bases at the 5' end
of the siRNA and a pair of A/U bases at its 3' end appears to enhance the interference effect and
confirm the functional non-symmetry of the siRNA molecule (Ref: Tomari Y. et al., 2004).
Moreover, this non-symmetry suggests differential roles of the sense and antisense RNA strands.
For instance, it supports the notion that unzipping of the double-stranded RNA molecule (required
for hybridisation of the antisense strand with the target gene) occurs in a 3' to 5' direction.
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Another pertinent observation was the fact that combinations of siRNAs, each targeting different
sites within the same gene, do not enhance the knockdown effect achieved by using a single
siRNA (see figure 4.9). This finding is perhaps somewhat intuitive if indeed the interference
effect occurs through siRNA-directed cleavage of the mRNA molecule when a single site would
clearly suffice in rendering the mRNA functionally useless.
The demonstration that non-complementary sense and antisense strands, that cannot form a
double-stranded RNA molecule, are unable to produce gene knockdown was used as evidence to
argue against so-called "transitive RNAi" operating in mammalian cells (see figure 4.10). The
basis for this conclusion assumes that each of the non-complementary RNA strands might act as
guide siRNAs able to prime RNA-dependent RNA polymerisation of the mRNA template. In so
doing, they would generate a double-stranded RNA molecule that could then initiate gene
interference. Such a mechanism appears to be physiologically relevant in C. elegans but not in
Drosophila or mammalian systems. However, in C. elegans, transitive RNAi requires the
presence of a pair of double-stranded RNAs (Ref: Alder M.N. et al., 2003) to occur rather than a
pair of single-stranded RNAs as used here. Hence, this experiment, and any conclusions derived
from it, is potentially flawed as it is arguably based upon the wrong model of transitive RNAi.
Analysis of the dynamic aspects of the siRNA-induced interference revealed that gene knockdown
occurs commensurately with expression of the co-transfected reporter such that there is a
discernible dose-dependent suppression at every time-point measured from four hours onwards
(see figure 4.11). Notably, there is no lag period of the interference effect relative to reporter gene
translation implying that the siRNAs act at least as rapidly as the epigene is expressed. This
argues against the requirement for induction of the necessary effectors of RNA interference and
their accumulation in the cell. Rather, it suggests that the interference machinery is already
primed within the cell, possibly for the purpose of handling endogenously produced miRNAs, and
is simply hijacked by the transfected siRNAs. Such a conclusion also comes from the
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demonstration that siRNA-induced knockdown is overcome in a competitive manner by increasing
amounts of co-transfected epigene (see figures 4.12 and 4.13). Indeed, in this regard, RNA
interference might be considered akin to a chemical reaction with a dosage-response curve that is
reminiscent of classical first order kinetics. Moreover, pre-transfection of the siRNA, up to 48
hours prior to the plasmid, leads to gene knockdowns of the expected magnitude (see figures 4.14
and 4.15), thereby indicating that the siRNA molecules themselves, whether free or bound to the
RNA silencing machinery, possess considerable cellular stability.
The demonstration that siRNAs can knockdown a stably integrated reporter gene in an apparently
similar fashion to a transiently expressed one suggests that the molecular mechanisms are closely
analogous to one another if not identical (see figure 4.16) with persistence of many days (see
figure 4.17). The unexpected finding of paradoxical "enhancement" of luciferase activity when
the cells were challenged with high doses of RNA was shown to have temporal and dosage
profiles that were markedly different to that of true RNA interference (see figures 4.18 and 4.19).
While this phenomenon was not fully characterised, it is tempting to speculate that it represents an
artefactual measurement of luciferase activity arising due to widespread cellular apoptosis
possibly triggered by the non-specific interferon response.
Attempts to improve the liposomal delivery of siRNA molecules into cells were based upon the
use of short peptides derived from the transduction domain of the HIV-1 TAT protein. The results
suggest a small but statistically significant enhancement of transfection efficiency, as judged by
the level of reporter gene knockdown, but the method requires further characterisation and
optimisation (see figure 4.22). The other technical aspect of knockdown efficiency that was
explored in this study was the use of in vitro transcribed siRNAs. In our hands, these failed to
show either the consistency or potency of their chemically synthesised counterparts (see figures
4.20 and 4.21) and hence were not adopted in subsequent experiments.
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7.6 Molecular biology of siRNAs
The siRNA/target-gene co-transfection method used in this thesis provided a versatile strategy for
investigating mechanistic aspects of the RNAi process facilitating a piecemeal dissection of the
interference effect in mammalian cells. This shed light on some of the molecular determinants of
effective siRNA design and yielded provocative insights into the level at which the siRNA
molecule acts to suppress gene expression. Using chimaeric siRNA duplexes, it was shown that
sequence fidelity of the antisense strand is paramount while fidelity of the sense strand is less
critical (see figures 5.1, 5.2 and 5.3). Thus, antisense mismatch at three discrete nucleotide sites
within the siRNA molecule abrogates the interference effect while the same mismatch in the sense
strand is well tolerated (Refs: Amarzguioui M. et ah, 2003, Schwarz D.S. el al., 2003, Holen T. et
al., 2005).
This important finding suggests that the role of the sense strand is principally to serve as a
chaperone for its complementary antisense partner by annealing with it to produce an RNA duplex
that is less susceptible to the action of endogenous RNAses. Subsequent unravelling of the duplex
would then allow the antisense strand to recognise and base pair with the target mRNA leading to
sequence-directed cleavage of the latter and post-transcriptional knockdown of the gene. It is also
possible that this base pairing occurs with the nascent transcribed mRNA strand, while still
attached to the DNA and prior to RNA processing, thereby inhibiting gene expression at a peri-
transcriptional level. A third conceivable possibility would involve the antisense strand
recognising and base pairing with the non-coding strand of the DNA, leading in some manner to
inhibition of gene expression at the transcriptional level. The theoretical possibility that the sense
strand might play an analogous role by base pairing with the coding strand of the DNA seems to
be inconsistent with the observation that sequence fidelity of the sense strand is not an absolute
requirement for successful gene knockdown to occur.
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In mammalian cells, prior 5'-terminal phosphorylation of the siRNA molecule did not have any
discernible effect on the knockdown of a co-transfected plasmid-borne gene (see figure 5.3). This
implies either that 5'-phosphorylation is physiologically irrelevant for effective siRNA action or
alternatively that mammalian cells contain their own endogenous 5'-nucleotide kinase activity
able to perform this function post-transfection. There was also no evidence in these experiments
to support the view that 5'-phosphorylated antisense strands on their own (and not duplexed with a
sense strand partner) also possess gene knockdown potential (see figures 5.2 and 5.3) as suggested
by other investigators (Ref: Martinez J. et al., 2002).
A modification of the siRNA/target-gene co-transfection method, using an mRNA reporter
molecule in place of the plasmid-borne reporter, was employed to challenge the paradigm-held
view that interference acts at a post-transcriptional level. This revealed the unexpected result that
siRNAs that are effective at knocking down a DNA-encoded gene are unable to do likewise for an
RNA-encoded gene, in both mammalian CHO and arguably 3T3 cells (see figures 5.4, 5.5, 5.6 and
5.7). The simplest interpretation of this finding is that the siRNA-induced interference can be
bypassed using mRNA that is pre-transcribed. The converse explanation is that siRNA action is
dependent in some fashion upon the presence of the DNA. Either way, this evidence argues that
in the mammalian cell lines tested, the site-of-action of the siRNA is not at a post-transcriptional
level but rather at a transcriptional or peri-transcriptional level instead.
However, the non-physiological nature of the previous experiment raises the possibility that the
outcome described is simply an artefact that does not reflect the true situation operating with in the
cell. For instance, the exogenous RNA reporter molecule may behave unlike the normally
transcribed endogenous mRNA molecule for reasons of spatial, temporal, or chemical differences
between the two. In order to address this possibility, it was necessary to validate the experimental
strategy of siRNA/mRNA co-transfection in mammalian cells by showing that this could indeed
yield gene knockdown in non-mammalian cells.
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Validation of the siRNA/mRNA co-transfection experimental system was achieved by using two
Drosophila cell lines in place of the mammalian ones used above. This revealed that Drosophila
KC cells do indeed produce a potent and unequivocal knockdown of the RNA-encoded reporter
gene by co-transfected siRNAs that is qualitatively identical to the result obtained using the DNA-
encoded gene (see figure 5.8). Strangely, the same is not also true of Drosophila S2 cells which,
like CHO and 3T3 cells, exhibit siRNA-induced knockdown of the DNA-encoded but not RNA-
encoded reporter gene (see figure 5.8). Only by using 5'-phosphorylated siRNAs can S2 cells be
made to behave similarly to KC cells and produce knockdown of both DNA and RNA-encoded
reporter genes, suggesting that this is an important pre-requisite for siRNA action. If so, then it
points to a higher level of endogenous 5' nucleotide kinase activity in KC cells relative to S2 cells
(see figures 5.12, 5.13 and 5.14). Thus, siRNAs in Drosophila cells do appear to act at a post-
transcriptional level, but only if they are 5'-phosphorylated.
By contrast with the above result in Drosophila cells, 5 '-phosphorylation of the siRNA molecule
fails to make any significant difference in mammalian cells (see figures 5.12, 5.13 and 5.14).
Here, both 5'-phosphorylated and non-phosphorylated siRNAs behave identically to one another
in terms of their ability to knockdown DNA-encoded but not RNA-encoded reporter genes. Thus,
there is a clear qualitative difference between the cells derived from the two species.
A further important qualitative difference between cells of the two species is apparent with the use
of mismatched heteroduplex siRNAs described previously (see figures 5.15, 5.16 and 5.17). Here,
in mammalian CHO and 3T3 cells, mismatch in the sense strand of the siRNA duplex is well
tolerated so long as there is fidelity of the antisense strand. By contrast, in Drosophila KC and S2
cells, these same heteroduplex siRNAs fail to produce any significant gene knockdown. However,
if they are first modified by 5'-phosphorylation of their terminal ends then their knockdown action
is restored in both KC and S2 cells, but only against the DNA-encoded and not RNA-encoded
reporter gene.
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Thus, at risk of over-interpreting this data, the knockdown action of (antisense-fidelitous/sense-
mismatch) heteroduplex siRNAs against DNA-encoded genes appears to be 5'-phosphate
independent in mammalian cells but 5'-phosphate dependent in Drosophila cells, with no
demonstrable knockdown against RNA-encoded genes in either mammalian or Drosophila cells
irrespective of 5'-phophorylation status. These findings are consistent with other published
evidence (Refs: Martinez J. and Tuschl T., 2004; Schwarz D.S. et al., 2002; Nykanen A. et al.,
2001). However, further studies are warranted to confirm that these results are experimentally
robust and applicable equally to other siRNA molecules and cell lines.
7.7 A model of siRNA action
How is it possible to interpret these inter-species differences in terms of a mechanistic
understanding of the mode of action of siRNA molecules to induce gene interference in cells?
One interpretation argues that siRNA molecules can affect gene expression at both the DNA
transcriptional level and at the mRNA post-transcriptional level, and that in any given cell one or
other of these mechanisms predominates. Thus, in mammalian CHO and 3T3 cells, transcriptional
interference prevails while in Drosophila KC cells, post-transcriptional interference prevails;
Drosophila S2 cells behave similarly to KC cells but only if 5'-phosphorylated siRNA molecules
are used. Finally, mammalian and Drosophila cells behave differently to one another in regard to
heteroduplex siRNA molecules that have sense-strand mismatch and antisense-strand fidelity.
These produce transcriptional interference but not post-transcriptional interference in both
mammalian and Drosophila cells, but in the latter only when 5'-phosphorylated.
In summary, post-transcriptional level interference appears to be the predominant mechanism of
siRNA-induced gene silencing in Drosophila KC cells. By contrast, in Drosophila S2 cells post-
transcriptional level interference occurs but only if the molecule is 5'-phosphorylated. This
suggests that post-transcriptional level interference requires 5'-phosphorylation of the siRNA
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molecule and that this occurs endogenously in KC cells but not S2 cells. The situation in
mammalian cells is qualitatively different. Here, transcriptional level interference appears to be
the predominant mechanism of siRNA-induced gene silencing, and this is irrespective of siRNA
5'-phosphorylation. This transcriptional level interference appears to be remarkably tolerant of
sense-strand mismatch so long as the antisense strand of the heteroduplex molecule retains
sequence fidelity. The same heteroduplex siRNAs produce gene silencing in Drosophila cells
only if 5'-phosphorylated when transcriptional level, and not post-transcriptional level, gene
silencing is seen, suggesting that this pattern is perhaps a hallmark feature of transcriptional level
knockdown.
There is a risk in constructing this model of over-interpretation of the data and hence the model
remains purely speculative at this stage pending further experiments. However, the demonstration
of siRNA-induced knockdown of an mRNA luciferase reporter molecule in Drosophila KC cells
not only validates the experimental methodology but reveals the absence of knockdown in CHO
cells to be apparently genuine. If so, then the simplest interpretation is that siRNA knockdown in
mammalian cells is not solely post-transcriptional as previously assumed but also transcriptional.
A schematic model illustrating this proposed mechanistic dichotomy of siRNA-induced gene
silencing at post-transcriptional and transcriptional levels is shown overleaf (Figure 7.1).
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Figure 7.1: Schematic model of the mechanism ofaction of siRNAs in gene silencing in eukarvotic cells.
siRNA molecules that are introduced exogenously into mammalian cells appear to be able to mediate gene
silencing at two different levels. The first is at a post-transcriptional level via cleavage of the target mRNA
molecule within the site ofbinding. The other is at a transcriptional level via mechanisms that are less well
defined and may include base-pairing with the DNA, cleavage of the nascent mRNA strand, and induction
ofepigenetic changes such as CpG methylation and histone modification that cause heterochromatinisation.
Post-transcriptional level gene silencing:
5'-phosphorylation obligatory?
Intolerant of sense strand mismatch?
Predominant in Drosophila KC cells
and in S2 cells if 5'-phosphorylated
Transcriptional level gene silencing:
5'-phosphorylation not obligatory?
Tolerant of sense strand mismatch?
Predominant in mammalian cells
and in S2 cells if non-phosphorylated
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7.8 Probing ES cells with siRNAs
The original intention of the experimental work presented above relating to the biology of RNA
interference in mammalian cells was to explore the application of this technology for the purpose
of analysing gene function specifically in embryonic stem cells. As outlined previously, the
knockdown of discrete genes using sequence specific siRNAs is a versatile tool for probing gene
function since it permits a tight correlation between phenotype and genotype. Given appropriate
methods of phenotypic analysis in the case of embryonic stem cells, siRNA technology represents
a powerful method for dissecting out the function of differentiation genes that play key roles
during early development. The demonstration that siRNAs operate to induce gene knockdown in
embryonic stem cells, as they do in other more tractable mammalian cell lines, was the final goal
of this thesis.
A stepwise approach was taken with murine ES cells: firstly, the demonstration that siRNAs can
induce knockdown of a transiently expressed luciferase epigene in a manner that was qualitatively
identical to other mammalian cell lines (see figure 6.2); secondly, that siRNAs can induce
knockdown a stably expressed GFP transgene introduced by random genomic integration (see
figure 6.3); and thirdly, that siRNAs can induce knockdown of stably expressed P-galactosidase
transgene that had been targeted to the physiologically active Oct3/4 locus (see figure 6.5). This
latter experiment also served to confirm that the siRNA-induced knockdown is clonally inherited
through several cell divisions, that knockdown is specific to the gene targeted and not the allelic
locus, and that failure of knockdown arises stochastically for reasons either technical or biological
(see figure 6.6).
Thus, it is clear that RNA interference does indeed operate in murine ES cells and this conclusion
is consistent with other evidence published contemporaneously with this work (Refs: Yang S. et
al., 2001; Zou G.M. et al., 2003; Hay D.C. et al., 2004; and Tang F.C. et al., 2004).
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In light of the earlier results suggesting that siRNAs act at a transcriptional level in mammalian
cells, experiments were devised to investigate the possibility that siRNA-induced gene knockdown
might lead to permanent epigenetic silencing of the targeted locus. These experiments aimed to
derive mutant "knockout" clones using negative selection of ES cells transfected with siRNAs
specific for the purine and pyrimidine salvage pathway genes, Hprt and Tk respectively. In
neither case were such clones isolated (in excess of the spontaneous background rate) indicating
failure of siRNA-induced permanent silencing of the targeted gene locus (see figure 6.8).
Importantly, these experiments used coding sequence siRNAs and not promoter sequence siRNAs
used by other investigators to induce epigenetic modifications such as DNA methylation (Refs:
Morris K. V. et al., 2004; Kawasaki H. and Taira K., 2004).
When the foregoing experiment was performed in CHO cells, there was widespread cellular
apoptosis caused by Tk-specific siRNAs (see figure 6.9) and to a lesser extent Hprt-specific
siRNAs (see figure 6.10). This finding validated the biological activity of both these siRNAs,
compared with non-specific control siRNAs, and suggests critical dependency of CHO cells on
salvage pathway synthesis of nucleotides that is not the case for ES cells. If this result is also
borne out in tumour cell lines, then targeting of the Tk and Hprt genes using sequence-specific
siRNAs represents a feasible anti-cancer strategy that would target malignant cells but spare
normal cells. Such was the rationale likewise for targeted knockdown of telomerase activity in
human breast cancer cell lines using hTERT-specific siRNAs (see figure 6.7), although for reasons
that were not fully explored this experiment proved unsuccessful.
With regard to ES cells, three endogenous genes were targeted using siRNAs. Two of these were
putative stem cell genes expressed in undifferentiated ES cells, namely Ehox (Ref: Jackson M. et
al., 2002) and Esgl (Ref: Tanaka T.S. et al., 2002). However, for both these genes, sequence-
specific siRNAs failed to induce any discernible differentiation of ES cells grown in LIF-
containing medium (data not shown) and hence further experiments were not undertaken.
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The third endogenous gene chosen for siRNA-induced gene knockdown was the maintenance
methyltransferase gene Dnmtl, which is responsible for maintaining normal levels of genomic
methylation in undifferentiated ES cells. Here, serial transfection of ES cells using sequence-
specific siRNAs resulted in a small but significant loss (approximately 16.4%; p<0.001) of
methylated cytosines residing within CpG dinucleotides (see figure 6.12). Thus, siRNA-induced
knockdown of Dnmtl can induce modest genomic demethylation of ES cells even in the face of
continued expression of the de novo methyltransferase genes Dnmt3a and Dnmt3b. The use of a
combination of siRNAs that target all three of the DNA methyltransferase genes expressed in ES
cells might be expected to produce a more potent demethylating effect. Demethylating agents
such as azadeoxycytidine and zebularine have been shown to induce "reprogramming" of
differentiated cells and reversion of transformed cells suggesting that siRNA-induced knockdown
of Dnmt genes, commonly over-expressed in tumour cells, represents a further potential anti¬
cancer application of the RNAi technology (Refs: Gowher H. and Jeltsch A., 2004; Esteller M.
2005; Laird P.W., 2005).
7.9 Where is the siRNA site-of-action?
The experiments presented in this thesis sought to cast light on how siRNA molecules induce gene
silencing in mammalian cells. In particular, they were designed to determine the site-of-action of
the siRNA within the molecular chain of events that lead to gene expression. In this regard, do the
siRNA molecules act a post-transcriptional level by targeting the mRNA or at a transcriptional or
peri-transcriptional level involving the DNA possibly in association with the nascent RNA strand.
Clearly, the experimental results presented fail to resolve this issue but do nonetheless raise some
intriguing questions of their own. In particular, they uncover qualitative differences between
mammalian and Drosophila cells as well as intra-species differences between the cell lines. Most
notably, this relates to the discrepant way in which mammalian CHO cells and Drosophila KC
cells respond to co-transfection of the siRNA molecules together with the target mRNA reporter
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molecule: while in the KC cells the siRNAs silence the reporter, in CHO cells there is no
discernable reporter knockdown. This major qualitative difference points to fundamental
mechanistic discrepancies in the manner of action of siRNAs in mammalian cells as compared
with Drosophila cells. Obviously, it remains possible that these results have arisen on account of
the artificial nature of the experiment, for instance how the two species' cells handle transfected
mRNAs, but the fact that there are differences also between the two Drosophila lines would
perhaps argue against this.
How might this question of siRNA site-of-action be resolved? The most important experiment
that was not performed here is the nuclear run-on assay. This would identify the precise site of
action of the siRNA by distinguishing a transcriptional level of interference from a post-
transcriptional/translational level based upon incorporation of radio-labelled nucleotides into
nascent mRNA strands in isolated nuclei and subsequent autoradiography. In the former case,
mRNA transcripts would cease to be produced upon siRNA action while in the latter, they would
continue to be produced and then destroyed by siRNA-induced strand cleavage. Thus, the nuclear
run-on assay represents a key future experiment that might be applied to the siRNA/plasmid co-
transfection knockdown assay.
Another obvious strategy for discerning the site of action of the siRNA-induced interference might
be to knockdown endogenous genes using siRNAs that target splice junction sites that bridge
introns. Such siRNAs, it would be predicted, should only induce gene knockdown if their site-of-
action occurs after splicing of the hnRNA into mRNA. In other words, it would confirm a post-
transcriptional site-of-action. An alternative approach would be to use siRNAs to target non-
coding promoter regions that are not transcribed into mRNA and therefore not relevant to post-
transcriptional gene knockdown. Indeed, such an experiment has been performed and shown to
lead to promoter methylation associated with gene silencing (Refs: Morris K. V. et al., 2004;
Kawasaki H. and Taira K., 2004).
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However, the phenomenon of siRNA-induced promoter methylation in mammalian cells remains
somewhat contentious. The debate has been fuelled lately by the partial retraction of one of the
papers originally claiming to show this phenomenon (Ref: Kawasaki H. and Taira K., 2006).
Interestingly, one final experiment presented in this thesis might have some bearing on this matter.
This is the demonstration that siRNAs are able to induce knockdown of a luciferase reporter gene
even in cells lacking DNA methyltransferase activity through targeted deletion of both the
maintenance methyltransferase Dnmtl or the de novo methyltransferases Dnmt3a and Dnmt3b
(see figure 6.11).
Thus, based on these results, siRNA-induced knockdown in mammalian cells does not appear to
be contingent upon methyltransferase activity. A similar conclusion has been borne out by other
investigators who have targeted promoter regions of endogenous genes using the same
methyltransferase deficient ES cells as used here (Ref: Ting A.H. et al., 2005).
7.10 Conclusion
This thesis aimed to explore two novel strategies, antisense gene trapping and RNA interference,
for elucidation of gene function in mammalian cells and in particular sought to apply them to
biological analysis of the murine embryonic stem cell. The antisense gene trapping strategy was
applied using a classical forward genetic approach in an attempt to identify putative differentiation
genes in ES cells. By contrast, the RNA interference strategy was applied using a reverse genetic
approach using sequence-specific short interfering RNAs to manipulate discrete genes both in ES
and other mammalian cells. Thus, antisense gene trapping is essentially a phenotype-based
strategy while RNA interference is essentially a genotype-based strategy. The former is inherently
a more powerful approach for genetic analysis but is wholly dependent upon the effectiveness of
the phenotypic screen. The latter, by contrast, requires prior gene sequence knowledge and as
such is a timely new technology in the post-genomic era.
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The functional dissection of the mammalian genome represents the overarching goal of
contemporary molecular biology. Antisense gene trapping and RNA interference represent two
complementary methodologies, each with its own strengths and weaknesses relative to the other.
At the heart of both these processes is double-stranded RNA suggesting that there might exist a
commonality in their respective molecular mechanisms. Such a possibility, namely that RNA
antisense and RNA interference represent different facets of the same cellular process, represents
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